<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html40/strict.dtd">
<!-- Created from PDF via Acrobat SaveAsXML -->
<!-- Mapping table version: 28-February-2003 -->
<HTML>
<HEAD>
<META http-equiv="Content-Type" content="text/html; charset=UTF-8">
<STYLE type="text/css">
DIV[class="Part"] {
 text-align:left;
 margin-bottom:0px;
 margin-top:0px;
 margin-right:0px;
 text-indent:0px;
 direction:ltr
}
H1 {
 text-align:center;
 margin-bottom:67px;
 margin-top:0px;
 margin-right:0px;
 text-indent:0px;
 direction:ltr;
 line-height:38px
}
SPAN {
 font-family:'Arial','Helvetica',sans-serif;
 font-size:24pt;
 font-style:normal;
 font-weight:bold
}
P {
 text-align:center;
 margin-bottom:67px;
 margin-top:0px;
 margin-right:0px;
 text-indent:0px;
 direction:ltr;
 line-height:22px
}
DIV[class="Sect"] {
 text-align:left;
 margin-bottom:0px;
 margin-top:0px;
 margin-right:0px;
 text-indent:0px;
 direction:ltr
}
H3 {
 text-align:center;
 margin-bottom:98px;
 margin-top:0px;
 margin-right:0px;
 text-indent:0px;
 direction:ltr;
 line-height:22px
}
IMG {
 text-align:left;
 vertical-align:top;
 margin-bottom:101px;
 margin-top:0px;
 margin-right:0px;
 margin-left:0px;
 direction:ltr
}
UL {
list-style-type:disc;
 text-align:left;
 margin-bottom:0px;
 margin-top:0px;
 margin-right:0px;
 text-indent:0px;
 direction:ltr
}
LI {
 list-style-type:disc;
 text-align:left;
 margin-bottom:8px;
 margin-top:0px;
 margin-right:48px;
 margin-left:16px;
 text-indent:-15px;
 direction:ltr
}
DT {
 text-align:left;
 margin-bottom:8px;
 margin-top:0px;
 margin-right:48px;
 margin-left:16px;
 text-indent:-15px;
 direction:ltr
}
DD {
 text-align:left;
 margin-bottom:8px;
 margin-top:0px;
 margin-right:48px;
 margin-left:16px;
 text-indent:-15px;
 direction:ltr
}
H4 {
 text-align:justify;
 margin-bottom:16px;
 margin-top:0px;
 margin-right:0px;
 text-indent:0px;
 direction:ltr
}
TABLE {
 border-width:thin;
 border-collapse:collapse;
 padding:3px;
 text-align:center;
 vertical-align:top;
 margin-bottom:11px;
 margin-top:0px;
 margin-right:0px;
 margin-left:0px;
 direction:ltr;
 width:auto;
 height:auto;
 display:table;
 float:none
}
TR {
 vertical-align:top;
 height:auto
}
TH {
 text-align:left;
 vertical-align:top
}
TD { 
 text-align:left;
 vertical-align:middle
}
CAPTION {
 text-align:left;
 margin-bottom:0px;
 margin-top:0px;
 margin-right:0px;
 text-indent:0px;
 direction:ltr
}
</STYLE>
<META
 name="dc.creator"
 content="Kathy Brethauer" >
<META
 name="dc.title"
 content="Report 07.pm" >
<META
 name="dc.date"
 content="2008-06-11T15:39:09Z" >
<META
 name="generator"
 content="Adobe Acrobat Exchange-Pro 9.1.3" >
</HEAD>
<BODY bgcolor=white text=black link=blue vlink=purple alink=fushia >
<DIV class="Part"
><H1>
<SPAN style="color:#000000"
>2007 ANNUAL REPOR</SPAN
><SPAN style="color:#000000"
>T 
</SPAN
><SPAN style="color:#000000"
>ESRD CLINICAL PERFORMANC</SPAN
><SPAN style="color:#000000"
>E 
</SPAN
><SPAN style="color:#000000"
>MEASURES PROJEC</SPAN
><SPAN style="color:#000000"
>T 
</SPAN
></H1>
<P>
<SPAN style="font-size:14pt; color:#000000"
>OPPORTUNITIE</SPAN
><SPAN style="font-size:14pt; color:#000000"
>S 
</SPAN
><SPAN style="font-size:14pt; color:#000000"
>TO IMPROVE CARE FO</SPAN
><SPAN style="font-size:14pt; color:#000000"
>R 
</SPAN
><SPAN style="font-size:14pt; color:#000000"
>IN-CENTER HEMODIALYSI</SPAN
><SPAN style="font-size:14pt; color:#000000"
>S 
</SPAN
><SPAN style="font-size:14pt; color:#000000"
>AND PERITONEAL DIALYSI</SPAN
><SPAN style="font-size:14pt; color:#000000"
>S 
</SPAN
><SPAN style="font-size:14pt; color:#000000"
>PATIENT</SPAN
><SPAN style="font-size:14pt; color:#000000"
>S 
</SPAN
></P>
<DIV class="Sect">
<H3>
<SPAN style="font-size:14pt; color:#000000"
>DECEMBER 200</SPAN
><SPAN style="font-size:14pt; color:#000000"
>7 
</SPAN
></H3>
<DIV class="Sect">
<IMG width=151 height=141 style="display:block; float:none" src="images/ESRDCPMYear2007Report_img_0.jpg">
</DIV>
<P style="margin-bottom:131px; line-height:19px">
<SPAN style=" font-weight:normal"
><IMG style="vertical-align:text-bottom; margin-bottom:131px" src="images/ESRDCPMYear2007Report_img_1.jpg" >
</SPAN
><SPAN style="font-size:14pt; font-weight:normal; color:#000000"
>Department of Health and Human Service</SPAN
><SPAN style="font-size:14pt; font-weight:normal; color:#000000"
>s 
</SPAN
><SPAN style="font-size:12pt; font-weight:normal; color:#000000"
>Centers for Medicare &amp; Medicaid Service</SPAN
><SPAN style="font-size:12pt; font-weight:normal; color:#000000"
>s 
</SPAN
><SPAN style="font-size:12pt; font-weight:normal; color:#000000"
>Office of Clinical Standards &amp; Qualit</SPAN
><SPAN style="font-size:12pt; font-weight:normal; color:#000000"
>y 
</SPAN
><SPAN style="font-size:12pt; font-weight:normal; color:#000000"
>Baltimore, Marylan</SPAN
><SPAN style="font-size:12pt; font-weight:normal; color:#000000"
>d 
</SPAN
></P>
<P style="margin-bottom:0px; line-height:24px">
<SPAN style="font-size:11pt; font-weight:normal; color:#000000"
>Data on adult and pediatric in-center hemodialysis patients are from October–December 200</SPAN
><SPAN style="font-size:11pt; font-weight:normal; color:#000000"
>6 
</SPAN
><SPAN style="font-size:11pt; font-weight:normal; color:#000000"
>Data on adult and pediatric peritoneal dialysis patients are from October 2006–March 200</SPAN
><SPAN style="font-size:11pt; font-weight:normal; color:#000000"
>7 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:29px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Suggested citation for this Report is as follows: </SPAN
></P>
</DIV>
<P style="text-align:justify; margin-bottom:164px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Centers for Medicare &amp; Medicaid Services. 2007 Annual Report, End Stage Renal Disease Clinical Performance Measures Project.  Department of Health and Human Services, Centers for Medicare &amp; Medicaid Services, Office of Clinical Standards &amp; Quality, Baltimore, Maryland, December 2007. </SPAN
></P>
<P style="text-align:justify; margin-bottom:76px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Note: The clinical data collected for the 2007 ESRD Clinical Performance Measures Project were from the time period of October–December 2006 for the in-center hemodialysis patients and October 2006–March 2007 for the peritoneal dialysis patients. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:11pt; color:#000000"
>2008 Data Collection Effort </SPAN
></P>
</DIV>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>In 2008, we will again collect data for the ESRD Clinical Performance Measures on a national sample of adult in-center hemodialysis and peritoneal dialysis patients and all pediatric in-center hemodialysis and peritoneal dialysis patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:218px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Any questions about the Project may be addressed to your ESRD Network staff (APPENDIX 1). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Look for this Report, as well as other ESRD Clinical Performance Measures Project and Core Indicators Project Reports, on the Internet at: </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>www.cms.hhs.gov/CPMProject</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Copyright Information: All material appearing in this Report is in the public domain and may be reproduced or copied without permission; citation of the source, however, is appreciated. </SPAN
></P>
<P style="margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>TABLE OF CONTENT</SPAN
><SPAN style="font-size:12pt; color:#000000"
>S 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px; text-indent:-159px; line-height:18px">
<SPAN style="font-size:12pt; color:#000000"
>SECTIO</SPAN
><SPAN style="font-size:12pt; color:#000000"
>N 	</SPAN
><SPAN style="font-size:12pt; color:#000000"
>TITLE ........................................................................................................PAG</SPAN
><SPAN style="font-size:12pt; color:#000000"
>E 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Table of Contents ...............................................................................................................................</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>3 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Acknowledgments/Acronyms.............................................................................................................</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>4 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>I</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>INTRODUCTION ...............................................................................................................................</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>5 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>II</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>BACKGROUND AND PROJECT METHODS....................................................................................</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>6 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>A. Medicare’s ESRD Program ...........................................................................................................</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>6 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>B. Project Methods ............................................................................................................................</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>7 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>C. Sample Selection ..........................................................................................................................</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>7 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>D. Report Format .............................................................................................................................1</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>0 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>III</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>CLINICAL PERFORMANCE MEASURES (CPMs) .........................................................................1</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>IV</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>OTHER SIGNIFICANT FINDINGS AND TRENDS ..........................................................................1</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>6 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>V</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ADULT IN-CENTER HEMODIALYSIS PATIENTS ...........................................................................2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>3 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>A. Adequacy of Hemodialysis CPMs ...............................................................................................2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>3 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>B. Adequacy of Hemodialysis Tables ...............................................................................................2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>3 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>C. Vascular Access CPMs ...............................................................................................................2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>5 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>D. Vascular Access Tables ...............................................................................................................2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>5 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>E. Anemia Management  CPMs ......................................................................................................2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>8 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>F. Anemia Management Tables ........................................................................................................2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>8 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>G. Serum Albumin Table ..................................................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>1 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>VI</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ADULT PERITONEAL DIALYSIS PATIENTS ...................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>A. Adequacy of Peritoneal Dialysis CPMs.......................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>B. Adequacy of Peritoneal Dialysis Tables .......................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>3 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>C. Anemia Management  CPMs ......................................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>4 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>D. Anemia Management Table .........................................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>4 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>E. Serum Albumin Table ..................................................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>5 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>VII</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>PEDIATRIC IN-CENTER HEMODIALYSIS PATIENTS ....................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>6 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>A. Clearance Table ..........................................................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>6 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>B. Vascular Access Table ................................................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>7 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>C. Anemia Management Table.........................................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>7 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>D. Serum Albumin Table ..................................................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>8 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>VIII</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>PEDIATRIC PERITONEAL DIALYSIS PATIENTS............................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>9 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>A. Clearance Table ..........................................................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>9 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>B. Anemia Management Table.........................................................................................................3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>9 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>C. Serum Albumin Table ..................................................................................................................4</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>0 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>IX</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>REFERENCES ................................................................................................................................4</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>1 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>X</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>LIST OF TABLES AND FIGURES ...................................................................................................4</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:178px; text-indent:-17px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>1</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>List of Tables ...............................................................................................................................4</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:178px; text-indent:-17px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>List of Figures..............................................................................................................................4</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>4 
</SPAN
></P>
<P style="margin-bottom:0px; margin-left:136px; text-indent:-135px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>XI</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>APPENDICES .................................................................................................................................4</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>5 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>1. Centers for Medicare &amp; Medicaid Services (CMS) Offices and ESRD Networks ........................4</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>5 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:178px; text-indent:-17px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>.	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  ESRD CPMs for 2007 Data Collection Effort ..............................................................................4</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>7 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:160px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>3. 2007 CPM Data Collection Form – In-Center Hemodialysis .......................................................5</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:178px; text-indent:-17px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>4</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2007 CPM Data Collection Form – Peritoneal Dialysis...............................................................5</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>8 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:178px; text-indent:-17px; line-height:18px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>5</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>.	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  2007 National CPM Data Collection, Adult In-Center Hemodialysis Patients –     National and Network Profiles ....................................................................................................64 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:178px; text-indent:-17px; line-height:18px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>6</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>.	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  2007 ESRD CPM Outcome Comparison Tool – Adult In-Center Hemodialysis Patients ............6</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>7
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:178px; text-indent:-17px; line-height:18px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 7</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>.	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  2007 ESRD CPM Outcome Comparison Tool – Adult Peritoneal Dialysis Patients....................6</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>8 
</SPAN
></P>
<P style="margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>ACKNOWLEDGMENT</SPAN
><SPAN style="font-size:12pt; color:#000000"
>S 
</SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The Centers for Medicare &amp; Medicaid Services (CMS) wishes to acknowledge the following groups and persons without whose efforts this Report would not have been possible: </SPAN
></P>
<ul style="list-style-type:disc">
<LI>
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The eighteen ESRD Network Organizations throughout the United States (See Appendix 1). </SPAN
></LI>
<DIV class="Sect">
<DL class="unexpected-ListItem">
<DT>
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
></DT>
<DD>
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The following CMS Central Office staff:  Jacqueline Abt. </SPAN
></DD>

</DIV>
<LI style="line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The following staff at FMQAI: The Florida ESRD Network:  Kelly Mayo, Executive Director; Christain Campbell, Study Director; and Harold Anthony Seabrook, IT Analyst. </SPAN
></LI>
<LI style="line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The following staff at The Renal Network, Inc.:  Susan A. Stark, Executive Director; Bridget Carson, Assistant Director; Raynel Kinney, RN, CNN, CPHQ, QI Director; and Rick Coffin, Program Analyst. </SPAN
></LI>
<LI style="line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The staff at more than 3,500 dialysis facilities in the United States who abstracted the requested information from medical records on more than 8,000 adult in-center hemodialysis, adult peritoneal dialysis, and pediatric in-center hemodialysis and peritoneal dialysis patients. </SPAN
></LI>
<LI style="margin-bottom:36px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The many other individuals in the renal community and CMS who contributed to this work. </SPAN
></LI>
</ul>
<P style="margin-bottom:16px; line-height:19px">
<SPAN style="font-size:12pt; color:#000000"
>ACRONYM</SPAN
><SPAN style="font-size:12pt; color:#000000"
>S 
</SPAN
><SPAN style="font-size:12pt; color:#000000"
>List of Commonly Used Acronym</SPAN
><SPAN style="font-size:12pt; color:#000000"
>s 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:-5px; line-height:22px">
<SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; color:#000000"
>AM </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>AV</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Arterio Venous </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>AVF</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Arteriovenous Fistula </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>BBA</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Balanced Budget Act </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>BCG </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Bromcresol Green Laboratory Method </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>BCP</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Bromcresol Purple Laboratory Method </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>BSA</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Body Surface Area </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>BUN</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Blood Urea Nitrogen </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>CAPD</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Continuous Ambulatory Peritoneal Dialysis </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>CCPD</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Continuous Cycling Peritoneal Dialysis </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>CI </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Confidence Interval </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>CIP </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Core Indicators Project </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>CMS </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Centers for Medicare &amp; Medicaid Services </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>CPM</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Clinical Performance Measure </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>CQI</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Continuous Quality Improvement </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>CrCl</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Creatinine Clearance </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>DM </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Diabetes Mellitus </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>DOQI</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Dialysis Outcomes Quality Initiative </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>D/P Cr Ratio </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Dialysate/Plasma Creatinine Ratio </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>ESA </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Erythropoetin Stimulating Agents </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>ESRD </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>End-Stage Renal Disease </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>FSGS</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Focal and Segmental Glomerulosclerosis </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>GFR </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Glomerular Filtration Rate </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>HCFA </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Health Care Financing Administration </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>HCQIP</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Health Care Quality Improvement Program </SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
><SPAN style="font-size:9.5pt"
>HD </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal"
>Hemodialysis </SPAN
><SPAN style="font-size:9.5pt"
>Hgb</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal"
> Hemoglobin </SPAN
><SPAN style="font-size:9.5pt"
>IV </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal"
>Intravenous </SPAN
><SPAN style="font-size:9.5pt"
>K/DOQI</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal"
>  Kidney Disease Outcomes Quality Initiative </SPAN
><SPAN style="font-size:9.5pt"
>Kt/V or Kt/V</SPAN
><SPAN style="font-size:5.5pt"
><Sub>urea </Sub></SPAN
>Urea Clearance x Time/the Volume of </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:22px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Distribution of Urea (fractional clearance of urea) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>LDO </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Large Dialysis Organization </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>NIH</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> National Institutes of Health </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>NIPD</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Nightly Intermittent Peritoneal Dialysis </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>NKF </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>National Kidney Foundation </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>PET </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Peritoneal Equilibration Test </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>PD </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Peritoneal Dialysis </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>QA </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Quality Assurance </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>QI</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Quality Improvement </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>RRF</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Residual Renal Function </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>SD</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Standard Deviation </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>SI Units</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Systéme International Units </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>SLE</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Systemic Lupus Erythematosis </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>SPSS</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Statistical Package for the Social Sciences </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>spKt/V</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Single-Pool Kt/V </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>TSAT</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Transferrin Saturation </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>UKM </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Urea Kinetic Modeling </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>URR</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Urea Reduction Ratio </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>USRDS</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> United States Renal Data System </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>VA</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Vascular Access </SPAN
></P>
</DIV>
<DIV class="Sect">
<DIV class="Sect">
<H4>
<SPAN style="font-size:12pt; color:#000000"
>I.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  INTRODUCTION </SPAN
></H4>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The ESRD Clinical Performance Measures (CPM) Project, now in its fourteenth year, is a national effort led by the Centers for Medicare &amp; Medicaid Services (CMS) and its eighteen ESRD Networks to assist dialysis providers to improve patient care and outcomes. Since 1994 the Project has documented continued improvements, specifically in the areas of adequacy of dialysis and anemia management. The providers of dialysis services are to be commended for their ongoing efforts to improve patient care. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The 2007 ESRD CPM Annual Report describes the findings of several important clinical measures and/or characteristics of a nationally representative random sample of adult (aged </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years) in-center hemodialysis patients and peritoneal dialysis patients. This report also includes the findings for all in-center hemodialysis and peritoneal dialysis patients aged &lt; 18 years. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The most recent data described in this Report are from the 2007 study period which includes the months of October-December 2006 for the in-center hemodialysis patients and October 2006</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>March 2007 for the peritoneal dialysis patients.This Report also compares the 2007 study period findings to findings from previ</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ous study periods AND it identifies opportunities to improve care for dialysis patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:29px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The full Report can be found on the Internet at </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>www.cms.hhs.gov/CPMProject. </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>NOTE:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Highlights of important findings from the 2007 ESRD CPM Project may be found on the following pages: </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>CPM highlights for adult hemodialysis patients, page 14 </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; margin-right:38px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>CPM highlights for adult peritoneal dialysis patients, page 15 </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; margin-right:30px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Selected significant findings for adult in-center hemo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>dialysis patients, page 19 </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; margin-right:18px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Selected significant findings for adult peritoneal dialysis patients, page 20 </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; margin-right:10px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Selected significant findings for pediatric in-center hemo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>dialysis patients, page 21 </SPAN
></P>
<P style="text-align:justify; margin-bottom:25px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Selected significant findings for pediatric peritoneal dialysis patients, page 22 </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>This Report contains some features or tools to assist dialysis providers in using the information from this Project. Appendices 6 and 7 (pages 67 and 68) contain Outcomes Comparison Tools (one for hemodialysis and one for peritoneal dialysis) that pro<SPAN style="font-size:9.5pt; font-weight:normal"
></SPAN
>viders can download and use to record their facility-specific re<SPAN style="font-size:9.5pt; font-weight:normal"
></SPAN
>sults for comparisons to national and ESRD Network findings (ESRD Network rates are only available for hemodialysis). (Note: Each provider will have to calculate its own facility-specific re<SPAN style="font-size:9.5pt; font-weight:normal"
></SPAN
>sults to record on this tool.) Even though the national and ESRD Network hemodialysis findings included in this Report are from the time period October – December 2006 (national peritoneal dialysis findings are from the time period October 2006 – March </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2007), the facility data that you calculate and enter on this form can be from any time period. Appendix 5 provides you with some ESRD Network-level hemodialysis findings that you can use to record on your ESRD Network’s Outcomes Comparison Tool (Appendix 6).We encourage dialysis facilities to use these tools. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>Background and Project Methods</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> section beginning on page 6, provides information on the Medicare ESRD program and why the ESRD CPM Project was initiated. Patient selection criteria and data collection and analysis methodologies are also described. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>ESRD Clinical Performance Measures (CPMs)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> section beginning on page 12, has a short summary of each CPM col</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lected for this project as well as a brief summary of the 2007 CPM findings. Appendix 2 (page 47) provides a more detailed description of each CPM. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>Other Significant Findings and Trends</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> section begin</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ning on page 16, provides highlights of important findings from the 2007 ESRD CPM Project. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>Adult In-Center Hemodialysis Patients, Adult Peritoneal Dialysis Patients, Pediatric In-Center Hemodialysis Patients and Pediatric Peritoneal Dialysis Patients</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> sections describe the CPM findings for each cohort for the 2007 study period and display tables depicting other findings. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>This Report provides the dialysis community with an initial look at ESRD Network and national profiles for the clinical measures that were collected for the ESRD CPM Project.While significant improvements in care have occurred, the opportunities to im</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>prove care for dialysis patients in the U.S. in the areas of ad</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>equacy of dialysis, vascular access, and anemia management continue.  Every dialysis caregiver should be familiar with the clinical practice guidelines developed by the Renal Physicians Association (1) and the National Kidney Foundation Kidney Dis</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ease Outcomes Quality Initiative (NKF-K/DOQI) (2-5). Your ESRD Network staff and Medical Review Board are also avail</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>able to assist you in identifying opportunities for improvement. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>In the future, the ESRD Networks, in collaboration with dialysis facilities, will continue to assess the ESRD CPMs for dialysis patients in the U.S. The purpose of this effort will be to assess improvement in care and to encourage further improvements. The ultimate goal is to improve patient care and outcomes for all ESRD patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Serum Albumin </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Although serum albumin is not a CPM for this data collection period, it is one of the original core indicators and was chosen as an indicator for assessing mortality risk for adult in-center hemodialysis patients and adult peritoneal dialysis patients. Lower serum albumin values have been shown to be associ<SPAN style="font-size:9.5pt; font-weight:normal"
></SPAN
>ated with diminished survival (6-8).This project collects the se<SPAN style="font-size:9.5pt; font-weight:normal"
></SPAN
>rum albumin value as well as the test method, (bromcresol green [BCG] method and bromcresol purple [BCP] method), because these two methods are commonly used for determining serum albumin concentrations and have been reported to yield sys<SPAN style="font-size:9.5pt; font-weight:normal"
></SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tematically different results—the BCG method yielding higher serum albumin concentrations than the BCP method (9). </SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For the history of this project, mean serum albumin values </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5 g/dL (35 g/L) by the BCG method have been defined as an indicator of inadequate serum albumin. Since the percent of mean serum albumin values &lt; 3.2 g/dL (32 g/L) by the BCP method was nearly the same as the percent of mean serum albumin values &lt; 3.5 g/dL (35 g/L) by the BCG method, we have historically for the purpose of this report also defined a BCP result &lt; 3.2 g/dL (32 g/L) as an indicator of inadequate serum albumin. In June 2000, the NKF-K/DOQI Guidelines for Nutrition in Chronic Renal Failure were published. Guideline 3 of the Clinical Practice Guidelines states that a pre-dialysis or stabilized serum albumin equal to or greater than the lower limit of normal range (approximately 4.0 g/dL [40 g/L] for the bro</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>mcresol green method) is the outcome goal (10). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Findings from this project allow us to report the percent of patients with mean serum albumin values </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0 g/dL (40 g/L) (BCG method) or </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.7 g/dL (37 g/L) (BCP method) and the percent of patients with mean serum albumin values </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5 g/dL (35 g/L) (BCG method) or </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.2 g/dL (32 g/L) (BCP method) for adult hemodialysis patients in each ESRD Network area and nationally, and nationally for adult peritoneal dialysis patients, pediatric hemodialysis, and pediatric peritoneal dialysis patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-right:18px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Pediatric In-Center Hemodialysis and Peritoneal Dialysis Patients </SPAN
></P>
<P style="text-align:justify; margin-bottom:44px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Although there are no CPMs established for the pediatric age group, demographic and clinical information from October-December 2006 were collected on all hemodialysis patients aged &lt; 18 years and from October 2006-March 2007 on all perito</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>neal dialysis patients aged &lt; 18 years in the U.S. in order to describe several core indicators of dialysis care. These core indicators include dialysis clearance, vascular access (hemodi</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>alysis only), anemia management, and serum albumin. </SPAN
></P>
<dl>
<DT style="list-style-type:none; text-align:justify; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:12pt; color:#000000"
>II.</SPAN
></DT>
<DD style="list-style-type:none; text-align:justify; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:12pt; color:#000000"
>  BACKGROUND AND PROJECT METHODS </SPAN
></DD>

<DT style="list-style-type:none; text-align:justify; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:11pt; color:#000000"
>A.</SPAN
></DT>
<DD style="list-style-type:none; text-align:justify; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:11pt; color:#000000"
>  MEDICARE’S ESRD PROGRAM </SPAN
></DD>

</dl>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The Social Security Amendments of 1972 (PL 92-603) extended Medicare coverage to individuals with end-stage renal disease (ESRD) or chronic kidney failure who require dialysis or a kid</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ney transplant to maintain life.To qualify for Medicare under the renal provision, a person must have ESRD and either be en</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>titled to a monthly insurance benefit under Title II of the Social Security Act (or an annuity under the Railroad Retirement Act); or be fully or currently insured under Social Security; or be the spouse or dependent child of a person who meets at least one of these last two requirements. There is no minimum age for eligibility under the renal disease provision. The incidence of treated ESRD in the United States is 347 per million population (11). As of December 31, 2006, there were 339,983 patients receiving dialysis therapy in the United States (12). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-right:10px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>ESRD Health Care Quality Improvement Program (HCQIP) </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The CMS, which oversees the Medicare program, contracts with 18 ESRD Network Organizations throughout the United States. The ESRD Networks stimulate and facilitate improvements in the quality of care for ESRD patients throughout the U.S. In 1994, CMS, with input from the renal community, reshaped the approach of the ESRD Network program to quality assurance and improvement in order to respond to the need to improve the care of Medicare ESRD patients (13). This approach was named the ESRD Health Care Quality Improvement Program (HCQIP). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The ESRD HCQIP gives the ESRD Networks and CMS an op</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>portunity to demonstrate that health care provided to Medicare beneficiaries with renal disease can be measurably improved. The HCQIP is based on the assumption that most health care providers welcome information and, where necessary, help in applying the tools and techniques of quality management (14). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>ESRD Core Indicators Project </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>One activity included in the ESRD HCQIP was the national ESRD Core Indicators Project (CIP). This project was initiated in 1994 as a national intervention approach to assist dialysis providers in the improvement of patient care and outcomes.The ESRD CIP was CMS’s first nationwide population-based project designed to assess and identify opportunities to improve the care of patients with ESRD (15). This project established the first consistent clinical ESRD database. The elements included in the database represent clinical measures thought to be in</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>dicative of key components of care surrounding dialysis. As such, the data points are considered “indicators” for use in trig</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>gering improvement activities.The ESRD CIP was merged with the ESRD CPM Project in 1999. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>ESRD Clinical Performance Measures Project </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Section 4558(b) of the Balanced Budget Act (BBA) of 1997 re</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>quired CMS to develop and implement by January 1, 2000, a method to measure and report quality of renal dialysis services provided under the Medicare program. To implement this legis</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lation, CMS funded the development of clinical performance measures (CPMs) based on the National Kidney Foundation (NKF) Dialysis Outcomes Quality Initiative (DOQI) Clinical Prac</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tice Guidelines (16-19). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For information regarding the development of the CPMs, refer to the 1999 Annual Report, End-Stage Renal Disease Clinical Performance Measures Project on the Internet at </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>www.cms.hhs.gov/esrdQualityImproveInit/08_Archives.asp </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>On March 1, 1999, the ESRD CIP was merged with the ESRD CPM Project, and this project is now known as the ESRD CPM Project. The ESRD CPMs are similar to the core indicators with the addition of measures for assessing vascular access. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>This 2007 ESRD CPM Project Annual Report provides the re<SPAN style="font-size:9.5pt; font-weight:normal"
></SPAN
>sults of the CPMs on a sample of adult in-center hemodialysis </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>patients and adult peritoneal dialysis patients. Findings on all pediatric (aged &lt; 18 years) in-center hemodialysis patients and all pediatric (aged &lt; 18 years) peritoneal dialysis patients are also included.The Report does not provide results on a dialysis facility-specific basis. The quality of dialysis services is reported for adult and pediatric in-center hemodialysis patients for the last quarter in 2006 and adult and pediatric peritoneal dialysis patients for the time period October 2006–March 2007. </SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>CMS and the ESRD Networks are committed to improving ESRD patient care and outcomes by providing tools that can be used by the renal community in assessing patient care processes and outcomes and by identifying opportunities for improvement. One of these tools includes data feedback reports based on the clinical information obtained from the ESRD CPM Project. We invite the renal community to provide us with ideas and feed</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>back as to ways CMS and the Networks can best help the com</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>munity to improve patient care. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>B.</SPAN
><SPAN style="font-size:11pt; color:#000000"
>  PROJECT METHODS </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The purpose of the ESRD CPM Project is to provide compara</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tive data to ESRD caregivers to assist them in assessing and improving the care provided to dialysis patients. The data col</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lected in 1994 (for the time period October-December 1993) established a baseline estimate for important clinical measures of care for adult in-center hemodialysis patients in the United States (20).  From 1994 to 1998, CMS collected ESRD data under the ESRD CIP. The purpose of these data collections was to determine whether patterns in these clinical measures had changed and if opportunities to improve care continued to exist (21-25). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The initial data collection effort for the ESRD CPMs was con</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ducted in 1999. This effort examined data from October–De</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>cember 1998 for adult  in-center hemodialysis patients, and from October 1998 to March 1999 for adult peritoneal dialysis pa</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tients. Information to calculate the CPMs was collected and fur</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ther opportunities to improve care were identified (26). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>This Report describes the findings from the ninth data collec</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tion effort for the ESRD CPMs which was conducted in 2007. Data were collected from October-December 2006 for adult and pediatric in-center hemodialysis patients, and from October 2006 -March 2007 for adult and pediatric peritoneal dialysis patients. These data help to determine if there are opportunities to im</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>prove care and to evaluate patterns of care across the nation. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>The Sample </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Annually, each ESRD Network conducts a survey of ESRD fa</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>cilities to validate the census of ESRD patients in the ESRD Network at the end of the calendar year. In April 2007, a listing of adult (aged </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years as of September 30, 2006) in-center hemodialysis and adult peritoneal dialysis patients who were alive and dialyzing on December 31, 2006, was obtained from each of the 18 ESRD Networks. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>From this universe of patients, a national random sample, strati<SPAN style="font-size:9.5pt; font-weight:normal"
></SPAN
>fied by ESRD Network, of adult in-center hemodialysis patients </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
><SPAN style="font-size:9.5pt; font-weight:normal"
>was drawn. The sample size of adult in-center hemodialysis patients was selected to allow estimation of a proportion with a 95% confidence interval (CI) around that estimate no larger than 10 percentage points (i.e., </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal"
> 5%) for ESRD Network-specific estimates of the key hemodialysis CPMs and other indicators. Additionally, a 30% over-sample was drawn to compensate for an anticipated non-response rate and to assure a large enough sample of the adult in-center hemodialysis patient population who were dialyzing at least six months prior to October 1, 2006. The final sample consisted of 8,937 adult in-center hemodialy</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal"
></SPAN
>sis patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The peritoneal dialysis patient sample included a random se</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lection of 5% of adult peritoneal dialysis patients in the nation. Additionally, a 10% over-sample was drawn to compensate for an anticipated non-response rate. The final sample consisted of 1,474 peritoneal dialysis patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All pediatric (aged &lt; 18 years) in-center hemodialysis patients in the U.S. (n = 720) and all pediatric peritoneal dialysis pa</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tients in the U.S. (n = 759) were included in the 2007 ESRD CPM Study. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>C. </SPAN
><SPAN style="font-size:11pt; color:#000000"
>SAMPLE SELECTION </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Data Collection </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Two data collection forms were used: a four-page in-center he</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>modialysis form and a four-page peritoneal dialysis form (Ap</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>pendices 3, 4); the use of these forms was authorized through the National Institutes of Health (NIH) clinical exemption pro</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>cess. Descriptive information on each selected patient and di</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>alysis facility was printed onto the data collection forms that were downloaded by ESRD Networks from a custom database application. If demographic information (e.g., name, date of birth, race) or clinical information (e.g., date that initial dialysis oc</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>curred) was incorrect, facility staff were asked to correct the information on the forms. Staff at ESRD facilities were also asked to abstract clinical information from the medical record of each selected patient, and were instructed to obtain ethnicity infor</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>mation from the patient. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Electronic data for some of the data elements were accepted from the large dialysis organizations (LDOs) (Fresenius Medi</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>cal Care N.A., Dialysis Clinic, Inc., and Davita, Inc.) The elec</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tronically submitted data were printed onto paper forms, and these paper forms were sent to facilities for sampled patients. Facility staff were instructed to supply the data not already pro</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>vided on the paper form. These updated paper collection forms were then forwarded to the appropriate ESRD Network, where data were reviewed for acceptability and manually entered us</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ing a custom database application. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Facilities that were not part of an LDO (non-LDO facilities) with one or more patients in the samples received a blank paper data collection form as in past study years. Clinical information contained in the medical record was abstracted for each patient in the adult hemodialysis sample and for all pediatric in-center hemodialysis patients who received in-center hemodialysis at any time during October, November, and December 2006. </SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Clinical information contained in the medical records was also abstracted for each patient in the adult peritoneal dialysis sample and for all pediatric peritoneal dialysis patients who were re</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ceiving peritoneal dialysis at any time during October 2006</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>March 2007. The completed data collection forms were then forwarded to the appropriate ESRD Network, where data were reviewed for acceptability and manually entered using a cus</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tom database application. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>In September 2007, each ESRD Network completed data entry of the forms.The data were then forwarded to CMS’s contractor where the data were aggregated and analyzed. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Adult In-Center Hemodialysis </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Initial analyses for the CPMs and other indicators focused on the following elements: paired pre- and post-dialysis BUN val</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ues with patient height and weight and dialysis session length (used to calculate spKt/V values); hemoglobin values; vascular access information; and serum albumin. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Inclusion of a case in the analysis file required that data be available for at least one of the months in the three-month project period, with at least one paired pre- and post-dialysis BUN, at least one hemoglobin, and at least one serum albumin.We were able to include for analysis 8,740 of the 8,937 patients from the sample (response rate = 97.8%) (TABLE 1). In the vascular ac</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>cess section, some findings are presented for incident patients (see definition of incident patients, Table 9 page 25) alone. Other findings in this section are presented for prevalent or all pa</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tients, which includes incident patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Characteristics regarding the gender, race, ethnicity, age, diag</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>nosis, and duration of dialysis (years) for these patients are shown in Table 2. As expected, the characteristics of this ran</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>dom sample were very similar to the characteristics of the over</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>all U.S. hemodialysis population (11). Data regarding erythropoetin stimulating agent (ESA) use, serum ferritin con</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>centrations, transferrin saturation, iron use, and actual time on dialysis were also analyzed. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For this Report, each patient’s mean value for the three-month project period was determined from the available data for the following items: spKt/V (calculated using the Daugirdas II for</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>mula [27]), dialysis session length,  hemoglobin, transferrin satu</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ration, serum ferritin concentration, and serum albumin. Because we had data from a stratified random sample of patients (i.e., a separate random sample from each of the 18 ESRD Networks), it was necessary to weight the collected data in order to obtain unbiased estimates of mean clinical values for the total popula</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tion. This weighting was done according to the proportion of each ESRD Network’s total population sampled. Aggregate na</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tional results shown in this report were derived from weighted data using Statistical Package for the Social Science (SPSS) software (28).ESRD Network-specific comparisons were derived from unweighted data. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>In 2005, CMS launched the Fistula First Breakthrough Initia</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tive. The goal of this initiative is to increase the percentage of patients using an AV Fistula as their access to at least 66% by </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 1:  </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Number of adult in-center hemodialysis patients in each Network in December 2006, sample size and response rate for the 2007 ESRD CPM Project. </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:8pt; color:#000000"
>Ntwk # HD Facs  # HD Pts # HD Facs  Pt Sample Accepted Response            Dec ‘06^  Dec ‘06  in Sample Size  Forms^^ Rate </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; color:#000000"
>1 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>158 10023 138 490 484 98.8% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>2 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>240 21370 178 502 486 96.8% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>3 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>150 13338 130 493 487 98.8% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>4 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>248 14048 196 493 485 98.4% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>5 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>303 18398 219 498 488 98.0% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>6 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>506 29831 295 501 490 97.8% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>7 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>313 17767 212 502 483 96.2% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>8 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>302 17405 224 498 488 98.0% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>9 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>408 22231 243 500 484 96.8% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>10 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>205 12932 154 498 479 96.2% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>11 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>376 19596 236 498 481 96.6% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>12 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>249 11198 188 492 476 96.7% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>13 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>264 12354 200 494 487 98.6% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>14 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>399 28258 266 500 485 97.0% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>15 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>237 14145 177 493 487 98.8% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>16 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>139 7890 117 483 480 99.4% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>17 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>183 15893 147 497 495 99.6% </SPAN
><SPAN style="font-size:9pt; color:#000000"
>18 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>261 25044 198 505 495 98.0% </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; color:#000000"
>Total 4941 311721 3518 8937 8740 97.8% </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^ Source:  ESRD Networks 1-18 Annual Reports, 2006. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^ A form was considered accepted if the patient met the selection criteria for inclusion in the study and if the data were provided for at least one of the months in the fourth quarter of 2006 for the following items: 1) hemoglobin; 2) paired pre- and post-dialysis BUN values; and 3) serum albumin value. </SPAN
></P>
<P style="text-align:left; margin-bottom:36px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Two or more monthly values for these clinical measures were available for 96% of patients for hemoglobin and 96% for serum albumin by either BCG or BCP method. Monthly hemoglobin values were available for 91% of patients. At least one monthly paired pre-and post-dialysis BUN value was available for 100% of the patients, and two or more were available for 95%. Monthly paired pre-and post-dialysis BUN values were available for 85% of patients. </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2010. Findings from this project allow us to report progress to</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>wards this goal. </SPAN
></P>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Adult Peritoneal Dialysis </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The initial analysis focused on the adequacy of peritoneal di</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>alysis CPMs, anemia management CPMs, and serum albumin values. Inclusion of a case for analysis required that the patient received peritoneal dialysis at least one month during the time period October 2006–March 2007, and that at least one hemo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>globin and at least one serum albumin value were reported dur</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ing the six-month study period. Of the 1,474 patients sampled, 1,433 patients were included in the sample for analysis (97.2% response rate) (TABLE 3). Selected patient characteristics of this sample for analysis were similar to the characteristics of the overall U.S. peritoneal dialysis population (TABLE 4). </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For this Report, each patient’s mean value for the six-month study period was determined from available data for the follow</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ing items: weekly Kt/V weekly creatinine clearance, hemo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; margin-left:127px">
<SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea,</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>globin, serum albumin, prescribed epoetin or darbepoetin dose, serum ferritin concentration, and transferrin saturation. Informa</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 2: </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> Characteristics of adult in-center hemodialysis patients in the 2007 ESRD CPM Project compared to those of all in-center hemodialysis patients in the U.S. in 2005. </SPAN
></P>
<TABLE>
<TR>
<TH colspan=2 style="width:106px; height:45px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>Patient  Characteristic</SPAN
></TH>
<TH colspan=5 style="width:140px; height:45px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>2007 CPM Sample              for Analysis # ^ % </SPAN
></TH>
<TH colspan=3 style="width:107px; height:45px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>All U.S. in 2005* # in 1,000s % </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:99px; height:24px; border-style: solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>TOTAL </SPAN
></TH>
<TD colspan=3 style="width:87px; height:24px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>8,740 </SPAN
></TD>
<TD colspan=3 style="width:59px; height:24px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>100 </SPAN
></TD>
<TD style="width:75px; height:24px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>311.9 </SPAN
></TD>
<TD colspan=2 style="width:32px; height:24px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>100 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:99px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER Male Female </SPAN
></TH>
<TD colspan=3 style="vertical-align:bottom; width:87px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4911 3829 </SPAN
></TD>
<TD colspan=3 style="vertical-align:bottom; width:59px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>56 44 </SPAN
></TD>
<TD style="vertical-align:bottom; width:75px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>169.9 142.0 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:32px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>54 46 </SPAN
></TD>
</TR>
<TR>
<TH colspan=3 style="width:145px; height:120px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>RACE American Indian/  Alaska Native Asian/Pacific Islander Black or African American White Other/Unknown </SPAN
></TH>
<TD colspan=2 style="vertical-align:bottom; width:45px; height:120px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>149 423 3185 4960 23 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:56px; height:120px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2 5 36 57 &lt;1 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:78px; height:120px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4.7 13.4 119.2 169.9 4.7 </SPAN
></TD>
<TD style="vertical-align:bottom; width:29px; height:120px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2 4 38 54 2 </SPAN
></TD>
</TR>
<TR>
<TH colspan=3 style="vertical-align:middle; width:145px; height:55px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>ETHNICITY Hispanic Non-Hispanic </SPAN
></TH>
<TD colspan=2 style="vertical-align:bottom; width:45px; height:55px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1253 7475 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:56px; height:55px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>14 86 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:78px; height:55px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>46.9 265.0 </SPAN
></TD>
<TD style="vertical-align:bottom; width:29px; height:55px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>15 85 </SPAN
></TD>
</TR>
<TR>
<TH colspan=3 style="width:145px; height:118px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>AGE GROUP (years) 18 - 49 50 - 59 60 - 64 65 - 69 70 - 79 80+ </SPAN
></TH>
<TD colspan=2 style="vertical-align:bottom; width:45px; height:118px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1858 1872 1018 997 1934 1060 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:56px; height:118px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>21 21 12 11 22 12 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:78px; height:118px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>69.0 66.3 36.2 36.4 67.1 37.0 </SPAN
></TD>
<TD style="vertical-align:bottom; width:29px; height:118px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>22 21 12 12 22 12 </SPAN
></TD>
</TR>
<TR>
<TH colspan=3 style="width:145px; height:88px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>CAUSE of ESRD Diabetes Mellitus Hypertension Glomerulonephritis Other/Unknown </SPAN
></TH>
<TD colspan=2 style="vertical-align:bottom; width:45px; height:88px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>3795 2293 848 1804 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:56px; height:88px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>43 26 10 21 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:78px; height:88px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>136.6 89.0 33.6 52.7 </SPAN
></TD>
<TD style="vertical-align:bottom; width:29px; height:88px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>44 29 11 17 </SPAN
></TD>
</TR>
<TR>
<TH colspan=6 style="vertical-align:bottom; width:191px; height:110px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>DURATION OF DIALYSIS (years) &lt; 0.5 1052 0.5 - 0.9 989 1.0 - 1.9 1608 2.0 - 2.9 1150 3.0 - 3.9 935 4.0 + 2924 </SPAN
></TH>
<TD style="vertical-align:bottom; width:54px; height:110px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>12 11 18 13 11 33 </SPAN
></TD>
<TD colspan=3 style="vertical-align:top; width:107px; height:110px"/>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> USRDS:  2007 Annual Data Report, Bethesda, MD, National Institutes of Health</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>, 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>2006. Table D.1</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>1 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^ Subgroup totals may not equal total due to missing dat</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>a 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: Percentages may not add up to 100% due to rounding</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tion on iron prescription and route of administration was col</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lected. The data are from a random sample, not stratified by ESRD Network; thus, only national aggregate data are reported. No ESRD Network-specific or facility-specific analyses were conducted. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>In 2006, the KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Peritoneal Dialysis Adequacy were updated and published. Guideline 2 (Peritoneal Dialysis Solute Clearance Targets and Measurements) of the Clinical Practice Guidelines for Peritoneal Dialysis Adequacy states for patients with and without renal kidney function the minimal “de-</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 3: </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> Number of adult peritoneal dialysis patients in each Network in December 2006, sample size and response rate for the 2007 ESRD CPM Project. </SPAN
></P>
<TABLE style="margin-bottom:11px">
<TR>
<TH colspan=2 style="width:126px; height:14px">
<SPAN style="font-size:9.5pt; color:#000000"
>Network  # PD Pts </SPAN
></TH>
<TH style="text-align:center; width:65px; height:14px">
<SPAN style="font-size:9.5pt; color:#000000"
>Sample </SPAN
></TH>
<TH style="text-align:center; width:86px; height:14px">
<SPAN style="font-size:9.5pt; color:#000000"
>Acceptable  </SPAN
></TH>
<TH style="text-align:center; width:72px; height:14px">
<SPAN style="font-size:9.5pt; color:#000000"
>Response</SPAN
></TH>
</TR>
<TR>
<TH colspan=2 style="width:126px; height:16px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
> Dec 2006 </SPAN
></TH>
<TH style="text-align:center; width:65px; height:16px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>Size </SPAN
></TH>
<TH style="text-align:center; width:86px; height:16px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>Forms^ </SPAN
></TH>
<TH style="text-align:center; width:72px; height:16px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>Rate </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:19px; border-style: solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>1 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:19px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1087 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:19px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>58 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:19px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>56 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:19px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>96.6% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>2 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1171 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>68 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>67 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>98.5% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>3 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>876 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>39 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>38 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>97.4% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>4 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>916 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>53 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>53 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>100.0% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>5 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1618 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>96 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>96 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>100.0% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>6 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2593 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>137 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>134 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>97.8% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>7 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1404 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>80 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>78 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>97.5% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>8 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1759 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>107 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>103 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>96.3% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>9 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2106 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>107 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>102 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>95.3% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>10 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1106 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>64 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>63 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>98.4% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>11 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1605 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>77 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>71 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>92.2% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>12 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1245 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>54 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>51 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>94.4% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>13 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1079 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>59 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>59 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>100.0% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>14 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2005 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>121 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>118 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>97.5% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>15 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1256 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>70 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>69 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>98.6% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>16 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1057 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>60 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>60 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>100.0% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>17 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1889 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>115 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>114 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>99.1% </SPAN
></TD>
</TR>
<TR>
<TH style="width:53px; height:19px">
<SPAN style="font-size:9pt; color:#000000"
>18 </SPAN
></TH>
<TD style="text-align:center; width:74px; height:19px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2011 </SPAN
></TD>
<TD style="text-align:center; width:65px; height:19px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>109 </SPAN
></TD>
<TD style="text-align:center; width:86px; height:19px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>101 </SPAN
></TD>
<TD style="text-align:center; width:72px; height:19px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>92.7% </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:bottom; width:53px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>TOTAL </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:74px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>26783 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:65px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>1474 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:86px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>1433 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:72px; height:16px">
<SPAN style="font-size:9pt; color:#000000"
>97.2% </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:justify; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>A form was considered acceptable if the patient met the selection criteria for inclu</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>sion in the study and if data were provided at least once during the six-month study period for hemoglobin and serum albumin. </SPAN
></P>
<P style="text-align:left; margin-bottom:12px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Two or more values were available for 98% of patients for hemoglobin and 97% for serum albumin by either BCG or BCP methods. Three hemoglobin values were available for 82% of patients; three serum albumin values were available for 84% of patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>livered” dose of total small-solute clearance should be a total (peritoneal and kidney) Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>of at least 1.7 per week (29). Findings from this project allow us to report the percent of pa</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tients with mean Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>values </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.7 per week nationally for adult peritoneal dialysis patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Pediatric In-Center Hemodialysis Patients </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Inclusion of a pediatric in-center hemodialysis record for analy</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>sis required that data were available for at least one of the months in the three-month project period, with at least one paired pre-and post-dialysis BUN, at least one hemoglobin, and at least one serum albumin. Of the 720 pediatric hemodialysis patients, 681 patients were included in the sample for analysis (95%). Selected patient characterstics of this sample for analysis are shown in Table 5. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For this Report, each patient’s mean value for the three-month project period was determined from the available data for the following items: spKt/V, dialysis session length, hemoglobin, transferrin saturation, serum ferritin concentration, prescribed epoetin or darbepoetin dose, and serum albumin. Information on iron prescription and route of iron administration was col</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lected.The data were collected on all pediatric in-center hemo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>dialysis patients aged &lt; 18 years in the U.S. Only national ag</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>gregate data are reported. No ESRD Network-specific or facil</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ity-specific analyses were conducted. </SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 4</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>: Characteristics of adult peritoneal dialysis patients in the 2007 ESRD CPM Project compared to those of all peritoneal dialysis patients in the U.S. in 2005. </SPAN
></P>
<TABLE>
<TR>
<TH style="width:111px; height:46px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>Patient  Characteristics </SPAN
></TH>
<TH colspan=4 style="width:135px; height:46px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>2007 CPM Sample for Analysis #^ %</SPAN
></TH>
<TH colspan=2 style="width:105px; height:46px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>All U.S. in 2005* # in1,000s % </SPAN
></TH>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:142px; height:23px; border-style: solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>TOTAL </SPAN
></TH>
<TD style="width:43px; height:23px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>1,433 </SPAN
></TD>
<TD colspan=2 style="width:60px; height:23px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>100 </SPAN
></TD>
<TD style="width:74px; height:23px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>25.9 </SPAN
></TD>
<TD style="width:31px; height:23px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>100 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:142px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER Male Female </SPAN
></TH>
<TD style="vertical-align:bottom; width:43px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>744 689 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:60px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>52 48 </SPAN
></TD>
<TD style="vertical-align:bottom; width:74px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>13.4 12.5 </SPAN
></TD>
<TD style="vertical-align:bottom; width:31px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>52 48 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:142px; height:120px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>RACE American Indian/  Alaska Native Asian/Pacific Islander Black or African American White Other/Uknown </SPAN
></TH>
<TD style="vertical-align:bottom; width:43px; height:120px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>12 107 366 946 * </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:60px; height:120px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1 6 26 66 * </SPAN
></TD>
<TD style="vertical-align:bottom; width:74px; height:120px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>0.3 1.5 6.8 16.9 0.4 </SPAN
></TD>
<TD style="vertical-align:bottom; width:31px; height:120px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1 6 26 65 2 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:142px; height:55px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>ETHNICITY Hispanic Non-Hispanic </SPAN
></TH>
<TD style="vertical-align:bottom; width:43px; height:55px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>185 1246 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:60px; height:55px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>13 87 </SPAN
></TD>
<TD style="vertical-align:bottom; width:74px; height:55px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>3.3 22.6 </SPAN
></TD>
<TD style="vertical-align:bottom; width:31px; height:55px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>13 87 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:142px; height:118px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>AGE GROUP (years) 18 - 49 50 - 59 60 - 64 65 - 69 70 - 79 80+ </SPAN
></TH>
<TD style="vertical-align:bottom; width:43px; height:118px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>525 327 186 130 191 74 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:60px; height:118px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>37 23 13 9 13 5 </SPAN
></TD>
<TD style="vertical-align:bottom; width:74px; height:118px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>8.3 6.1 2.8 2.5 4.0 1.3 </SPAN
></TD>
<TD style="vertical-align:bottom; width:31px; height:118px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>32 24 11 10 15 5 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:142px; height:88px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>CAUSE of ESRD Diabetes Mellitus Hypertension Glomerulonephritis Other/Unknown </SPAN
></TH>
<TD style="vertical-align:bottom; width:43px; height:88px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>487 317 261 368 </SPAN
></TD>
<TD colspan=2 style="vertical-align:bottom; width:60px; height:88px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>34 22 18 26 </SPAN
></TD>
<TD style="vertical-align:bottom; width:74px; height:88px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>8.8 6.3 4.8 6.0 </SPAN
></TD>
<TD style="vertical-align:bottom; width:31px; height:88px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>34 24 19 23 </SPAN
></TD>
</TR>
<TR>
<TH colspan=4 style="vertical-align:bottom; width:191px; height:110px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>DURATION OF DIALYSIS (years) &lt; 0.5 159 0.5 - 0.9 221 1.0 - 1.9 324 2.0 - 2.9 211 3.0 - 3.9 147 4.0 + 357 </SPAN
></TH>
<TD style="vertical-align:bottom; width:54px; height:110px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>11 15 23 15 10 25 </SPAN
></TD>
<TD colspan=2 style="vertical-align:top; width:105px; height:110px"/>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:47px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*USRDS: 2007 Annual Data Report, Bethesda, MD, National Institutes of Health</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>, 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>2007. Table D.1</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>1 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^Subgroup totals may not equal total due to missing data</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: Percentages may not add up to 100% due to rounding</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Pediatric Peritoneal Dialysis Patients </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Inclusion of a pediatric peritoneal dialysis record for analysis required that the patient received peritoneal dialysis at least one month during the time period October 2006-March 2007 and that at least one hemoglobin value and at least one serum albumin value were reported during the six-month study period. Of the 759 pediatric peritoneal dialysis patients identified, 740 (97%) were included in the sample for analysis (TABLE 6). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For this Report, each patient’s mean value for the six-month study period was determined from available data for the follow</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ing items: weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>, weekly creatinine clearance, hemo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>globin, serum albumin, prescribed epoetin or darbepoetin dose, serum ferritin concentration, and transferrin saturation.  Infor</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>mation on iron prescription and route of administration was col</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lected.The data were collected on all pediatric peritoneal dialy</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>sis patients aged &lt; 18 years in the U.S. Only national aggregate data are reported. No ESRD Network-specific or facility-spe</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>cific analyses were conducted. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>In 2006, the KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Peritoneal Dialysis Adequacy were updated and published. Clinical Practice Recommenda</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tions for Guideline 6 (Pediatric Peritoneal Dialysis) states for patients with and without renal kidney function the minimal “de</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>livered” dose of total small-solute clearance should be a total (peritoneal and kidney) Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>of at least 1.8 per week (29). Findings from this project allow us to report the percent of pa</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tients with mean Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>values </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.8 per week nationally for pediatric peritoneal dialysis patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>D.</SPAN
><SPAN style="font-size:11pt; color:#000000"
>  REPORT FORMAT </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>This Report describes the clinical performance measures and other findings for both the adult in-center hemodialysis patient sample and the adult peritoneal dialysis patient sample for the following study periods: October–December 2006 for the adult in-center hemodialysis patients, and October 2006–March 2007 for the adult peritoneal dialysis patients. This report also de</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>scribes findings on clinical parameters of care for pediatric in-center hemodialysis and peritoneal dialysis patients in the U.S. for October-December 2006 (hemodialysis) and October 2006</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>March 2007 (peritoneal dialysis). </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The national results are presented separately in tables by gen</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>der, race, ethnicity, age group (for adult patients: 18-44, 45-54, 55-64, 65-74, and 75+ years of age, for pediatric patients: 0-4, 5-9, 10-14, and 15 to &lt; 18 years of age), diagnosis of ESRD, and duration of dialysis. The diagnoses are categorized as dia</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>betes mellitus, hypertension, glomerulonephritis, and other/un</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>known for adult patients. In some instances clinical characteris</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tics for patients in each ESRD Network area are also shown. </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:-10px; margin-right:28px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 5:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Characteristics of pediatric (aged &lt; 18 years) </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 6:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> Characteristics of pediatric (aged &lt; 18 years) in-center hemodialysis patients in the 2007 ESRD CPM peritoneal dialysis patients in the 2007 ESRD CPM Project. Project. </SPAN
></P>
<P style="text-align:; margin-bottom:-10px; margin-right:45px; margin-left:111px; text-indent:368px; line-height:16px">
<SPAN style="font-size:9.5pt; color:#000000"
>Patient                                     2007 CPM Project Patient Characteristics  2007 CPM ProjectCharacteristic #^ % #^ % </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:-15px; margin-left:219px; text-indent:-218px; line-height:16px">
<SPAN style="font-size:9.5pt; color:#000000"
>TOTA</SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>L 	</SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>740 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; margin-right:48px; text-indent:651px; line-height:16px">
<SPAN style="font-size:9.5pt; color:#000000"
>100 TOTAL 681 100 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:368px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER GENDER Male 411 56 Male 380 56 Female 329 44 Female 301 44 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:368px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>RACE RACE American Indian/Alaska Native 15 2 American Indian/Alaska Native 17 2 Asian/Pacific Islander 19 3 Asian/Pacific Islander 18 3 Black or African American 198 27 Black or African American 255 37 White 504 68 White 386 57 Other/Unknown * * Other/Unknown * * </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:368px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>ETHNICITY ETHNICITY Hispanic 245 33 Hispanic 213 31 Non-Hispanic 492 66 Non-Hispanic 466 68 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:368px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>AGE GROUP (years) AGE GROUP (years) 0 - 4 184 25 0 - 4 43 6 5 - 9 12917 5 - 9 65 10 10 - 14 216 29 10 - 14 211 31 15 to &lt;18 211 29 15 to &lt;18 362 53 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:368px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>CAUSE of ESRD CAUSE of ESRD Congenital / Urologic 253 34 Congenital / Urologic 172 25 Glomerulonephritis 55 7 Glomerulonephritis 89 13 FSGS^^ 103 14 FSGS^^ 99 15 SLE^^^ 19 3 SLE^^^ 42 6 Cystic Disease 32 4 Cystic Disease * * Hypertension 13 2 Hypertension 26 4 Other/Unknown 265 36 Other/Unknown 243 36 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:368px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>DURATION OF DIALYSIS (years) DURATION OF DIALYSIS (years) &lt; 0.5 164 22 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:368px; text-indent:-367px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.5 120 1</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>8 	</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>0.5 - 0.9 146 20 </SPAN
></P>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 0.9 107 1</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>6 	</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1.0 - 1.9 166 22 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 1.9 136 2</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>0 	</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2.0 - 2.9 93 13 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 2.9 84 1</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2 	</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>3.0 - 3.9 42 6 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 3.9 46 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>7 	</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4.0 + 123 17 </SPAN
></LI>
<DIV class="Sect">
<DL class="unexpected-ListItem" style="margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:16px">
<DT style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4.0</SPAN
></DT>
<DD style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>+ 	</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>178 26 </SPAN
></DD>

</DIV>
</ol>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; margin-right:105px; margin-left:368px; line-height:11px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^ Subgroup totals may not equal total due to missing data. ^^ FSGS - Focal and Segmental Glomerulosclerosis </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^ Subgroup totals may not equal total due to missing data. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:368px; line-height:11px">
<SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^^ SLE - Systemic Lupus Erythematosis </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^ FSGS - Focal and Segmental Glomerulosclerosis </SPAN
></SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>* Value suppressed because n &lt; 11 </SPAN
></SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^^ SLE - Systemic Lupus Erythematosis </SPAN
></SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: Percentages may not add up to 100% due to rounding. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>* </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Value suppressed because n &lt; 11 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:-5px; margin-right:5px; margin-left:368px; text-indent:-367px; line-height:11px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: Percentages may not add up to 100% due to rounding</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 	</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>A form was considered acceptable if the patient met the selection criteria for inclusion in the study and if data were provided at least once during the six-month </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>A form was considered acceptable if the patient met the selection criteria for </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; text-indent:368px; line-height:11px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>study period for hemoglobin and serum albumin. </SPAN
></P>
</DIV>
<P style="text-align:; margin-bottom:-5px; margin-right:134px; margin-left:123px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>inclusion in the study and if data were provided at least one of the months in the fourth quarter of 2006 for the following items:  1) hemoglobin; 2) paired pre- and Two or more values were available for 98% of patients for hemoglobin and 97% for post-dialysis BUN values; and 3) serum albumin value. serum albumin by either BCG or BCP methods. Three hemoglobin values were available for 84% of patients; three serum albumin values were available for 78% of </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Two or more monthly values for these clinical measures were available for 95% of </SPAN
></P>
<P style="margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>patients. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-right:368px; line-height:11px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>patients for hemoglobin and 94% for serum albumin by either BCG or BCP method. Monthly hemoglobin values were available for 86% of patients. At least one monthly paired pre- and post-dialysis BUN value was available for 100% of patients, and two or more were available for 92%. Monthly paired pre- and post-dialysis BUN values were available for 79% of patients. </SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:16px; margin-right:52px; margin-left:25px; text-indent:-24px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>III</SPAN
><SPAN style="font-size:11pt; color:#000000"
>. 	</SPAN
><SPAN style="font-size:11pt; color:#000000"
>CLINICAL PERFORMANCE MEASURES (CPMs) </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The clinical information abstracted by facility staff is used in this Report to describe some of the CPMs that were developed from the NKF-DOQI Guidelines and other quality indicators for sev</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>eral aspects of care for adult dialysis patients. These CPMs do not apply to patients under the age of 18 years.The CPMs were developed in the areas of hemodialysis and peritoneal dialysis adequacy, vascular access and anemia management. A complete description of the 13 CPMs appears in Appendix 2 </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(p. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>47). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-right:18px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>The Hemodialysis Adequacy CPMs described in this Report are: </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM I. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The patient’s delivered dose of hemodialysis is mea</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>sured at least once per month. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM II. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The patient’s delivered dose of hemodialysis reported in the patient’s chart is calculated by using formal urea kinetic modeling (UKM) or the Daugirdas II formula for spKt/V. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM III. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The patient’s (for those patients on hemodialysis six months or longer and dialyzing three times per week) delivered dose calculated from data points on the data collection form (monthly measurement averaged over the three-month study period) of hemodialysis is spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The clinical information collected to calculate these adequacy CPMs also allows us to describe other aspects of dialysis adequacy (or indicators), such as the mean spKt/V values for hemodialysis patients in each ESRD Network area and in the US. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-right:72px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>The Peritoneal Dialysis Adequacy CPMs described in this Report are: </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM I. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The patient’s total solute clearance for urea and creati</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>nine is measured routinely (defined for this report as at least once during the six-month study period). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM II.</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  The patient’s total solute clearance for urea (weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> ) and creatinine (weekly creatinine clearance) is calcu</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lated in a standard way. (See Peritoneal Dialysis Adequacy  CPM II in Appendix 2, p. 48). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM III.</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  For patients on continuous ambulatory peritoneal di</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>alysis (CAPD), the delivered peritoneal dialysis dose is a total Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least 2.0 per week and a total creatinine clearance (CrCl) of at least 60 L/week/1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> OR evidence that the dialy</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>sis prescription was changed if the adequacy measurements were below these thresholds. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For cycler patients, the weekly delivered peritoneal dialysis dose is a total Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least 2.1 and a weekly total creatinine clearance of at least 63L/week/1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2 </Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>OR evidence that the dialysis prescription was changed if the adequacy measure</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ments were below these thresholds. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-right:40px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>The Vascular Access CPMs described in this Report are: </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM I.</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  A primary arteriovenous fistula (AVF) should be the access for at least 50% of all new patients initiating hemodialy</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>sis. A native AVF should be the primary access for 40% of preva</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lent patients undergoing hemodialysis. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM II. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Less than 10% of chronic maintenance hemodialysis patients should be maintained on catheters continuously for </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 90 days as their permanent chronic dialysis access. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM III. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>A patient’s AV graft should be routinely monitored for stenosis. (See Vascular Access CPM III in Appendix 2, p. 49 for a list of techniques and frequency of monitoring used to screen for the presence of stenosis). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-right:10px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>The Anemia Management CPMs described in this Report are: </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM I. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The target hemoglobin for patients prescribed epoetin is 11-12 g/dL (110-120 g/L).  Patients with a mean hemoglobin &gt; 12 g/dL (120 g/L) and not prescribed epoetin were excluded from analysis for this CPM. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM IIa</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>.  For anemic patients (hemoglobin &lt; 11 g/dL (110 g/L) in at least one study month) or patients prescribed epoetin, the percent transferrin saturation and serum ferritin concentration are assessed (measured) at least once in a three-month period for hemodialysis patients and at least two times during the six-month study period for peritoneal dialysis patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM IIb. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For anemic patients (hemoglobin &lt; 11 g/dL (110 g/L) in at least one study month) or patients prescribed epoetin, at least one serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL and at  least one transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% were documented during the three-month study period for hemodialysis patients or during the six-month study period for peritoneal dialysis pa</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>CPM III.</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  All anemic patients (hemoglobin &lt; 11 g/dL (110 g/L) in at least  one study month) or patients prescribed epoetin, and with at least one transferrin saturation &lt; 20% or at least one serum ferritin concentration &lt; 100 ng/mL during the study period  are prescribed IV iron; UNLESS the mean transferrin saturation was </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 50% or the mean serum ferritin concentration was </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 800 ng/mL; UNLESS the patient was in the first three months of dialysis and was prescribed oral iron. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The clinical information collected to calculate these CPMs al</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lows us to describe other aspects of anemia management (or indicators). For example, the percents of patients with a mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL (110 g/L) and &lt; 10 g/dL (100 g/L) are profiled in this Report. Additionally, the percents of all patients with mean transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20%, mean serum ferritin con</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>centration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL, and the percents of patients prescribed ESA or IV iron are profiled. </SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Information was collected on epoetin and darbepoetin use and on IV iron doses again during this data collection period. All monthly recorded data were used in determining the percent of patients prescribed epoetin or darbepoetin. All monthly recorded data were used in determining the percent of patients prescribed any IV iron product. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The CPMs may have been calculated slightly differently than other findings reported in this Annual Report. Please refer to Appendix 2 (p. 47) for the specific inclusion and exclusion crite</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ria for each CPM. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Note Regarding Race </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>In this Report several tables describe important clinical charac</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>teristics of adult in-center hemodialysis and peritoneal dialysis patients for the following race groups: American Indian/Alaska Native, Asian/Pacific Islander, Black, White, and Other/Unknown. In the figures, these clinical characteristics are compared by race group; however, the comparisons are limited to White vs. Black. The reason for this is sample size. Because of small sample size (TABLE 2), the 95% confidence intervals for esti</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>mates for the American Indian/Alaska Native, Asian/Pacific Is</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lander, and Other/Unknown race groups are very broad. On the other hand, the sample size for White and Black patients was large enough to provide stable estimates; i.e., the 95% confi</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>dence intervals are narrow. </SPAN
></P>
</DIV>
<P style="text-align:justify; margin-bottom:12px; margin-left:12px">
<SPAN style="font-size:11pt; color:#000000"
>CPM HIGHLIGHTS FROM THE NATIONAL 2007 ESRD PROJECT </SPAN
></P>
<TABLE style="margin-bottom:28px">
<TR>
<TH style="width:719px; height:379px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:11pt; color:#000000"
>Random Sample of Adult In-Center Hemodialysis (HD) Patients (n=8,740 sample for analysis) The data are from OCT-DEC 2006: HD Adequacy </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>87% of patients had monthly adequacy measurements per</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>formed (HD Adequacy CPM I) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>74% of patients had their delivered spKt/V calculated using either UKM or the Daugirdas II formula (27) (HD Adequacy CPM II) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>93% of patients on dialysis for 6 months or more and dia</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lyzing three times a week had a mean delivered adequacy dose of spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2 calculated using the Daugirdas II formula (HD Adequacy CPM III) </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Vascular Access (VA) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>41% of incident patients were dialyzed using an AV fistula (AVF) (VA CPM I) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>45% of prevalent patients were dialyzed using an AVF (VA CPM I) (FIGURE 1) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>22% of prevalent patients were dialyzed with a chronic catheter continuously for 90 days or longer (VA CPM II) (FIGURE 1) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>70% of prevalent patients with an AV graft were routinely monitored for the presence of stenosis (VA CPM III) </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Anemia Management (AM) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>33% of targeted patients prescribed epoetin had a mean hemoglobin 11.0-12.0 g/dL (110-120 g/L) (AM CPM I) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>97% of patients who met the inclusion criteria</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>1</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> had at least one documented transferrin saturation value and one doc</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>umented serum ferritin concentration value during the study period (AM CPM IIa) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>82% of patients who met the inclusion criteria</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>1</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> had at least one transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% and one serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL during the study period (AM CPM IIb) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>83% of patients who met the inclusion criteria</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>1</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> were pre</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>scribed intravenous iron in at least one month during the study period (AM CPM III) </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:719px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>1</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>See Appendix 1 for a description of the inclusion and exclusion criteria. </SPAN
></TH>
</TR>
</TABLE>
<TABLE style="margin-bottom:0px">
<TR>
<TH style="vertical-align:middle; width:719px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; color:#000000"
>Year ESRD CPM Trends (percent of patients meeting the CPMs)</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:5.5pt; color:#000000"
>1 </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; color:#000000"
>1998 2000 2002 2004 2005 2006 </SPAN
></TH>
</TR>
<TR>
<TH style="width:719px; height:345px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; color:#000000"
>HD Adequacy </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
>HD Adequacy CPM I (monthly measurement of delivered HD dose) 79 80 83 83 82 87 HD Adequacy CPM II (method of measurement of delivered HD dose) 99</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:5.5pt; color:#000000"
>4 </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
>52 67 76 76 74 HD Adequacy CPM III (mean delivered HD dose </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2) 85 91 92 95 94 93 </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; color:#000000"
>Vascular Access </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
>Vascular Access CPM Ia (incident patients with an AVF</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:5.5pt; font-weight:normal; color:#000000"
>2</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
> as access) 26 27 27 37 54 41 Vascular Access CPM Ib  (prevalent patients with an AVF as access) 26 30 33 39 44 45 Vascular Access CPM II  (dialyzed with a chronic catheter</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:5.5pt; font-weight:normal; color:#000000"
>3</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
>) 14 17 21 21 21 22 Vascular Access CPM III  (AV graft was routinely monitored for stenosis) 37 47 61 67 69 70 </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; color:#000000"
>Anemia Management </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia CPM I (mean Hgb 11-12 g/dL) 36 38 36 34 35 33 Anemia CPM IIa 90 91 94 95 95 97 (iron stores assessed for anemic patients or patients prescribed Epoetin) Anemia CPM IIb (iron stores maintained at K/DOQI targets) 67 71 78 80 80 82 Anemia CPM III (administration of IV iron to anemic patients) 63 73 79 82 81 83 </SPAN
></TH>
</TR>
<TR>
<TH style="width:719px; height:63px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>1 </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>See Appendix 1 for a description of the inclusion and exclusion criteria. </SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>2</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> Arteriovenous fistula </SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>3</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> For 90 days or longer </SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>4</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> For 1998 only, accepted HD dose calculated using urea kinetic modeling (UKM), Daugirdas II, or urea reduction ratio (URR); for all subsequent years, only UKM or Daugirdas II accepted. </SPAN
></TH>
</TR>
</TABLE>
<P style="text-align:justify; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>NOTE: Please note that when a single year such as 2006 is used in displaying data, it refers to October, November, and December of that year for the hemodialysis patients. </SPAN
></P>
<P style="text-align:justify; margin-bottom:12px; margin-left:12px">
<SPAN style="font-size:11pt; color:#000000"
>CPM HIGHLIGHTS FROM THE NATIONAL 2007 ESRD PROJECT </SPAN
></P>
<TABLE style="margin-bottom:7px">
<TR>
<TH style="width:719px; height:374px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:11pt; color:#000000"
>Random Sample of Adult Peritoneal Dialysis (PD) Patients (n=1,433 sample for analysis) The data are from OCT 2006–MAR 2007: PD Adequacy </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>84% of patients had at least one measured total solute clearance for urea and creatinine (PD Adequacy CPM I) during the six-month study period (FIGURE 2) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>49% of patients had their total solute clearance for urea and creatinine calculated in a standard way</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>1</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> (PD Ade</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>quacy CPM II) (FIGURE 2) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>75% of CAPD patients had a mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 2.0 and a mean weekly creatinine clearance </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 60L/week/ 1.73m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> OR there was evidence the dialysis prescription was changed if the adequacy measurements were below these thresholds during the six-month study period (PD Adequacy CPM III) (FIGURE 3) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>64% of Cycler</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> patients had a mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 2.1 and a mean weekly creatinine clearance </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 63 L/week/1.73m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>2 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>OR there was evidence the dialy</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>sis prescription was changed if the adequacy measure</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ments were below these thresholds during the six-month study period (PD Adequacy CPM III) (FIGURE 3) </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Anemia Management (AM) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>37% of targeted patients prescribed epoetin had a mean he</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>moglobin between 11.0-12.0 g/dL (110-120 g/L) (AM CPM I) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>74% of patients who met the inclusion criteria</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> for this CPM had at least two documented transferrin saturation values and two documented serum ferritin concentration values during the six-month study period (AM CPM IIa) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>85% of patients who met the inclusion criteria</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>3 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>for this CPM had at least one transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% and one serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL during the six-month study period (AM CPM IIb) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>41% of patients who met the inclusion criteria</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>3</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> for this CPM were prescribed intravenous iron in at least one of the two-month periods during the six-month study period (AM CPM III) </SPAN
></TH>
</TR>
<TR>
<TH style="width:719px; height:87px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>1</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> See Appendix 1 for a description of standard ways for calculating total solute clearance. </SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>2</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> For the Oct 2006-Mar 2007 collection, CCPD and NIPD modalities were not distinguishable. </SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>3 </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>See Appendix 1 for a description of the inclusion and exclusion criteria. Using the 1997 NKF-DOQI guidelines (17):  For CAPD patients: weekly Kt/V</SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>urea </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 2.0; weekly CrCl </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 60 L/week/1.73m</SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>2</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>  For cycler patients: weekly Kt/V</SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>urea </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 2.1; weekly CrCl </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 63 L/week/1.73m</SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>2 </SPAN
></TH>
</TR>
</TABLE>
<TABLE style="margin-bottom:0px">
<TR>
<TH style="vertical-align:middle; width:590px; height:42px; border-style: solid none solid solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; color:#000000"
>Year ESRD CPM Trends (percent of patients meeting the CPMs)</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:5.5pt; color:#000000"
>1</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; color:#000000"
> 1999 2001 2003 2005 </SPAN
></TH>
<TH style="vertical-align:bottom; width:44px; height:42px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; color:#000000"
>2006 </SPAN
></TH>
<TH style="vertical-align:bottom; width:85px; height:42px; border-style: solid solid solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; color:#000000"
>2007 </SPAN
></TH>
</TR>
<TR>
<TD style="vertical-align:top; width:590px; height:323px; border-style: border-style:solid none solid solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; color:#000000"
>PD Adequacy </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
>PD Adequacy CPM 1 (measurement of total solute clearance at regular intervals) 82 85 88 82 PD Adequacy CPM II 55 62 65 41 (weekly Kt/V</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:5.5pt; font-weight:normal; color:#000000"
>urea</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
> &amp; weekly CrCl calculated in a standard way)</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:5.5pt; font-weight:normal; color:#000000"
>2 </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
>PD Adequacy CPM III (delivered PD dose meets K/DOQI thresholds) CAPD 55 69 71 73 Cycler with daytime dwell 58 62 66 59 Cycler without daytime dwell 45 64 67 58 Cycler</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:5.5pt; font-weight:normal; color:#000000"
>3 </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; color:#000000"
>Anemia Management </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia CPM I (mean Hgb 11-12 g/dL) 32 39 39 33 Anemia CPM IIa 70 72 77 77 (iron stores assessed for anemic patients or patients prescribed epoetin) Anemia CPM IIb (iron stores maintained at K/DOQI targets) 72 75 81 82 Anemia CPM III (administration of IV iron to anemic patients) 17 23 32 31 </SPAN
></TD>
<TD style="vertical-align:bottom; width:44px; height:323px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
>80 41 72 59 30 76 83 39 </SPAN
></TD>
<TD style="vertical-align:bottom; width:85px; height:323px; border-style: border-style:solid solid solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-weight:normal; color:#000000"
>84 49 7564 37 7485 41 </SPAN
></TD>
</TR>
<TR>
<TD style="width:590px; height:43px; border-style: border-style:solid none solid solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>1 </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>See Appendix 1 for a description of the inclusion and exclusion criteria. </SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>2</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> See Appendix 1 for a description of standard ways for calculating total solute clearance. </SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>3 </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>For the Oct 2005-Mar 2006 and the Oct 2006-Mar 2007 collections, CCPD and NIPD modalities were not distinguishable. </SPAN
></TD>
<TD style="vertical-align:top; width:44px; height:43px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
<TD style="vertical-align:top; width:85px; height:43px; border-style: border-style:solid solid solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
</TABLE>
<P style="text-align:justify; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>NOTE: When a single year, such as 2007, is used for the peritoneal dialysis patients, it refers to January, February, and March of that year as well as October, November, and December of the previous year. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>IV.</SPAN
><SPAN style="font-size:11pt; color:#000000"
>  OTHER SIGNIFICANT FINDINGS AND TRENDS </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-left:13px">
<SPAN style="font-size:11pt; color:#000000"
>ESRD Data Trends </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:16px; margin-left:12px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The figures on the following pages show the trends in the ESRD data for various study periods. </SPAN
></P>
<P style="text-align:left; margin-bottom:20px; margin-right:12px; margin-left:12px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Please note that when a single year such as 2006 is used in displaying data, it refers to October, November, and December of that year for the hemodialysis patients. When a single year, such as 2007, is used for the peritoneal dialysis patients, it refers to January, February, and March of that year as well as October, November, and December of the previous year. Also, “adult” refers to ages </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years and “pediatric” refers to ages &lt; 18 years. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px">
<SPAN style="font-size:11pt; color:#000000"
>Vascular Access Trends Peritoneal Dialysis Adequacy Trends </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 1:  </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Vascular access type for all adult in-center hemodi-</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 2:  </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Percent of adult peritoneal dialysis patients with total alysis patients on their last hemodialysis session during the solute clearance for urea and creatinine measured at least once study period. 2007 ESRD CPM Project. during the study period (PD Adequacy CPM I) and with total </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; margin-left:369px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>solute clearance calculated in a standard way* (PD Adequacy </SPAN
></P>
<P style="text-align:left; margin-bottom:-10px; margin-left:52px">
<SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style="font-size:6.9pt; color:#000000"
>AV Fistula* </SPAN
><SPAN style="font-size:6.9pt; color:#000000"
>AV Graft </SPAN
></SPAN
><SPAN style="font-size:6.9pt; color:#000000"
>Temporary Catheter </SPAN
></SPAN
><SPAN style="font-size:6.9pt; color:#000000"
>Chronic Catheter** </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:369px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>CPM II), October 2006-March 2007 compared  to previous study </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-left:13px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>100 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-left:369px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>periods. 2007 ESRD CPM Project. </SPAN
></P>
<P style="text-align:left; margin-bottom:355px">
<SPAN style="font-size:9pt; color:#000000"
>Percent of Patients </SPAN
></P>
</DIV>
<TABLE style="margin-bottom:0px">
<TR>
<TH style="width:188px; height:17px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>80 </SPAN
></TH>
<TH style="vertical-align:bottom; width:206px; height:17px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>100 </SPAN
></TH>
<TH colspan=2 style="text-align:center; width:106px; height:17px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>PD Adequacy CPM I </SPAN
></TH>
<TH style="text-align:center; width:24px; height:17px"/>
<TH colspan=3 style="width:151px; height:17px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>PD Adequacy CPM II </SPAN
></TH>
</TR>
<TR>
<TD style="vertical-align:top; width:188px; height:39px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>50 70 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>60 </SPAN
></TD>
<TD style="vertical-align:bottom; width:206px; height:39px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>90 80 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:43px; height:39px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:63px; height:39px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>85 </SPAN
></TD>
<TD style="vertical-align:top; width:24px; height:39px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:88px; height:39px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="vertical-align:bottom; width:34px; height:39px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>80 </SPAN
></TD>
<TD style="text-align:right; width:30px; height:39px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>84 </SPAN
></TD>
</TR>
</TABLE>
<DIV class="Sect">
<P style="margin-bottom:0px">
<SPAN style="font-size:9pt; color:#211D1E"
>Percent of Patients</SPAN
></P>
<P style="margin-bottom:4px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>65</SPAN
></P>
<P style="text-align:justify; margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>70 </SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-left:104px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>62 </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>60 </SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-left:53px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>55 </SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-right:310px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>50 </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>41 </SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-left:53px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>40</SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>40 </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>1998 2000 2002 2004 2005 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>2006 </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>30 </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> CMS has set a goal to have </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 66% of prevalent hemodialysis patients </SPAN
></P>
<P style="margin-bottom:0px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>20 </SPAN
></P>
<P style="text-align:left; margin-bottom:29px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>using an AV Fistula as their access by the year 2010</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>** Chronic catheter defined as use of a catheter access continuously for 9</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>0 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>days or longer</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<P style="text-align:left; margin-bottom:8px">
<SPAN style="font-size:11pt; color:#000000"
>Peritoneal Dialysis Adequacy Trends </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 3:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; color:#000000"
> </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Percent of adult peritoneal dialysis patients meeting 1997 NKF-DOQI guidelines for weekly Kt/V</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:5.8pt; font-style:italic; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>and weekly creatinine clearance (PD Adequacy CPM III). 2007 ESRD CPM </SPAN
></P>
<TABLE style="margin-bottom:13px">
<TR>
<TH colspan=3 style="text-align:center; width:352px; height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Project. </SPAN
></TH>
</TR>
<TR>
<TH style="text-align:center; vertical-align:bottom; width:58px; height:14px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>100 </SPAN
></TH>
<TD colspan=2 style="width:294px; height:14px">
<SPAN style="font-size:8.4pt; color:#211D1E"
>CAPD </SPAN
></TD>
</TR>
<TR>
<TH style="text-align:center; vertical-align:middle; width:58px; height:26px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>90 </SPAN
></TH>
<TD colspan=2 style="vertical-align:top; width:294px; height:26px; background-color:#FFFFFF">
<SPAN style="font-size:8.4pt; color:#211D1E"
>Cycler Patients with a Daytime Dwell Cycler Patients, No Daytime Dwell</SPAN
></TD>
</TR>
<TR>
<TH style="text-align:center; vertical-align:bottom; width:58px; height:13px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>80 </SPAN
></TH>
<TD style="vertical-align:top; width:211px; height:13px; background-color:#FFFFFF">
<SPAN style="font-size:8.4pt; color:#211D1E"
> Cycler Patients </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:13px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>75 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:8px; margin-left:22px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>10 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:25px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>0 </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; margin-left:59px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>1999 2001 2003 2005 2006 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>2007 </SPAN
></P>
<P style="text-align:left; margin-bottom:29px; margin-left:39px; line-height:11px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*See Appendix 1 for a complete description of the standard methods to calculate the solute clearance for urea and creatinine. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px">
<SPAN style="font-size:11pt; color:#000000"
>Hemodialysis Adequacy Trends </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 4: </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Percent of adult in-center hemodialysis patients with mean delivered calculated, single session single pool (sp)Kt/V </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 1.2 in October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. </SPAN
></P>
<P style="text-align:; margin-bottom:-5px; margin-left:53px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>73 72</SPAN
></P>
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
><Sup>71</Sup></SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>66 67</SPAN
></P>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:9pt; color:#211D1E"
>Percent of Patients</SPAN
></P>
<P style="margin-bottom:4px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>100</SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-left:82px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>69 </SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-right:43px; margin-left:85px">
<SPAN style="font-size:8.8pt; font-weight:normal; color:#211D1E"
>91 91</SPAN
></P>
<P style="text-align:justify; margin-bottom:8px">
<SPAN style="font-size:8.8pt; font-weight:normal; color:#211D1E"
>86 89</SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-right:256px; margin-left:68px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>64 </SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-right:67px; margin-left:258px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>64</SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; margin-left:52px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>62 </SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-left:324px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>90</SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-right:111px; margin-left:213px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>59</SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>59 58 </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>58 </SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-left:422px">
<SPAN style="font-size:8.8pt; font-weight:normal; color:#211D1E"
>80</SPAN
></P>
<P style="text-align:justify; margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>55 </SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-right:83px; margin-left:340px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>80 </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:8.8pt; font-weight:normal; color:#211D1E"
>74</SPAN
></P>
<P style="text-align:justify; margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>50 </SPAN
></P>
<P style="text-align:; margin-bottom:4px; margin-left:58px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>45 </SPAN
></P>
<P style="margin-bottom:0px">
<SPAN style="font-size:9pt; color:#211D1E"
>Percent of Patients</SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>70 </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>60 </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>50 </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>40 </SPAN
></P>
<P style="margin-bottom:0px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>30 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-left:59px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>1999 2001 2003 2005 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>2006* </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>2007* </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>20 </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; margin-left:348px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>10</SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; margin-right:359px; line-height:11px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*For collection years 2006 and 2007, CCPD and NIPD modalities were not distinguishable. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; margin-left:353px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>0 </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; margin-left:384px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>1996 1998 2000 2002 2004 2005 2006 </SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Anemia Management Trends </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:12px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 5:  </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Percent of adult in-center hemodialysis patients with </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 6:  </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Distribution of mean hemoglobin values for adult in-mean hemoglobin </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 11 g/dL, October-December 2006 compared center hemodialysis patients, October</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>-December 2006 compared to previous study periods. 2007 ESRD CPM Project. to previous study periods. 2007 ESRD CPM Project. </SPAN
></P>
<DIV class="Sect">
<IMG width=352 height=252 style="display:block; float:none; margin-bottom:0px" src="images/ESRDCPMYear2007Report_img_2.jpg">
<P style="margin-bottom:8px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#211D1E"
>1997 1999 2001 2003 2005 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#211D1E"
>2006 </SPAN
></P>
<TABLE style="text-align:left; margin-bottom:0px">
<TR>
<TH style="vertical-align:middle; width:25px; height:24px">
<SPAN style="font-size:8pt; font-weight:normal; color:#211D1E"
>50 </SPAN
></TH>
<TH style="width:128px; height:24px; background-color:#FFFFFF">
<SPAN style="font-size:8pt; color:#211D1E"
>1997 10.7 </SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:8pt; color:#211D1E"
> 1.2 Mean </SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:8pt; color:#211D1E"
> SD Hemoglobin (g/dL) </SPAN
></TH>
</TR>
<TR>
<TD style="width:25px; height:24px">
<SPAN style="font-size:8pt; font-weight:normal; color:#211D1E"
>45</SPAN
></TD>
<TD style="vertical-align:top; width:128px; height:24px; background-color:#FFFFFF">
<SPAN style="font-size:8pt; color:#211D1E"
>1999 11.4 </SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:8pt; color:#211D1E"
> 1.3 2001 11.7 </SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:8pt; color:#211D1E"
> 1.2 </SPAN
></TD>
</TR>
<TR>
<TD style="width:25px; height:23px">
<SPAN style="font-size:8pt; font-weight:normal; color:#211D1E"
>40 </SPAN
></TD>
<TD style="vertical-align:bottom; width:128px; height:23px; background-color:#FFFFFF">
<SPAN style="font-size:8pt; color:#211D1E"
>2003 11.9 </SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:8pt; color:#211D1E"
> 1.2 2005 11.9 </SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:8pt; color:#211D1E"
> 1.2 </SPAN
></TD>
</TR>
</TABLE>
<IMG width=349 height=188 style="display:block; float:none; text-align:right; margin-bottom:14px" src="images/ESRDCPMYear2007Report_img_3.jpg">
<P style="text-align:left; margin-bottom:52px; margin-right:13px; line-height:11px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10. </SPAN
></P>
<P style="text-align:left; margin-bottom:4px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 7:  </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Percent of adult peritoneal dialysis patients with mean hemoglobin </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 11 g/dL, October 2006-March 2007 compared to previous study periods. 2007 ESRD CPM Project. </SPAN
></P>
<P style="text-align:left; margin-bottom:12px; margin-left:17px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>100 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:22px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>90 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:309px">
<SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style="font-size:8.9pt; font-weight:normal; color:#211D1E"
>83</SPAN
><SPAN style="font-size:8.9pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></SPAN
><SPAN style="font-size:8.9pt; font-weight:normal; color:#211D1E"
>81</SPAN
></SPAN
><SPAN style="font-size:8.9pt; font-weight:normal; color:#211D1E"
>76</SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; margin-left:104px; text-indent:-81px; line-height:18px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>8</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>0 
</SPAN
><SPAN style="font-size:8.9pt; font-weight:normal; color:#211D1E"
>6</SPAN
><SPAN style="font-size:8.9pt; font-weight:normal; color:#211D1E"
>9
</SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-left:22px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>70 </SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#211D1E"
>&lt; 9 9—9.9 10—10.9 11—11.9 12—12.9 13—13.9 14.0 + </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:9pt; color:#211D1E"
>Hemoglobin (g/dL) </SPAN
></P>
<P style="text-align:justify; margin-bottom:29px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10. </SPAN
></P>
<P style="text-align:justify; margin-bottom:12px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 8:  </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Distribution of mean hemoglobin values for adult peritoneal dialysis patients, October 2006-March 2007 com</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>pared to previous study periods. 2007 ESRD CPM Project. </SPAN
></P>
<TABLE style="margin-bottom:0px">
<TR>
<TD colspan=4 style="text-align:center; vertical-align:top; width:341px; height:12px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>50 </SPAN
></TD>
</TR>
<TR>
<TD style="text-align:center; vertical-align:bottom; width:43px; height:26px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>45</SPAN
></TD>
<TD style="text-align:right; vertical-align:top; width:38px; height:26px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Mean </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
></TD>
<TH colspan=2 style="text-align:right; vertical-align:bottom; width:260px; height:26px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; color:#211D1E"
>1998 11.1 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; color:#211D1E"
> 1.4 SD Hemoglobin (g/dL) </SPAN
></TH>
</TR>
<TR>
<TD style="text-align:center; vertical-align:top; width:43px; height:11px"/>
<TD style="text-align:right; vertical-align:top; width:38px; height:11px; background-color:#FFFFFF"/>
<TD style="text-align:right; width:62px; height:11px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; color:#211D1E"
>2000 11.6 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
></TD>
<TD style="width:198px; height:11px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; color:#211D1E"
> 1.4 </SPAN
></TD>
</TR>
<TR>
<TD style="text-align:center; vertical-align:top; width:43px; height:13px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>40 </SPAN
></TD>
<TD style="text-align:right; vertical-align:top; width:38px; height:13px; background-color:#FFFFFF"/>
<TD style="text-align:right; width:62px; height:13px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; color:#211D1E"
>2002 11.8 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
></TD>
<TD style="width:198px; height:13px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; color:#211D1E"
> 1.4 </SPAN
></TD>
</TR>
<TR>
<TD style="text-align:center; vertical-align:top; width:43px; height:10px"/>
<TD style="text-align:right; vertical-align:top; width:38px; height:10px; background-color:#FFFFFF"/>
<TD style="text-align:right; vertical-align:bottom; width:62px; height:10px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; color:#211D1E"
>2004 12.0 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
></TD>
<TD style="vertical-align:bottom; width:198px; height:10px; background-color:#FFFFFF">
<SPAN style="font-size:7.9pt; color:#211D1E"
> 1.3 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:justify; margin-bottom:-10px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>35 </SPAN
></P>
<P style="text-align:; margin-bottom:-5px; margin-left:77px">
<IMG width=24 height=8 style="display:block; float:left; margin-bottom:-5px; margin-left:77px" src="images/ESRDCPMYear2007Report_img_4.jpg">
<SPAN style="font-size:7.9pt; color:#211D1E"
>2006 12.0 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; color:#211D1E"
> 1.3 </SPAN
></P>
</DIV>
<IMG width=720 height=249 style="display:block; float:none; text-align:right; margin-bottom:0px" src="images/ESRDCPMYear2007Report_img_5.jpg">
<DIV class="Sect">
<P style="margin-bottom:0px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>&lt; 9 9—9.9 10—10.9 11—11.9 12—12.9 13—13.9 14.0 + </SPAN
></P>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:9pt; color:#211D1E"
>Percent of Patients</SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:25px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>60 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:29px">
<SPAN style="font-size:8.9pt; font-weight:normal; color:#211D1E"
>55 </SPAN
></P>
<P style="margin-bottom:8px; margin-right:322px; line-height:25px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>50 40 30 20 10 0 </SPAN
></P>
<IMG width=319 height=207 style="display:block; float:none; text-align:center; margin-bottom:4px; margin-left:13px" src="images/ESRDCPMYear2007Report_img_6.jpg">
<P style="margin-bottom:8px">
<SPAN style="font-size:6.9pt; font-weight:normal; color:#211D1E"
>1998 2000 2002 2004 2006 </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#211D1E"
>2007 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; margin-left:509px">
<SPAN style="font-size:8.9pt; color:#211D1E"
>Hemoglobin (g/dL)</SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Pediatric Dialysis Trends </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 9:  </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Distribution of mean delivered calculated, single session spKt/V values for pediatric (aged &lt; 18 years) in-center hemodialysis patients, October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. </SPAN
></P>
<TABLE style="margin-bottom:12px">
<TR>
<TD colspan=5 style="text-align:center; vertical-align:top; width:341px; height:12px">
<SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>50 </SPAN
></TD>
</TR>
<TR>
<TD style="text-align:center; vertical-align:bottom; width:50px; height:16px">
<SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>45</SPAN
></TD>
<TD style="width:46px; height:16px; background-color:#FFFFFF">
<SPAN style="font-size:7pt; color:#000000"
>Mean </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>±</SPAN
></TD>
<TH colspan=3 style="vertical-align:middle; width:244px; height:16px; background-color:#FFFFFF">
<SPAN style="font-size:7pt; color:#000000"
> SD spKt/V </SPAN
></TH>
</TR>
<TR>
<TD style="text-align:center; vertical-align:bottom; width:50px; height:19px">
<SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>40 </SPAN
></TD>
<TH colspan=2 style="vertical-align:bottom; width:78px; height:19px; background-color:#FFFFFF">
<SPAN style="font-size:7pt; color:#000000"
>Oct–Dec 2001 Oct–Dec 2003 </SPAN
></TH>
<TD style="vertical-align:bottom; width:26px; height:19px; background-color:#FFFFFF">
<SPAN style="font-size:7pt; color:#000000"
>1.55 </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:7pt; color:#000000"
>1.55 </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>±</SPAN
></TD>
<TD style="vertical-align:bottom; width:187px; height:19px; background-color:#FFFFFF">
<SPAN style="font-size:7pt; color:#000000"
> 0.32 0.32 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:29px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 10:  </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Vascular access type for pediatric (aged &lt; 18 years) in-center hemodialysis patients on their last hemodialysis session during the study period, October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:52px">
<SPAN style="font-size:6.9pt; color:#000000"
>AV Fistula </SPAN
></P>
<P style="text-align:left; margin-bottom:-10px; margin-left:103px">
<IMG width=13 height=9 style="display:block; float:left; margin-bottom:-10px; margin-left:103px" src="images/ESRDCPMYear2007Report_img_7.jpg">
<SPAN style="font-size:6.9pt; color:#000000"
>AV Graft </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-left:147px">
<SPAN style="font-size:6.9pt; color:#000000"
><IMG width=12 height=7 style="display:block; float:left; margin-bottom:12px; margin-left:147px" src="images/ESRDCPMYear2007Report_img_8.jpg">
Temporary Catheter </SPAN
><SPAN style="font-size:6.9pt; color:#000000"
>Chronic Catheter* </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:13px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>100 </SPAN
></P>
<IMG width=319 height=216 style="display:block; float:none; text-align:center; margin-bottom:0px" src="images/ESRDCPMYear2007Report_img_9.jpg">
</DIV>
<P style="text-align:; margin-bottom:-10px; margin-left:58px">
<IMG width=24 height=19 style="display:block; float:left; margin-bottom:-10px; margin-left:58px" src="images/ESRDCPMYear2007Report_img_10.jpg">
<SPAN style="font-size:7pt; color:#000000"
>Oct–Dec 2005 1.58 </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:7pt; color:#000000"
> 0.33 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>90</SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:-5px">
<SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>35 </SPAN
></P>
<P style="text-align:; margin-bottom:0px; margin-right:227px; margin-left:58px">
<SPAN style="font-size:7pt; color:#000000"
>Oct–Dec 2006 1.62 </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:7pt; color:#000000"
> 0.34 </SPAN
></P>
<P style="text-align:; margin-bottom:8px; margin-left:369px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>80</SPAN
></P>
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>30</SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:29px">
<SPAN style="font-size:9pt; color:#000000"
>Percent of Patients </SPAN
></P>
<IMG width=345 height=108 style="display:block; float:none; margin-bottom:12px" src="images/ESRDCPMYear2007Report_img_11.jpg">
<DIV class="Sect">
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>70 </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>60 </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>50 </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>40 </SPAN
></P>
<P style="margin-bottom:0px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>30 </SPAN
></P>
<P style="text-align:left; margin-bottom:70px; margin-left:18px; line-height:18px">
<SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>25 20 </SPAN
></P>
</DIV>
<DL class="unexpected-ListItem" style="margin-bottom:4px; margin-right:0px; margin-left:0px; text-indent:0px">
<DT style="list-style-type:none; margin-bottom:4px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>&lt;</SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:4px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:8pt; font-weight:normal; color:#000000"
> 1.0 1.0—1.19 1.2—1.39 1.4—1.59 1.6—1.79 1.8—1.99 2.0 + </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>20 </SPAN
></DD>

<P style="text-align:left; margin-bottom:16px; margin-left:337px; text-indent:-220px; line-height:18px">
<SPAN style="font-size:9pt; color:#000000"
>spKt/V </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>1</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>0 
</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#000000"
>0 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:25px; margin-left:344px; line-height:11px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*Chronic catheter use defined as continous catheter use 90 days or longer. </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:4px; margin-right:166px; margin-left:131px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Figure 11:  </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Distribution of mean hemoglobin values for pediatric (aged  &lt; 18 years) in-center hemodialysis patients, October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:-5px; margin-left:137px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>50 </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; margin-left:167px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Mean </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; color:#211D1E"
> SD Hemoglobin (g/dL)</SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; margin-left:137px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>45</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:164px">
<IMG width=24 height=8 style="display:block; float:left; margin-bottom:0px; margin-left:164px" src="images/ESRDCPMYear2007Report_img_12.jpg">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Oct–Dec 2001 11.2 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; color:#211D1E"
> 1.6 </SPAN
></P>
<P style="text-align:left; margin-bottom:-10px; margin-left:137px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>40 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-left:190px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Oct–Dec 2003 11.4 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; color:#211D1E"
> 1.6 </SPAN
></P>
</DIV>
<IMG width=351 height=127 style="display:block; float:none; text-align:center; margin-bottom:0px" src="images/ESRDCPMYear2007Report_img_13.jpg">
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>0 </SPAN
></P>
</DIV>
<P style="text-align:justify; margin-bottom:8px; margin-left:34px">
<SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>&lt;9.0 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>9—9.9 10—10.9 11—11.9 12—12.9 13—13.9 14.0+ </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:8.9pt; color:#211D1E"
>Hemoglobin (g/dL) </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; margin-left:12px; line-height:11px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-left:12px">
<SPAN style="font-size:11pt; color:#000000"
>SELECTED SIGNIFICANT FINDINGS FROM THE NATIONAL 2007 ESRD CPM PROJECT </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; margin-left:4px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Random Sample of Adult In-Center Hemodialysis (HD) Patients (n=8,740 sample for analysis</SPAN
><SPAN style="font-size:11pt; color:#000000"
>) 
</SPAN
><SPAN style="font-size:11pt; color:#000000"
>The data are from OCT-DEC 2006</SPAN
><SPAN style="font-size:11pt; color:#000000"
>: 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-383px">
<SPAN style="font-size:11pt; color:#000000"
>HD Adequacy </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>5% of patients had a mean hemoglobin &lt; 10.0 g/dL (100 </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; margin-right:229px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>90% of prevalent patients had a mean delivered calcu-g/L) (T</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ABLE 13) lated, single session adequacy dose of spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2 </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; margin-left:24px; text-indent:336px; line-height:11px">
<SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD hemoglobin was 12.0 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2 g/d</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>L
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(FIGURE 4</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; margin-left:384px; line-height:11px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(120 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 12 g/L) (FIGURE 6, TABLE 13) </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; margin-left:24px; text-indent:-23px; line-height:11px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>94% of female patients and 87% of male patients were </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:-5px; margin-left:24px; text-indent:336px; line-height:11px">
<SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>79% of patients had a mean transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% receiving dialysis with a mean delivered calculated, single </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:24px; text-indent:360px; line-height:11px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(TABLE 15</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>session spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2 in OCT-DEC 2006 (TABLE 7</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-23px; line-height:11px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>95% of patients had a mean serum ferritin concentration </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:24px; text-indent:-23px; line-height:11px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD spKt/V was 1.55 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.27 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; line-height:11px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL (TABLE 15) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:24px; text-indent:-23px; line-height:11px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>87% of patients had a mean URR </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 65% </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-left:384px; text-indent:-23px; line-height:11px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>23% of patients had a mean serum ferritin &gt; 800 ng/mL </SPAN
></P>
</DIV>
<ul style="list-style-type:disc">
<LI style="margin-bottom:4px; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:11px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD URR was 72.0 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 7% (T</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ABLE 15) </SPAN
></LI>
<LI style="margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD dialysis session length was 217 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 32 minutes • </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>70% of patients were prescribed IV iron during the study period (TABLE 15) </SPAN
></LI>
</ul>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Opportunity to Improve Adequacy </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; margin-left:24px; text-indent:-23px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>10% of patients did not have a mean spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥ </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>1.2 during </SPAN
><SPAN style="font-size:11pt; color:#000000"
><Sup>Opportunities to Improve Anemia Management </Sup></SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-right:8px; margin-left:384px; text-indent:-359px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>the three-month study perio</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>d 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 16% of patients did not have a mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥ </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>11 g/dL (110 g/L) during the three-month study period </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-383px">
<SPAN style="font-size:11pt; color:#000000"
>Vascular Access </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>21% of patients did not have a mean transferrin satura</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>41% of incident and 45% of prevalent patients</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>1</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> were dia-tion </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% and 5% of patients did not have a mean serum lyzed with an AVF during their last hemodialysis session ferritin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL OCT-DEC 2006 (TABLE 9) </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; margin-left:360px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Serum Albumin </SPAN
></P>
</DIV>
<ul style="list-style-type:disc">
<ul style="list-style-type:disc">
<DIV class="Sect">
<DL class="unexpected-ListItem" style="margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<DT style="margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
></DT>
<DD style="margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>68% of patients with an AVF or AV graft had their access </SPAN
></DD>

</DIV>
<LI style="margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>routinely monitored for the presence of stenosis during </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>34% of patients had a mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL the three-month study period (40/37 g/L) (BCG/BCP)</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2 </Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(TABLE 16) </SPAN
></LI>
</ul>
<LI style="margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:360px; line-height:13px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>81% of patients had a mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Opportunities to Improve Vascular Access </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(35/32 g/L) (BCG/BCP) (TABLE 16) </SPAN
></LI>
<DIV class="Sect">
<DL class="unexpected-ListItem" style="margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<DT style="margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
></DT>
<DD style="margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>58% of incident patients and 55% of all patients were not </SPAN
></DD>

</DIV>
</ul>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; color:#000000"
>•	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD serum albumin was 3.8 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.4/3.5 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.5 g/dL</SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>dialyzed with an AVF during their last hemodialysis </SPAN
></SPAN
><SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(38 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4/35 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 5 g/L) (BCG/BCP)</SPAN
></SPAN
></P>
<P style="text-align:left; margin-bottom:8px; text-indent:24px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>session OCT-DEC 2006 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:-5px; margin-right:68px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>32% of patients with an AVF or AV graft did not have their </SPAN
><SPAN style="font-size:11pt; color:#000000"
><Sub>Opportunity to Improve Serum Albumin </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>access routinely monitored for the presence of stenosis </SPAN
></P>
<P style="text-align:left; margin-bottom:-10px; margin-right:25px; margin-left:24px; text-indent:336px; line-height:11px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>66% of patients did not have a mean serum albumin during the three-month study period </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; margin-right:8px; margin-left:384px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (40/37 g/L) (BCG/BCP) during the three-month study period </SPAN
></P>
<P style="text-align:left; margin-bottom:4px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Anemia Management (AM) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>19% of patients did not have a mean serum albumin </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>84% of patients had a mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL (110 </SPAN
></SPAN
><SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (35/32 g/L) (BCG/BCP) during the three-</SPAN
></SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>g/L) in the last quarter of 2004 (FIGURE 5, TABLE 14) </SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>month study period </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; margin-right:172px; line-height:11px">
<SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
><Sup>1</Sup></SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> CMS has set a goal to have </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 66% of prevalent hemodialysis patients using an AV Fistula as their access by the year 2010. </SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
><Sup>2 </Sup></SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>BCG = bromcresol green, BCP = bromcresol purple; these are two different laboratory methods for assaying serum albumin. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-left:12px">
<SPAN style="font-size:11pt; color:#000000"
>SELECTED SIGNIFICANT FINDINGS FROM THE NATIONAL 2007 ESRD CPM PROJECT </SPAN
><SPAN style="font-size:11pt; color:#000000"
>SELECTED SIGNIFICANT FINDINGS FROM THE NATIONAL 2007 ESRD CPM PROJECT </SPAN
></P>
<TABLE style="margin-bottom:0px">
<TR>
<TH style="width:719px; height:531px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:11pt; color:#000000"
>Random Sample of Adult Peritoneal Dialysis (PD) Patients (n=1,433 sample for analysis) The data are from OCT 2006–MAR 2007: PD Adequacy</SPAN
><SPAN style="font-size:6.3pt; color:#000000"
>1 </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>85% of all peritoneal dialysis patients had a mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.7 </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> for CAPD patients was 2.31 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.65 </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>for Cycler patients was 2.22 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.64 (TABLE 18) </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Opportunities to Improve Adequacy </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The adequacy of dialysis was not assessed during the 2007 study period for 16% of the sampled peritoneal dialysis patients </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>15% of all peritoneal dialysis patients did not achieve the newly identified minimal “delivered” dose of Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.7 </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Anemia Management (AM) </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 82% of patients had a mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL (FIGURE 7) • 5% of patients had a mean hemoglobin &lt; 10.0 g/dL </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD hemoglobin was 12.0 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.3 g/dL (120 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 13 g/L) (FIGURE 8, TABLE 19) • 85% of patients had a mean transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% • 90% of patients had a mean serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL • 18% of patients had a mean serum ferritin &gt; 800 ng/mL • 29% of patients were prescribed IV iron during the six-month study period. </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Opportunities to Improve Anemia Management </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>18% of patients did not have a mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL (110 g/L) in the 2007 study period • 15% of patients did not have a mean transferrin satura</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tion </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% and 10% of patients did not have a mean serum ferritin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Serum Albumin </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>19% of patients had a mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (40/37 g/L) (BCG/BCP)</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>2 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(TABLE 20) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>63% of patients had a mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (35/32 g/L) (BCG/BCP) (TABLE 20) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD serum albumin was 3.6 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>± </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>0.5/3.3 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.6 g/dL (36 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 5/33 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 6 g/L) (BCG/BCP) </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Opportunities to Improve Serum Albumin </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>81% of PD patients did not have mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (40/37 g/L) (BCG/BCP) during the six-month study period </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>37% of PD patients did not have mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (35/32 g/L) (BCG/BCP) during the six-month study period </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:719px; height:51px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>1</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Using the 2006 KDOQI guidelines and recommendations (29):  For peritoneal dialysis patients with and without renal kidney function: weekly KtV</SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>urea </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 1.7. </SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>2</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>BCG = bromcresol green, BCP = bromcresol purple; these are two different laboratory methods for assaying serum albumin. </SPAN
></TH>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:8px; margin-left:4px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>100% Sample Pediatric In-Center Hemodialysis Patients (HD) (aged &lt; 18 years</SPAN
><SPAN style="font-size:11pt; color:#000000"
>) 
</SPAN
><SPAN style="font-size:11pt; color:#000000"
>(n=681 sample for analysis</SPAN
><SPAN style="font-size:11pt; color:#000000"
>) 
</SPAN
><SPAN style="font-size:11pt; color:#000000"
>The data are from OCT–DEC 2006</SPAN
><SPAN style="font-size:11pt; color:#000000"
>: 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:359px; text-indent:-358px">
<SPAN style="font-size:11pt; color:#000000"
>Clearanc</SPAN
><SPAN style="font-size:11pt; color:#000000"
>e 	</SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD hemoglobin was 11.5 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.6 g/dL (115 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 16) </SPAN
></P>
<P style="text-align:left; margin-bottom:-10px; margin-right:161px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>91% of patients had a mean delivered calculated, single </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
><Sup>g/L (FIGURE 11, TABLE 23) </Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>session adequacy dose of spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2 calculated using </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:-5px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>76% of patients had a mean transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% </SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>the Daugirdas II formula (26) (TABLE 21) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>82% of patients had a mean serum ferritin concentration </SPAN
></P>
<ul style="list-style-type:disc">
<LI style="margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD spKt/V was 1.62 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.34 (FIGURE 9) </SPAN
></LI>
</ul>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL </SPAN
></P>
<DL class="unexpected-ListItem" style="margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD dialysis session length was 203 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 30 </SPAN
></DD>

<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
><SPAN style="font-size:9.5pt"
>• 	</SPAN
>19% of patients had a mean serum ferritin &gt; 800 ng/mL </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>minutes </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:360px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Opportunity to Improve Anemia Management </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Opportunity to Improve Clearance </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>31% of patients did not have a mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>10% of patients did not have a mean spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>g/dL (110 g/L) during the three-month study period </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>during the three-month study period </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:360px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Serum Albumin </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Vascular Access </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>49% of patients had a mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
><SPAN style="font-size:9.5pt"
>• 	</SPAN
>31% of patients were dialyzed using an AV fistula (AVF) </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>g/dL (40/37 g/L) (BCG/BCP)<SPAN style="font-size:5.5pt; font-weight:normal"
><Sup>1 </Sup></SPAN
>(TABLE 24) </SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(FIGURE 10, TABLE 22) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>82% of patients had a mean serum albumin  </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2</SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
><SPAN style="font-size:9.5pt"
>• 	</SPAN
>52% of patients were dialyzed with a chronic catheter </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>g/dL (35/32 g/L) (BCG/BCP) (TABLE 24) </SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>continuously for 90 days or longer (FIGURE 10) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD serum albumin was 3.9 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.5/3.5 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.5 g/dL</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
><SPAN style="font-size:9.5pt"
>• 	</SPAN
>64% of patients with an AVF or an AV graft had their </SPAN
><SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(39 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 5/35 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 5 g/L) (BCG/BCP)</SPAN
></SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>access routinely monitored for the presence of stenosis </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:360px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Opportunity to Improve Serum Albumin </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Opportunitiy to Improve Vascular Access </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>51% of patients did not have a mean serum albumin </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
><SPAN style="font-size:9.5pt; font-weight:normal"
>• 	</SPAN
>36% of patients with an AVF or AV graft did not have </SPAN
><SPAN style=" font-weight:normal"
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (40/37 g/L) (BCG/BCP) during the three-</SPAN
></SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>this access routinely monitored for the presence of </SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>month study period </SPAN
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>stenosis during the three-month study period </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-right:9px; margin-left:384px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>18% of patients did not have a mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (35/32 g/L) (BCG/BCP) during the three-</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Anemia Management </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:384px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>month study period. </SPAN
></P>
<P style="text-align:left; margin-bottom:12px; margin-right:393px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>• 	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>69% of patients had a mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL (110 g/L) </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
><Sup>1</Sup></SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> BCG = bromcresol green, BCP = bromcresol purple; these are two different laboratory methods for assaying serum albumin. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>SELECTED SIGNIFICANT FINDINGS FROM THE NATIONAL 2007 ESRD CPM PROJECT </SPAN
></P>
<TABLE style="margin-bottom:29px">
<TR>
<TH style="width:720px; height:462px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:11pt; color:#000000"
>Clearance^ </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>87% of all peritoneal dialysis patients had a mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.8 </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> for CAPD was 2.20 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.74 (TABLE 25) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>for cycler patients was 2.52 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.74 (TABLE 25) </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Opportunities to Improve Clearance </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>13% of all PD patients did not have a mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
>urea </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.8 during the six-month study period </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Anemia Management </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>71% of patients had a mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL (110 g/L) (TABLE 26) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD hemoglobin was 11.6 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.4 g/dL (116 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 14 g/L) (TABLE 26) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>81% of patients had a mean transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>71% of patients had a mean serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL • 9% of patients had a mean serum ferritin concentration &gt; 800 ng/mL </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Opportunity to improve Anemia Management </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>29% of patients did not have a mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL (110 g/L) during the six-month study period </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Serum Albumin </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>27% of patients had a mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (40/37 g/L) (BCG/BCP) (TABLE 27) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>64% of patients had a mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (35/32 g/L) (BCG/BCP) (TABLE 27) </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean serum albumin was 3.6 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.6/3.3 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 0.6 g/dL (36 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 6/33 </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 6 g/L) (BCG/BCP) </SPAN
><SPAN style="font-size:11pt; color:#000000"
>Opportunity to Improve Serum Albumin </SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>• </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>73% of patients did not have a mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (40/37 g/L) (BCG/BCP) during the six-month study period • 36% of patients did not have a mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (35/32 g/L) (BCG/BCP) during the six-month study period </SPAN
><SPAN style="font-size:11pt; color:#000000"
>100% Sample Pediatric Peritoneal Dialysis Patients (PD) (aged &lt; 18 years) (n=740 sample for analysis) The data are from OCT 2006 – MAR 2007: </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:720px; height:37px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^Using the 2006 KDOQI guidelines and recommendations (29):  For pediatric peritoneal dialysis patients with and without renal kidney function: weekly KtV</SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>urea </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 1.8. </SPAN
></TH>
</TR>
</TABLE>
<P style="margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>IMPORTANT NOTE </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The data in this Report are intended to stimulate the development of quality improvement (QI) projects in dialysis facilities. The data collected for this project were necessarily limited: not all dialytic parameters that influence patient care for these clinical measures were collected. In addition, the project did not attempt to develop facility-specific profiles of care. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>As you review this Report, ask yourself questions about how your patients’ clinical characteristics compare to these national hemodialysis and peritoneal dialysis patient profiles and Network hemodialysis patient profiles. Additional information must be collected at your facility if you wish to answer these questions and develop ways to improve patient care for your patients. Your ESRD Network staff and Medical Review Board members are available to assist you in using these data in your QI activities and in developing facility-specific QI projects. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>V.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  ADULT IN-CENTER HEMODIALYSIS PATIENTS </SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>This section describes the findings for the sampled adult in-center hemodialysis patients for selected CPMs and other quality indicators related to adequacy of dialysis, vascular access, ane</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>mia management and serum albumin. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>A national random sample of adult ( </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years) in-center he</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>modialysis patients, stratified by Network, who were alive on December 31, 2006, was selected (n=8,937). 8,740 patients (97.8%) were included in the sample for analysis. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>A.</SPAN
><SPAN style="font-size:11pt; color:#000000"
>   ADEQUACY OF HEMODIALYSIS </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>CPM Findings for October–December 2006 CPMs </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Data to assess three hemodialysis adequacy CPMs were col</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lected in 2007. The time period from which these data were abstracted was October–December 2006. The results for these CPMs are included in this section of the report (Hemodialysis Adequacy CPMs I–III). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Hemodialysis Adequacy CPM I — </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The patient’s delivered dose of hemodialysis is measured at least once per month. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING: </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>87% of adult in-center hemodialysis patients in the sample for analysis had documented measurements of hemo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>dialysis adequacy (URR and/or spKt/V) for each month during the three-month study period (October–December 2006). These measurements were recorded in the patient’s chart, not calcu</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lated from individual data points. An additional 9% of the pa</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tients in the sample for analysis had documented adequacy mea</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>surements for two out of the three months, and another 4% of the patients had documented adequacy measurements for one of the three months. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Hemodialysis Adequacy CPM II — </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The patient’s delivered dose of hemodialysis recorded in the patient’s chart is calculated by using formal urea kinetic modeling (UKM) or the Daugirdas II formula (for spKt/V) (26). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 74% of adult in-center hemodialysis patients in the sample for analysis had delivered hemodialysis doses reported as spKt/V calculated using formal UKM or the Daugirdas II for</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>mula. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Hemodialysis Adequacy CPM III — </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The patient’s delivered dose of hemodialysis calculated from data points on the data collection form (monthly measurement averaged over the three-month study period) is spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2 using the Daugirdas II for</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>mula (26).This CPM is calculated on the subset of patients who had been on hemodialysis therapy for six months or longer and who were dialyzing three times per week (n=7,404). </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  For the last quarter of 2006, 93% of the adult in-center hemodialysis patients who met the inclusion criteria (only those patients who had been on hemodialysis therapy for six months or longer and who were dialyzing three times per week [n=7,404]) had a mean delivered calculated, single session (hereafter referred to as delivered) hemodialysis dose of spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2. </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>B. </SPAN
><SPAN style="font-size:11pt; color:#000000"
>ADEQUACY OF HEMODIALYSIS TABLES </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-right:28px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Hemodialysis Adequacy Findings for October-December 2006 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; color:#000000"
>TABLE 7:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; font-weight:normal; color:#000000"
>  Mean delivered calculated, single session spKt/V and percent of adult in-center hemodialysis patients with mean delivered calculated, single session spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; font-weight:normal; color:#000000"
> 1.2 and </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; font-weight:normal; color:#000000"
> 1.3 by characteristics, October-December 2006. 2007 ESRD CPM Project </SPAN
></P>
<P style="margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; color:#000000"
>Patient  Percent of Patients wit</SPAN
><SPAN style="font-size:9pt; color:#000000"
>h 
</SPAN
><SPAN style="font-size:9pt; color:#000000"
>Characteristics Mean spKt/V spKt/V </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; color:#000000"
> 1.2 spKt/V </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥ </SPAN
><SPAN style="font-size:9pt; color:#000000"
>1.</SPAN
><SPAN style="font-size:9pt; color:#000000"
>3 
</SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:8.5pt; color:#000000"
>TOTAL 1.55 90 83 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>GENDER Male 1.48 87 78 Female 1.63 94 89 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>RACE American Indian/Alaska Native 1.65 93 89 Asian/Pacific Islander 1.68 97 92 Black or African American 1.51 89 81 White 1.56 91 84 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Other</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>/Unknown </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>1.53 91 86 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ETHNICITY Hispanic 1.61 93 89 Non-Hispanic 1.54 90 82 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>AGE GROUP (years) 18 - 44 1.51 87 78 45 - 54 1.50 88 79 55 - 64 1.54 90 83 65 - 74 1.57 93 85 75+ 1.59 93 87 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>CAUSE of ESRD Diabetes Mellitus 1.54 90 82 Hypertension 1.55 91 84 Glomerulonephritis 1.55 91 84 Other/Unknown 1.56 91 83 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>DURATION OF DIALYSIS (years) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 0.5 1.39 73 60 </SPAN
></P>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 0.9 1.49 86 76 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 1.9 1.55 91 83 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 2.9 1.57 94 88 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 3.9 1.58 94 89 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> + 1.61 95 90 </SPAN
></LI>
</ol>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>QUINTILE POST-DIALYSIS BODY WEIGHT (kg) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>32.0</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 60.1 1.72 97 95 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>60.2</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 69.6 1.60 95 89 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>69.7</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 79.4 1.54 91 85 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>79.5</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 92.9 1.49 88 79 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>93.0</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 226.0 1.39 80 67 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ACCESS TYP</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>E 
</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>AV Fistula 1.57 93 8</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>6 
</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>AV Graft* 1.62 96 9</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>2 
</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Catheter 1.45 82 7</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>0 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>MEAN HGB (g/dL</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 11 1.56 92 8</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 
</SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 11 1.49 83 74 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:12px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>MEAN SERUM ALBUMIN (g/dL) </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 BCG/BCP^ 1.56 91 85 &lt; 3.5/3.2 BCG/BCP^ 1.50 86 77 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:368px; line-height:13px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*Includes grafts with and without AVF</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>^BCG/BCP = bromcresol green/bromcresol purple laboratory method</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>s 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
</DIV>
<P style="text-align:justify; margin-bottom:8px; margin-right:18px; line-height:18px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Table 8:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Percent of adult in-center hemodialysis patients receiving dialysis with a mean delivered, single session spKt/V </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 1.2, by gender, race, ethnicity, body weight, dialysis session length and Network, October-December 2006. 2007 ESRD CPM Project </SPAN
></P>
<TABLE style="margin-bottom:0px">
<TR>
<TH rowspan=2 style="vertical-align:middle; width:124px; height:63px; border-style:solid; border-color:#000000; border-width:2px 2px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>PATIENTCHARACTERISTIC </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:569px; height:35px; border-style:solid; border-color:#000000; border-width:2px">
<SPAN style="font-size:9.5pt; color:#000000"
>     NETWORK </SPAN
></TH>
<TH style="text-align:center; width:24px; height:35px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 2px"/>
</TR>
<TR>
<TD style="width:569px; height:27px; border-style:solid; border-color:#000000; border-width:2px">
<SPAN style="font-size:9.5pt; color:#000000"
>1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18</SPAN
></TD>
<TD style="text-align:right; width:24px; height:27px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 2px">
<SPAN style="font-size:9.5pt; color:#000000"
>   U.S. </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:bottom; width:695px; height:55px; border-style: solid solid none solid; border-color: #000000; border-width:2px 2px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>ALL 95 91 92 91 89 91 88 91 91 89 89 91 88 95 91 89 87 87 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:55px; border-style: border-style:solid solid none solid; border-color: #000000; border-width:2px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>90 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Male 94 88 91 89 86 87 86 88 89 85 86 88 84 93 88 86 83 83 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>87 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:64px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Female 97 95 93 95 95 94 92 94 94 94 93 95 91 97 95 95 92 93 RACE Black or</SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:64px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>94 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>  African American 93 89 92 91 90 91 88 89 89 85 88 91 88 93 89 83 83 82 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>89 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>White 95 92 91 91 87 91 88 93 93 91 89 91 86 96 91 89 84 87 ETHNICITY </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>91 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Hispanic 96 94 95 88 94 * 88 * * 100 92 86 * 96 93 98 88 91 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>93 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:64px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Non-Hispanic 95 91 90 91 89 91 88 91 91 87 89 92 88 94 90 88 86 84 POST-DIALYSIS BODY WEIGHT (kg)^ </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:64px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>90 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt; 74.83 99 97 96 96 95 94 92 96 98 97 92 95 96 98 96 94 94 92 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>95 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:64px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 74.83 90 84 87 87 84 88 84 87 86 79 87 88 80 92 86 84 76 79 DIALYSIS SESSION LENGTH </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:64px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>86 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt; 212.67 94 92 90 88 91 90 85 89 91 87 88 90 83 94 88 80 84 86 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>89 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:20px; border-style: none solid solid solid; border-color: #000000; border-width:1px 2px 2px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 212.67 97 91 93 93 87 92 91 92 92 90 91 93 92 95 94 94 93 91 </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:20px; border-style: border-style:none solid solid solid; border-color: #000000; border-width:1px 1px 2px 2px">
<SPAN style="font-size:9pt; color:#000000"
>92 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>* </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Value suppressed because n &lt; 11 ^ Post-dialysis body weight (kg) and dialysis session length categories were created at the median value for the study period Note:  A delivered spKt/V of 1.2 does not necessarily correlate with a delivered URR of 65% </SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>C. </SPAN
><SPAN style="font-size:11pt; color:#000000"
>VASCULAR ACCESS CPMs </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>CPM Findings for October-December 2006 </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Data to assess three vascular access CPMs were collected in 2007. The time period from which these data were abstracted was October–December 2006. Results for these CPMs are in</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>cluded in this report. </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Vascular Access CPM I —</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> A primary arteriovenous fistula (AVF) should be the access for at least 50% of all new patients initiat</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ing hemodialysis.  A native AVF should be the primary access for 40% of all prevalent patients undergoing hemodialysis. </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING: </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>41% of incident patients (initiating their most recent course of hemodialysis, on or between January 1, 2006 and August 31, 2006, [n = 1,302]) were dialyzed using an AVF on their last hemodialysis session during October–December 2006 (TABLE 9). </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>45% of all patients in the sample for analysis were dialyzed using an AVF during their last hemodialysis session October– December 2006 (TABLE 9). </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Vascular Access CPM II —</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Less than 10% of chronic mainte</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>nance hemodialysis patients should be maintained on catheters (continuously for 90 days or longer) as their permanent chronic dialysis access. </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  22% of all patients in the sample for analysis were dialyzed with a chronic catheter continuously for 90 days or longer during October–December 2006. </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Vascular Access CPM III —</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> A patient’s AV graft should be routinely monitored for stenosis. (See Vascular Access CPM III in Appendix 1 for a list of techniques and frequency of monitor</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ing used to screen for the presence of stenosis). </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  70% of patients with an AV graft (n=2,170) had this graft routinely monitored for the presence of stenosis during October–December 2006. </SPAN
></P>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>D. </SPAN
><SPAN style="font-size:11pt; color:#000000"
>VASCULAR ACCESS TABLES </SPAN
></P>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Vascular Access Findings for Oct-Dec 2006 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>TABLE 9:  Vascular access type for incident^ and all adult in-center hemodialysis patients during the last hemodialysis session of the study period, by selected patient characteristics, October-December 2006. 2007 ESRD CPM Project. </SPAN
></P>
<TABLE style="margin-bottom:0px">
<TR>
<TD style="width:229px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Incident (n = 1302) </SPAN
></TD>
<TD style="text-align:right; width:123px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Prevalent (n = 8740) </SPAN
></TD>
</TR>
<TR>
<TD style="vertical-align:top; width:229px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Patient  AVCharacteristic AVF  Graft Cath % % %</SPAN
></TD>
<TD style="text-align:right; vertical-align:top; width:123px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>          AV AVF^^ Graft  Cath % % % </SPAN
></TD>
</TR>
<TR>
<TD style="vertical-align:top; width:229px; height:639px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8pt; color:#000000"
>TOTAL </SPAN
><SPAN style="font-size:9pt; color:#000000"
>41 13 45 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER Male 49 12 39 Female 31 15 53 RACE American Indian/  Alaska Native * * * Asian/Pacific Islander 53 * 29 Black or African  American 34 16 50 White 44 12 44 Other/Unknown * * * ETHNICITY Hispanic 44 17 40 Non-Hispanic 41 13 46 AGE GROUP (years) 18 - 44 46 * 45 45 - 54 46 15 38 55 - 64 39 11 50 65 - 74 42 14 44 75+ 37 17 47 CAUSE of ESRD Diabetes Mellitus 41 15 44 Hypertension 39 16 45 Glomerulonephritis 50 * 44 Other/Unknown 41 8 51 DURATION OF DIALYSIS (years) &lt; 0.5 33 10 57 0.5 - 0.9 44 14 41 1.0 - 1.9 N/A N/A N/A 2.0 - 2.9 N/A N/A N/A 3.0 - 3.9 N/A N/A N/A 4.0 + N/A N/A N/A </SPAN
></TD>
<TD style="text-align:right; vertical-align:top; width:123px; height:639px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>45 26 29 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>53 22 25 35 32 38 59 24 17 56 24 20 40 23 28 48 22 30 * * * 52 26 22 44 26 30 52 20 27 48 27 25 44 27 29 43 29 28 41 26 33 43 28 29 45 28 27 54 24 22 45 20 34 23 8 69 44 14 41 49 25 26 53 27 19 51 32 17 46 36 18 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; margin-left:368px; line-height:11px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^An incident patient is defined as a patient initiating in-center hemodialysis on o</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>r 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>between January 1, 2006 and August 31, 2006</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^CMS has set a goal to have </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 66% of prevalent hemodialysis patients using a</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>n 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>AV Fistula as their access by the year 2010</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note:  Percentages may not add up to 100% due to rounding</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*Value suppressed because n &lt; 11</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:8px; margin-right:19px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Table 10:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Percent of all adult in-center hemodialysis patients with an AV fistula access^ on their last hemodialysis session during October-December 2006, by gender, race, ethnicity, age, cause of ESRD, and Network. 2007 ESRD CPM Project </SPAN
></P>
<TABLE style="margin-bottom:0px">
<TR>
<TH rowspan=2 style="vertical-align:middle; width:124px; height:63px; border-style:solid; border-color:#000000; border-width:2px 2px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>PATIENT CHARACTERISTIC </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:569px; height:35px; border-style:solid; border-color:#000000; border-width:2px">
<SPAN style="font-size:9.5pt; color:#000000"
>NETWORK </SPAN
></TH>
<TH style="text-align:center; width:24px; height:35px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 2px"/>
</TR>
<TR>
<TD style="width:569px; height:27px; border-style:solid; border-color:#000000; border-width:2px">
<SPAN style="font-size:9.5pt; color:#000000"
>1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18</SPAN
></TD>
<TD style="text-align:right; width:24px; height:27px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 2px">
<SPAN style="font-size:9.5pt; color:#000000"
>   U.S. </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:bottom; width:695px; height:58px; border-style: solid solid none solid; border-color: #000000; border-width:2px 2px 1px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>ALL 57 47 44 43 38 41 44 42 44 42 40 45 36 42 55 61 53 51 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:58px; border-style: border-style:solid solid none solid; border-color: #000000; border-width:2px 1px 1px 2px">
<SPAN style="font-size:9.5pt; color:#000000"
>45 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Male 64 55 53 51 44 50 53 53 53 52 45 51 46 51 63 66 62 59 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>53 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:64px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Female 47 37 33 33 32 32 31 28 32 25 36 38 25 34 45 55 40 39 RACE Black or</SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:64px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>35 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>  African American 48 41 40 41 37 40 44 41 40 38 35 41 34 38 39 57 47 42 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>40 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>White 59 50 48 46 39 44 44 44 45 44 41 46 38 45 55 60 58 51 ETHNICITY </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>48 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Hispanic 57 62 44 61 * * 49 * * 45 * 52 * 47 53 70 57 54 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>52 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Non-Hispanic 57 44 45 43 38 41 44 42 43 41 41 45 36 39 56 61 52 48 AGE GROUP (years) </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>44 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>18 - 44 67 60 40 48 53 52 57 52 53 41 44 55 43 48 59 71 52 58 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>52 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>45 - 54 53 47 57 44 38 45 50 38 47 47 45 47 42 52 54 68 57 51 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>48 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>55 - 64 60 42 34 48 34 46 42 44 44 47 35 50 45 38 57 61 52 50 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>44 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>65 - 74 52 52 43 44 43 36 39 38 43 41 34 39 31 40 56 52 49 47 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>43 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>75+ 56 41 51 37 30 27 38 35 38 31 46 40 21 35 51 60 56 50 CAUSE OF ESRD </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>41 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:32px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Diabetes Mellitus 50 49 41 38 33 38 38 40 44 40 39 43 34 42 57 61 50 48 Other Causes</SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:32px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>43 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:20px; border-style: none solid solid solid; border-color: #000000; border-width:1px 2px 2px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Combined 61 46 47 47 43 43 48 43 44 42 42 46 38 43 53 62 55 53 </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:20px; border-style: border-style:none solid solid solid; border-color: #000000; border-width:1px 1px 2px 2px">
<SPAN style="font-size:9pt; color:#000000"
>47 </SPAN
></TD>
</TR>
</TABLE>
<dl>
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>* </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Value suppressed because n &lt; 1</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>1 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^ CMS has set a goal to have </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 66% of prevalent hemodialysis patients using an AV Fistula as their access by the year 2010</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></DD>

<DIV class="Sect">
<DL class="unexpected-ListItem" style="margin-bottom:29px; margin-right:0px; margin-left:0px; text-indent:0px">
<DT style="list-style-type:none; margin-bottom:29px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>* </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:29px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Value suppressed because n &lt; 11 </SPAN
></DD>

</DIV>
</dl>
<P style="text-align:left; margin-bottom:8px; margin-right:39px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Table 11: </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> Percent of all adult in-center hemodialysis patients with a catheter access on their last hemodialysis session during October-December 2006, by gender, race, ethnicity, age, cause of ESRD, and Network. 2007 ESRD CPM Project </SPAN
></P>
<TABLE style="margin-bottom:8px">
<TR>
<TH rowspan=2 style="width:124px; height:63px; border-style:solid; border-color:#000000; border-width:2px 2px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>PATIENTCHARACTERISTIC </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:568px; height:35px; border-style:solid; border-color:#000000; border-width:2px">
<SPAN style="font-size:9.5pt; color:#000000"
>              NETWORK </SPAN
></TH>
<TH style="text-align:center; width:26px; height:35px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 2px"/>
</TR>
<TR>
<TD style="vertical-align:top; width:568px; height:27px; border-style:solid; border-color:#000000; border-width:2px">
<SPAN style="font-size:9.5pt; color:#000000"
>1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18</SPAN
></TD>
<TD style="text-align:right; vertical-align:top; width:26px; height:27px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 2px">
<SPAN style="font-size:9.5pt; color:#000000"
>   U.S. </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:bottom; width:693px; height:53px; border-style: solid solid none solid; border-color: #000000; border-width:2px 2px 1px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>ALL 27 27 35 32 30 26 33 25 32 33 35 32 36 24 30 22 23 20 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:26px; height:53px; border-style: border-style:solid solid none solid; border-color: #000000; border-width:2px 1px 1px 2px">
<SPAN style="font-size:9.5pt; color:#000000"
>29 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:693px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Male 24 23 29 31 28 21 30 23 26 29 33 28 32 20 25 20 18 17 </SPAN
></TH>
<TD style="text-align:right; width:26px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>25 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:693px; height:64px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Female 32 33 43 33 32 31 39 28 40 40 38 36 41 28 37 25 30 25 RACE Black or</SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:26px; height:64px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>33 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:693px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>  African American 31 28 34 27 27 23 29 23 31 36 26 34 32 28 40 * 31 19 </SPAN
></TH>
<TD style="text-align:right; width:26px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>28 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:693px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>White 26 29 35 34 34 34 37 29 33 32 41 31 43 22 31 23 22 21 ETHNICITY </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:26px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>30 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:693px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Hispanic * 21 31 * * * 31 * * 34 * * * 18 28 * 18 19 </SPAN
></TH>
<TD style="text-align:right; width:26px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>22 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:693px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Non-Hispanic 28 29 37 32 30 26 34 25 33 33 35 33 36 28 30 22 24 22 AGE GROUP (years) </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:26px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>30 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:693px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>18 - 44 28 25 44 28 27 25 26 20 28 39 30 29 33 26 29 18 28 22 </SPAN
></TH>
<TD style="text-align:right; width:26px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>27 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:693px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>45 - 54 23 24 30 34 27 17 29 31 34 25 30 27 28 16 29 19 17 22 </SPAN
></TH>
<TD style="text-align:right; width:26px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>25 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:693px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>55 - 64 24 30 37 25 34 26 37 22 34 27 38 26 33 25 26 19 25 21 </SPAN
></TH>
<TD style="text-align:right; width:26px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>27 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:693px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>65 - 74 27 20 30 31 23 24 33 26 28 36 38 36 34 28 30 29 24 23 </SPAN
></TH>
<TD style="text-align:right; width:26px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>28 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:693px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>75+ 31 34 34 38 37 39 38 29 35 41 36 39 50 24 33 22 21 15 CAUSE OF ESRD </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:26px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>33 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:693px; height:32px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Diabetes Mellitus 31 25 36 33 32 25 38 24 32 34 36 35 37 23 25 24 23 20 Other Causes</SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:26px; height:32px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>29 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:693px; height:18px; border-style: none solid solid solid; border-color: #000000; border-width:1px 2px 2px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Combined 25 29 34 31 28 27 30 26 32 33 34 30 35 26 34 21 23 21 </SPAN
></TH>
<TD style="text-align:right; width:26px; height:18px; border-style: border-style:none solid solid solid; border-color: #000000; border-width:1px 1px 2px 2px">
<SPAN style="font-size:9pt; color:#000000"
>29 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:8px; margin-left:145px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Table 12:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> Reasons for catheter placement in adult in-center hemodialysis patients using catheters on their last hemodialysis session during October-December 2006 compared to previous study periods. 2007 ESRD CPM Project.</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; margin-left:350px">
<SPAN style="font-size:9.5pt; color:#000000"
> 2002 2003 2004 2005 2006 </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; margin-left:145px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>No fistula or graf</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>t 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>surgically planned 22% 24% 27% 19% 29</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>% 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; margin-right:12px; margin-left:145px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Fistula or graft maturing</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>, 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>not ready to cannulate 27% 23% 26% 25% 30</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>% 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; margin-right:12px; margin-left:145px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Temporary interruption of fistula o</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>r 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>graft due to clotting or revisions 14% 12% 11% 10% 12</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>% 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; margin-right:12px; margin-left:145px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>No fistula or graft surgicall</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>y 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>created at this time 18% 22% 21% 19% 34</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>% 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:145px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>All fistula or graft site</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>s 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>have been exhausted 12% 13% 11% 18% 19</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>% 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>E.</SPAN
><SPAN style="font-size:11pt; color:#000000"
>  ANEMIA MANAGEMENT CPMs </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>CPM Findings for October–December 2006 </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Data were collected to assess three anemia management CPMs. The time period from which these data were abstracted was October–December 2006. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Anemia Management CPM I — </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The target hemoglobin is 11– 12 g/dL (110-120 g/L).  Patients with a mean hemoglobin &gt; 12 g/dL (120 g/L) and not prescribed epoetin were excluded from analysis for this CPM. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> For the last quarter of 2006, 33% of the in-center hemodialysis patients who met the inclusion criteria (n=8,110) had a mean hemoglobin 11–12 g/dL (110-120 g/L). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Anemia Management CPM IIa  —</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> For all anemic patients (he</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>moglobin &lt; 11 g/dL [110 g/L]) or patients prescribed epoetin, the percent transferrin saturation and the serum ferritin con</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>centration are assessed (measured) at least once in a three-month period. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> For the last quarter of 2006, 97% of the in-center hemodialysis patients who met the inclusion criteria (n=7,993) had at least one documented (measured) transferrin saturation value and at least one documented (measured) serum ferritin concentration value during the study period. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Anemia Management CPM IIb —</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> For all anemic patients (he</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>moglobin &lt; 11 g/dL [110 g/L]) or patients prescribed epoetin, at least one serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>100 ng/mL and at least one transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% were documented during the three-month study period. </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> For the last quarter of 2006, 82% of the in-center hemodialysis patients who met the inclusion criteria (n=7,993) had at least one documented transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% and at least one documented serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL during the study period. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Anemia Management CPM III —</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> All anemic patients (hemo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>globin &lt; 11 g/dL [110 g/L]), or patients prescribed epoetin, and with at least one transferrin saturation &lt; 20% or at least one serum ferritin concentration &lt; 100 ng/mL during the study pe</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>riod are prescribed intravenous iron; UNLESS the mean trans</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ferrin saturation was </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 50% or the mean serum ferritin concen</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tration was </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 800 ng/mL; UNLESS the patient was in the first three months of dialysis and was prescribed a trial dose of oral iron. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 83% of the in-center hemodialysis patients who met the inclusion criteria (n=2,874) were prescribed intravenous iron in at least one month during October–December 2006. </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>F.</SPAN
><SPAN style="font-size:11pt; color:#000000"
>  ANEMIA MANAGEMENT TABLES </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; margin-right:44px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Anemia Management Findings for October-December 2006 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:18px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 13:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Mean hemoglobin values (g/dL) for adult in-center hemodialysis patients in the U.S., by patient characteristics, October-December 2006. 2007 ESRD CPM Project </SPAN
></P>
<TABLE style="margin-bottom:6px">
<TR>
<TH style="width:113px; height:57px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Patient  Characteristics </SPAN
></TH>
<TH style="text-align:center; width:39px; height:57px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; color:#000000"
>Mean Hgb (g/dL) </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:30px; height:57px; border-style: solid none solid solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>&lt;10 </SPAN
></TH>
<TH style="vertical-align:bottom; width:149px; height:57px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Percent of Patients with hemoglobin values10-11-12-13</SPAN
><SPAN style="font-size:9pt; color:#000000"
></SPAN
><SPAN style="font-size:9pt; color:#000000"
>10.9 11.9 12.9 13.9 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:22px; height:57px; border-style: solid solid solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>14+ </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:bottom; width:113px; height:38px; border-style: solid solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>ALL </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>GENDER </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:39px; height:38px; border-style: border-style:solid solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:30px; height:38px; border-style: border-style:solid none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>5 </SPAN
></TD>
<TD style="vertical-align:top; width:149px; height:38px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>11 30 35 14 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:22px; height:38px; border-style: border-style:solid solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Male </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11 30 34 14 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>6 </SPAN
></TD>
</TR>
<TR>
<TH style="width:113px; height:47px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Female RACE American Indian/</SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:39px; height:47px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:30px; height:47px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
<TD style="vertical-align:top; width:149px; height:47px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12 31 35 13 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:22px; height:47px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>  Alaska Native </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.2 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>* </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>* 30 35 14 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>* </SPAN
></TD>
</TR>
<TR>
<TH style="width:113px; height:27px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Asian/Pacific Islander Black or</SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:39px; height:27px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:30px; height:27px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>* </SPAN
></TD>
<TD style="vertical-align:top; width:149px; height:27px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>10 33 35 15 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:22px; height:27px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>  African American </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>6 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11 30 34 14 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>6 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:14px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>White </SPAN
></TH>
<TD style="text-align:center; width:39px; height:14px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:14px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
<TD style="width:149px; height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12 31 36 13 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:14px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="width:113px; height:33px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Other/Unknown ETHNICITY </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:39px; height:33px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:30px; height:33px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>* </SPAN
></TD>
<TD style="vertical-align:top; width:149px; height:33px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>* * * * </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:22px; height:33px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>* </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Hispanic </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>3 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11 29 35 15 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="width:113px; height:34px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Non-Hispanic AGE GROUP (years) </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:39px; height:34px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:30px; height:34px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
<TD style="vertical-align:top; width:149px; height:34px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11 31 35 13 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:22px; height:34px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>18 - 44 </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>7 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12 29 32 14 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>6 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>45 - 54 </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>6 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12 30 32 15 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:14px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>55 - 64 </SPAN
></TH>
<TD style="text-align:center; width:39px; height:14px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:14px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
<TD style="width:149px; height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12 30 35 13 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:14px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>6 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>65 - 74 </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12 30 36 14 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
</TR>
<TR>
<TH style="width:113px; height:33px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>75+ CAUSE of ESRD </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:39px; height:33px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:30px; height:33px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
<TD style="vertical-align:top; width:149px; height:33px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>10 32 36 13 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:22px; height:33px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:14px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Diabetes Mellitus </SPAN
></TH>
<TD style="text-align:center; width:39px; height:14px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:14px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
<TD style="width:149px; height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12 31 34 14 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:14px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Hypertension </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11 31 36 14 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Glomerulonephritis </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>10 30 37 13 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>6 </SPAN
></TD>
</TR>
<TR>
<TH style="width:113px; height:47px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Other/Unknown DURATION OF DIALYSIS (years) </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:39px; height:47px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:30px; height:47px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>7 </SPAN
></TD>
<TD style="vertical-align:top; width:149px; height:47px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12 29 34 13 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:22px; height:47px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>&lt; 0.5 </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11.6 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>15 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>21 26 23 11 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>6 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:14px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>0.5 - 0.9 </SPAN
></TH>
<TD style="text-align:center; width:39px; height:14px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.3 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:14px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
<TD style="width:149px; height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>8 25 35 20 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:14px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>8 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>1.0 - 1.9 </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>10 32 36 14 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>2.0 - 2.9 </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.0 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>9 34 38 13 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>3 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:14px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>3.0 - 3.9 </SPAN
></TH>
<TD style="text-align:center; width:39px; height:14px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:14px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>3 </SPAN
></TD>
<TD style="width:149px; height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>9 33 39 13 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:14px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
</TR>
<TR>
<TH style="width:113px; height:33px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4.0 + MEAN spKt/V </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:39px; height:33px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:30px; height:33px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
<TD style="vertical-align:top; width:149px; height:33px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12 31 36 13 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:22px; height:33px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:14px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 1.2 </SPAN
></TH>
<TD style="text-align:center; width:39px; height:14px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:14px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
<TD style="width:149px; height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11 31 36 14 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:14px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="width:113px; height:47px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>&lt; 1.2 MEAN SERUM ALBUMIN (g/dL) </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:39px; height:47px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11.7 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:30px; height:47px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12 </SPAN
></TD>
<TD style="vertical-align:top; width:149px; height:47px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>17 28 27 12 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:22px; height:47px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:15px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 BCG/BCP^ </SPAN
></TH>
<TD style="text-align:center; width:39px; height:15px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.2 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:15px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>3 </SPAN
></TD>
<TD style="width:149px; height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>9 31 37 15 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:15px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>6 </SPAN
></TD>
</TR>
<TR>
<TH style="width:113px; height:34px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>&lt; 3.5/3.2 BCG/BCP^ ACCESS TYPE </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:39px; height:34px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11.5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:30px; height:34px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>14 </SPAN
></TD>
<TD style="vertical-align:top; width:149px; height:34px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>20 30 25 9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:22px; height:34px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>3 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:13px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>AV Fistula </SPAN
></TH>
<TD style="text-align:center; width:39px; height:13px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.2 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:13px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>3 </SPAN
></TD>
<TD style="width:149px; height:13px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>9 32 37 14 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:13px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:14px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>AV Graft** </SPAN
></TH>
<TD style="text-align:center; width:39px; height:14px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>12.1 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:14px; border-style: border-style:none none none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 </SPAN
></TD>
<TD style="width:149px; height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>10 31 37 13 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:14px; border-style: border-style:none solid none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:113px; height:14px; border-style: none solid solid solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Catheter </SPAN
></TH>
<TD style="text-align:center; width:39px; height:14px; border-style: border-style:none solid solid solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11.8 </SPAN
></TD>
<TD style="text-align:center; width:30px; height:14px; border-style: border-style:none none solid solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>10 </SPAN
></TD>
<TD style="width:149px; height:14px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>17 27 30 12 </SPAN
></TD>
<TD style="text-align:center; width:22px; height:14px; border-style: border-style:none solid solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>5 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; margin-left:368px; line-height:11px">
<SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>*Value suppressed because n &lt; 1</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>1 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>**Includes grafts with and without AVF</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>^BCG/BCP = bromcresol green/bromcresol purple laboratory methods</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note:  Percentages may not add up to 100% due to rounding</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:12px; line-height:18px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Table 14:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Percent of all adult in-center hemodialysis patients with mean hemoglobin </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 11 g/dL, by gender, race, ethnicity, age, access type, mean serum albumin, and Network, October-December 2006. 2007 ESRD CPM Project </SPAN
></P>
<TABLE style="margin-bottom:6px">
<TR>
<TH rowspan=2 style="vertical-align:middle; width:124px; height:63px; border-style:solid; border-color:#000000; border-width:2px 2px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>PATIENTCHARACTERISTIC </SPAN
></TH>
<TH style="text-align:right; vertical-align:bottom; width:569px; height:35px; border-style:solid; border-color:#000000; border-width:2px">
<SPAN style="font-size:9.5pt; color:#000000"
>           NETWORK </SPAN
></TH>
<TH style="text-align:center; width:24px; height:35px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 2px"/>
</TR>
<TR>
<TD style="width:569px; height:27px; border-style:solid; border-color:#000000; border-width:2px">
<SPAN style="font-size:9.5pt; color:#000000"
>1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18</SPAN
></TD>
<TD style="text-align:right; width:24px; height:27px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 2px">
<SPAN style="font-size:9.5pt; color:#000000"
>   U.S. </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:bottom; width:695px; height:60px; border-style: solid solid none solid; border-color: #000000; border-width:2px 2px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>ALL 83 84 83 82 82 84 82 79 83 81 85 81 83 86 86 87 85 85 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:60px; border-style: border-style:solid solid none solid; border-color: #000000; border-width:2px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>84 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Male 85 85 81 81 79 85 83 79 84 82 84 79 85 88 89 86 87 84 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>84 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:64px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Female 81 82 84 83 86 84 80 79 82 81 85 85 80 83 84 88 84 87 RACE Black or</SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:64px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>83 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>  African American 87 81 82 80 82 86 82 78 83 78 84 80 83 87 93 79 81 87 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>83 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>White 81 85 83 83 82 81 82 81 84 84 84 83 83 85 86 88 89 85 ETHNICITY </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>84 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Hispanic 76 89 84 78 94 * 88 * * 79 * 91 * 86 87 81 87 84 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>85 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Non-Hispanic 84 83 82 82 82 84 81 79 83 81 85 81 83 85 86 87 85 86 AGE GROUP (years) </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>83 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>18 - 44 75 78 81 77 86 82 78 76 81 74 75 82 75 86 87 86 86 86 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>81 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>45 - 54 84 78 76 71 76 84 83 74 82 76 82 80 82 88 88 83 87 82 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>82 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>55 - 64 88 82 84 82 85 85 82 79 84 85 80 82 88 88 82 89 81 86 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>84 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>65 - 74 78 90 81 85 86 86 77 79 86 83 82 79 86 83 88 81 85 83 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>84 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>75+ 86 86 89 86 79 85 88 88 82 84 93 84 80 82 89 92 90 90 ACCESS TYPE </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>86 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>AV Fistula 86 89 87 91 88 87 87 84 90 86 89 87 90 90 91 87 89 87 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>88 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>AV Graft** 86 85 89 82 86 86 84 83 80 88 90 78 87 91 85 91 83 88 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>86 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:695px; height:64px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Catheter 75 73 73 69 70 78 74 65 77 70 75 76 73 69 78 81 80 79 MEAN SERUM ALBUMIN (g/dL) </SPAN
></TH>
<TD style="text-align:right; vertical-align:top; width:24px; height:64px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>74 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:16px; border-style: none solid none solid; border-color: #000000; border-width:1px 2px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 3.5/3.2 BCG/BCP^ 88 87 88 86 87 88 87 82 88 84 91 84 86 91 89 90 89 89 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:16px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 2px">
<SPAN style="font-size:9pt; color:#000000"
>88 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:695px; height:18px; border-style: none solid solid solid; border-color: #000000; border-width:1px 2px 2px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt; 3.5/3.2 BCG/BCP^ 65 72 62 61 59 69 61 62 68 61 67 72 70 62 70 73 71 66 </SPAN
></TH>
<TD style="text-align:right; width:24px; height:18px; border-style: border-style:none solid solid solid; border-color: #000000; border-width:1px 1px 2px 2px">
<SPAN style="font-size:9pt; color:#000000"
>66 </SPAN
></TD>
</TR>
</TABLE>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>* </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Value suppressed because n &lt; 11 **Includes grafts with and without AVF ^BCG/BCP = bromcresol green/bromcresol purple laboratory methods. </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10. Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-right:28px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>Table 15:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Regional variation for various anemia management measures for adult in-center hemodialysis patients including the percent of patients with mean hemoglobin </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 11 g/dL, mean hemoglobin (g/dL), and mean serum albumin </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 4.0 (BCG)^ for these patients nationally and by Network, October-December 2006. 2007 ESRD CPM Project. </SPAN
></P>
<TABLE style="margin-bottom:0px">
<TR>
<TH rowspan=2 style="width:116px; height:52px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>PatientCharacteristic </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:571px; height:26px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; color:#000000"
>                                            Network </SPAN
></TH>
<TH style="text-align:center; width:34px; height:26px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="vertical-align:bottom; width:571px; height:26px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; color:#000000"
>1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:34px; height:26px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>U.S. </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:bottom; width:686px; height:37px; border-style: solid solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>% patients with mean hemoglobin </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:37px; border-style: border-style:solid solid none solid; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH colspan=2 style="width:686px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; color:#000000"
> 11 g/dL 83 84 83 82 82 84 82 79 83 81 85 81 83 86 86 87 85 85 Mean hemoglobin </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>84 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:686px; height:80px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>(g/dL) 11.9 12.0 12.0 11.9 12.0 12.1 12.1 11.9 12.0 12.0 12.0 11.9 12.0 12.1 12.2 12.1 12.1 12.1 % patients with mean serum albumin </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; color:#000000"
> 4.0 </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:80px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>12.0 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:686px; height:64px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>g/dL (BCG)^ 31 35 30 30 36 34 35 31 29 37 28 27 31 34 35 35 40 40 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Average transferrin saturation </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:64px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>34 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:686px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(TSAT) (%) </SPAN
><SPAN style="font-family:'sans-serif', 'Arial'; font-size:8.5pt; font-weight:normal; color:#000000"
>29 29 28 27 29 28 29 27 27 27 28 27 29 29 28 26 28 29 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>% patients with </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>28 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:686px; height:80px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>mean TSAT </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 20% </SPAN
><SPAN style="font-family:'sans-serif', 'Arial'; font-size:8.5pt; font-weight:normal; color:#000000"
>80 79 76 78 82 80 82 79 78 78 79 73 81 82 77 74 78 79 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Average serum ferritin concentration </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:80px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>79 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:bottom; width:686px; height:80px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(ng/mL) </SPAN
><SPAN style="font-family:'sans-serif', 'Arial'; font-size:8.5pt; font-weight:normal; color:#000000"
>572 570 596 586 579 586 596 565 586 586 566 556 623 600 544 504 571 631 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>% patients with mean serum ferritin concentration </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:80px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>583 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:686px; height:80px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 100 ng/mL </SPAN
><SPAN style="font-family:'sans-serif', 'Arial'; font-size:8.5pt; font-weight:normal; color:#000000"
>95 91 95 94 94 93 93 95 95 96 96 96 96 97 93 93 94 96 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>% patients with mean serum ferritin concentration </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:80px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>95 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:686px; height:64px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>&gt; 800 ng/mL </SPAN
><SPAN style="font-family:'sans-serif', 'Arial'; font-size:8.5pt; font-weight:normal; color:#000000"
>20 22 24 22 25 23 26 19 24 20 21 20 27 24 18 14 21 29 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>% of all patients with IV iron </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:64px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>23 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:686px; height:48px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>prescribed </SPAN
><SPAN style="font-family:'sans-serif', 'Arial'; font-size:8.5pt; font-weight:normal; color:#000000"
>68 65 71 71 63 69 69 72 72 75 72 72 73 72 65 72 64 68 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>% of patients </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:48px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>70 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:686px; height:80px; border-style: none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>prescribed ESA^^ </SPAN
><SPAN style="font-family:'sans-serif', 'Arial'; font-size:8.5pt; font-weight:normal; color:#000000"
>94 94 95 95 93 94 92 94 92 95 89 92 93 95 90 95 95 95 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>% of patients with mean hemoglobin &lt; 11 g/dL with </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:80px; border-style: border-style:none solid none solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>94 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="width:686px; height:20px; border-style: none solid solid solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESA prescribed </SPAN
><SPAN style="font-family:'sans-serif', 'Arial'; font-size:8.5pt; font-weight:normal; color:#000000"
>95 91 94 92 94 89 91 93 90 93 91 88 93 96 95 92 94 92 </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:34px; height:20px; border-style: border-style:none solid solid solid; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>94 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^ For subset of patients with serum albumin tested by the bromcresol green (BCG) laboratory metho</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>d 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^ ESA – Erythropoetin Stimulating Agent</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>s 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>G.</SPAN
><SPAN style="font-size:11pt; color:#000000"
>  SERUM ALBUMIN TABLE </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Serum Albumin Findings for October-December 2006 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-right:147px; margin-left:144px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 16:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Percent of adult in-center hemodialysis patients with mean serum albumin values </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (BCG/BCP)* and </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (BCG/BCP) in the U.S., by patient characteristics, October-December 2006. 2007 ESRD CPM Project.</SPAN
></P>
<P style="text-align:left; margin-bottom:8px; text-indent:211px; line-height:16px">
<SPAN style="font-size:10pt; color:#000000"
>                                                        Percent of Patients with Patient  Mean Serum Albumin Characteristics </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:10pt; color:#000000"
> 4.0/3.7 g/dL </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:10pt; color:#000000"
> 3.5/3.2 g/dL </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; color:#000000"
>TOTAL 34 81 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER Male 39 83 Female 28 78 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>RACE American Indian/Alaska Native 21 74 Asian/Pacific Islander 41 86 Black or African American 37 83 White 31 79 Other/Unknown 44 83 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>ETHNICITY Hispanic 38 83 Non-Hispanic 33 80 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>AGE GROUP (years) 18 - 44 49 86 45 - 54 41 86 55 - 64 33 81 65 - 74 29 79 75+ 23 76 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>CAUSE of ESRD Diabetes Mellitus 27 78 Hypertension 39 85 Glomerulonephritis 46 88 Other/Unknown 34 78 </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>DURATION OF DIALYSIS (years) </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.5 17 60 </SPAN
></P>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 0.9 27 78 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 1.9 33 82 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 2.9 38 85 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 3.9 38 85 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> + 40 86 </SPAN
></LI>
</ol>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>MEAN spKt/V </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 1.2 35 82 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 1.2 29 72 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>MEAN HGB (g/dL) </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 11 3785 &lt; 11 18 61 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>ACCESS TYPE AV Fistula 41 87 AV Graft** 36 85 Catheter 20 67 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:144px; line-height:11px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:8pt; font-weight:normal; color:#000000"
>*</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>BCG/BCP = bromcresol green/bromcresol purple laboratory method</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>s 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>**Includes grafts with and without AV</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>F 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>VI.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  ADULT PERITONEAL DIALYSIS PATIENTS </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>This section describes the findings for adult peritoneal dialysis patients for selected CPMs and other quality indicators related to adequacy of peritoneal dialysis, anemia management, and serum albumin. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>A national random sample of adult  (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years) peritoneal di</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>alysis patients who were alive on December 31, 2006, was se</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lected (sample size=1,474). 1,433 patients (97.2%) were in</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>cluded in the sample for analysis. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>A.</SPAN
><SPAN style="font-size:11pt; color:#000000"
>  ADEQUACY OF PERITONEAL DIALYSIS CPMs </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>CPM Findings for October 2006–March 2007 </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Data to assess three peritoneal dialysis adequacy CPMs were collected in 2007. The time period from which these data were abstracted was October 2006–March 2007. Tidal peritoneal di</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>alysis patients (n=52) were excluded from the peritoneal dialy</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>sis adequacy CPM calculations. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Peritoneal Dialysis Adequacy CPM I — </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The patient’s total solute clearance for urea and creatinine is measured routinely (defined for this report as at least once during the six-month study period). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 84% of adult peritoneal dialysis patients had both a weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>and a weekly creatinine clearance measurement reported at least once during the six-month study period (FIG</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>URE 2). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Peritoneal Dialysis Adequacy CPM II — </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The patient’s total solute clearance for urea (weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) and creatinine (weekly creatinine clearance) is calculated in a standard way. (See Peri</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>toneal Dialysis Adequacy CPM II in Appendix 1). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  49% of adult peritoneal dialysis patients who had reported adequacy measurements documented in their charts at least once during the six-month study period had these reported measurements (Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>and creatinine clearance) calculated in a standard way as described in Peritoneal Dialysis Adequacy CPM II in Appendix 1 (FIGURE 2). </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Peritoneal Dialysis Adequacy CPM III —</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> For patients on CAPD, the delivered peritoneal dialysis dose is a weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least 2.0 and a weekly creatinine clearance of at least 60 L/week/1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> OR there was evidence the dialysis prescription was changed if the adequacy measurements were below these thresholds during the six-month study period. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For CCPD patients (cycler patients with a daytime dwell), the delivered peritoneal dialysis dose is a weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>of at least </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2.1</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> and a weekly creatinine clearance of at least 63 L/week/ </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>1.73</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> OR there was evidence the dialysis prescription was changed if the adequacy measurements were below these thresholds during the six-month study period. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For NIPD patients (cycler patients without a daytime dwell), the delivered peritoneal dialysis dose is a weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2.2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> and a weekly creatinine clearance of at least 66 L/week/ </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>1.73</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2 </Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>OR there was evidence the dialysis prescription was changed if the adequacy measurements were below these thresholds during the six-month study period. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For the October 2006-March 2007 Study period, CCPD patients and NIPD patients were not distinguishable. For Cycler patients, the delivered peritoneal dialysis dose is a weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least 2.1 and a weekly creatinine clearance of at least 63 L/week/1.73m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  75% of CAPD patients had a mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 2.0 and a mean weekly creatinine clearance </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 60 L/week/ </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>1.73</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> OR there was evidence the dialysis prescription was changed if the adequacy measurements were below these thresholds during the six-month study period (FIGURE 3). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:12px">
<SPAN style="font-size:8pt; font-weight:normal; color:#000000; text-decoration:underline"
>ALTERNATE FINDING:</SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
> 85% (97/114) of CAPD patients with a Peritoneal Equilibration Test (PET) result within 12 months of or during the study pe</SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>riod met the revised 2000 NKF-K/DOQI thresholds for peritoneal dialysis adequacy (3) (a mean weekly Kt/V</SPAN
><SPAN style="font-size:4.6pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
> 2.0 and for high and high-average transporters, a weekly creatinine clearance </SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
> 60 L/week/1.73m</SPAN
><SPAN style="font-size:4.6pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>, for low and low-average transporters, a weekly creatinine clearance </SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
> 50 L/week/ 1.73m</SPAN
><SPAN style="font-size:4.6pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:8pt; font-weight:normal; color:#000000"
>, OR there was evidence the dialysis prescription was changed if the adequacy measurements were below these thresholds during the six-month study period). </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 64% of cycler patients had a mean weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 2.1 and a mean weekly creatinine clearance </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 63 L/week/ </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>1.73</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> OR there was evidence the dialysis prescription was changed if the adequacy measurements were below these thresholds during the six-month study period (FIGURE 3). </SPAN
></P>
<TABLE style="text-align:left; margin-bottom:4px">
<CAPTION  style="margin-bottom:4px">
<P style="text-align:left; margin-bottom:10px; line-height:14px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:8.8pt; font-style:italic; color:#211D1E"
>TABLE 17:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:8.8pt; font-style:italic; font-weight:normal; color:#211D1E"
>  Percent of adult CAPD patients with mean </SPAN
><SPAN style="font-size:8.8pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:8.8pt; font-style:italic; font-weight:normal; color:#211D1E"
> SD weekly adequacy values meeting 2000 NKF-K/DOQI guidelines and median adequacy values,by transporter type (4 hr. D/P Cr Ratio)*, October 2006–March 2007. 2007 ESRD CPM Project.</SPAN
></P>
</CAPTION>
<TR>
<TH style="width:150px; height:26px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px"/>
<TH colspan=2 style="text-align:center; vertical-align:middle; width:137px; height:26px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 3px">
<SPAN style="font-size:8.4pt; color:#211D1E"
>Oct 2000-Mar 2001 </SPAN
></TH>
<TH colspan=2 style="text-align:center; vertical-align:middle; width:135px; height:26px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 3px">
<SPAN style="font-size:8.4pt; color:#211D1E"
>Oct 2002-Mar 2003</SPAN
></TH>
<TH colspan=2 style="text-align:center; vertical-align:middle; width:137px; height:26px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 3px">
<SPAN style="font-size:8.4pt; color:#211D1E"
> Oct 2004-Mar 2005</SPAN
></TH>
<TH colspan=2 style="text-align:center; vertical-align:middle; width:136px; height:26px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 3px">
<SPAN style="font-size:8.4pt; color:#211D1E"
> Oct 2005-Mar 2006</SPAN
></TH>
<TH colspan=2 style="text-align:center; vertical-align:middle; width:136px; height:26px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:8.4pt; color:#211D1E"
> Oct 2006-Mar 2007</SPAN
></TH>
</TR>
<TR>
<TD style="vertical-align:top; width:150px; height:207px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Adequacy MeasureWeekly Kt/V</SPAN
><SPAN style="font-size:4.6pt; color:#211D1E"
>urea</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>% meeting 1997 NKF-K/DOQI^% meeting 2006 KDOQI^^mean </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> SD median</SPAN
><SPAN style="font-size:7.9pt; color:#211D1E"
>Weekly Creatinine Clearance(L/week/1.73m</SPAN
><SPAN style="font-size:4.6pt; color:#211D1E"
>2 </SPAN
><SPAN style="font-size:7.9pt; color:#211D1E"
>)</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>% meeting 1997 NKF-K/DOQImean </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> SD median </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:67px; height:207px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>High-Avg/High</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>75%2.35 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.572.2676%82.6 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 29.778.6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:70px; height:207px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Low/Low-Avg</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>71%2.35 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.582.3279%73.0 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 27.568.5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:69px; height:207px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>High-Avg/High</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>74%2.36 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.592.2666%80.1 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 30.072.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:66px; height:207px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Low/Low-Avg</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>81%2.37 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.482.4079%72.9 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 26.669.6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:69px; height:207px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>High-Avg/High</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>68%2.41 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.702.3673%81.0 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 27.676.4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:68px; height:207px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Low/Low-Avg</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>62%2.28 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.772.1061%75.4 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 32.267.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:70px; height:207px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>High-Avg/High</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>62%2.29 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.552.2770%81.1 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 30.969.1 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:66px; height:207px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Low/Low-Avg</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>71%2.26 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.602.2572%77.1 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 26.978.4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:69px; height:207px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>High-Avg/High</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>64%88%2.29 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.672.1769%77.4 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 28.467.2 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:68px; height:207px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Low/Low-Avg</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>69%90%2.38 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.702.3180%79.8 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 31.273.0 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; line-height:10px">
<SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>Transporter type (4 hr. D/P Cr Ratio):</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>*   Low = 0.34-0.49; Low-Average = 0.50-0.64; High-Average = 0.65-0.81; High = 0.82-1.03^ For CAPD patients, the delivered PD dose was a weekly Kt/V</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
>urea </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 2.0 and a weekly creatinine clearance </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 60 L/week/1.73m</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
>2</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> for high-average and high</SPAN
></P>
<P style="text-align:left; margin-bottom:8px; text-indent:6px; line-height:10px">
<SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>   transporters, and </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 50 L/week/1.73m</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
>2</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> for low and low-average transporters.^^ Using the 2006 KDOQI guidelines and recommendations (29):  For peritoneal dialysis patients with and without renal kidney function: weekly KtV</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
>urea </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 1.7 </SPAN
></P>
<P style="text-align:left; margin-bottom:12px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:8.8pt; font-style:italic; color:#211D1E"
>TABLE 18:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:8.8pt; font-style:italic; font-weight:normal; color:#211D1E"
>  Percent of adult cycler patients with mean </SPAN
><SPAN style="font-size:8.8pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:8.8pt; font-style:italic; font-weight:normal; color:#211D1E"
> SD weekly adequacy values meeting 2000 NKF-K/DOQI guidelines and median adequacy values, October 2006 </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:8.8pt; font-style:italic; font-weight:normal; color:#211D1E"
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:8.8pt; font-style:italic; font-weight:normal; color:#211D1E"
>March 2007. 2007 ESRD CPM Project.</SPAN
></P>
</DIV>
<TABLE style="text-align:right; margin-bottom:0px">
<TR>
<TH style="width:150px; height:24px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px"/>
<TH colspan=2 style="text-align:center; vertical-align:middle; width:135px; height:24px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 3px">
<SPAN style="font-size:8.4pt; color:#211D1E"
>Oct 2000-Mar 2001 </SPAN
></TH>
<TH colspan=2 style="text-align:center; vertical-align:middle; width:136px; height:24px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 3px">
<SPAN style="font-size:8.4pt; color:#211D1E"
>Oct 2002-Mar 2003</SPAN
></TH>
<TH colspan=2 style="text-align:center; vertical-align:middle; width:136px; height:24px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 3px">
<SPAN style="font-size:8.4pt; color:#211D1E"
> Oct 2004-Mar 2005</SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:137px; height:24px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 3px">
<SPAN style="font-size:8.4pt; color:#211D1E"
> Oct 2005-Mar 2006</SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:136px; height:24px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:8.4pt; color:#211D1E"
> Oct 2006-Mar 2007</SPAN
></TH>
</TR>
<TR>
<TD style="vertical-align:top; width:150px; height:208px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Adequacy MeasureWeekly Kt/V</SPAN
><SPAN style="font-size:4.6pt; color:#211D1E"
>urea</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>% meeting 1997 NKF-K/DOQI^% meeting 2006 KDOQI^^^mean </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> SD median</SPAN
><SPAN style="font-size:7.9pt; color:#211D1E"
>Weekly Creatinine Clearance(L/week/1.73m</SPAN
><SPAN style="font-size:4.6pt; color:#211D1E"
>2 </SPAN
><SPAN style="font-size:7.9pt; color:#211D1E"
>)</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>% meeting 1997 NKF-K/DOQImean </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> SD median </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:67px; height:208px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>w/daytimedwell</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>64%2.33 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.552.2455%71.9 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 25.665.7 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:68px; height:208px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>no daytimedwell</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>53%2.33 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.732.2261%77.6 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 31.075.3 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:68px; height:208px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>w/daytimedwell</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>64%2.31 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.542.2549%66.5 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 22.262.3 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:68px; height:208px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>no daytimedwell</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>58%2.53 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.802.3856%74.3 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 33.070.2 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:69px; height:208px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>w/daytimedwell</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>57%2.23 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.612.1949%66.8 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 23.262.4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:67px; height:208px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 1px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>no daytimedwell</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>60%2.37 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.772.3450%72.4 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 29.966.4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:137px; height:208px; border-style:solid; border-color:#000000; border-width:1px 3px 1px 3px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Cycler^^</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>57%2.26 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.622.1748%66.7 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 24.561.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:136px; height:208px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 3px">
<SPAN style="font-size:7.9pt; color:#211D1E"
>Cycler^^</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>55%83%2.22 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 0.642.1747%68.4 </SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
>±</SPAN
><SPAN style="font-size:7.9pt; font-weight:normal; color:#211D1E"
> 27.860.7 </SPAN
></TD>
</TR>
</TABLE>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>^For cycler patients with daytime dwell (CCPD patients): Kt/V</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
>urea </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 2.1; creatinine clearance </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 63 L/week/1.73m</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
>2</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>;</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:6px; line-height:10px">
<SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>  For nighttime cycler patients (no daytime dwell) (NIPD patients): Kt/V</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
>urea </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 2.2; creatinine clearance </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 66 L/week/1.73m</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
><Sup>2</Sup></SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>^^ For Oct 2005-Mar 2006 and Oct 2006-Mar 2007 CCPD and NIPD modalities were not distinguishable; For Cycler patients: Kt/V</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
>urea </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 2.1; creatinine clearance </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 63 L week/1.73m</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
><Sup>2 </Sup></SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>^^^ Using the 2006 KDOQI guidelines and recommendations (29):  For peritoneal dialysis patients with and without renal kidney function: weekly KtV</SPAN
><SPAN style="font-size:3.6pt; font-weight:normal; color:#211D1E"
>urea </SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.2pt; font-weight:normal; color:#211D1E"
> 1.7 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; margin-right:350px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2007 ESRD CLINICAL PERFORMANCE MEASURES PROJECT ADULT PERITONEAL DIALYSIS  PATIENTS (Adequacy) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:35px">
<SPAN style="font-size:11pt; color:#000000"
>B.</SPAN
><SPAN style="font-size:11pt; color:#000000"
>  ADEQUACY OF PERITONEAL DIALYSIS TABLES Peritoneal Dialysis Adequacy Findings for October 2006-March 2007 </SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>C.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  ANEMIA MANAGEMENT CPMs </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>CPM Findings for October 2006–March 2007 </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Data to assess three anemia management CPMs were collected in 2007. The time period from which these data were abstracted was October 2006–March 2007. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Anemia Management CPM I — </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The target hemoglobin is 11– 12 g/dL (110-120 g/L). Patients with a mean hemoglobin &gt; 12 g/dL (120 g/L) and not prescribed epoetin were excluded from analysis for this CPM. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  For the six-month study period, 37% of the perito</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>neal dialysis patients who met the inclusion criteria (n=1,266) had a mean hemoglobin 11–12 g/dL (110-120 g/L) during October 2006—March 2007. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Anemia Management CPM IIa  —</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> For all anemic patients (he</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>moglobin &lt; 11 g/dL [110 g/L]) or patients prescribed epoetin, the percent transferrin saturation and serum ferritin concentra</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tion are assessed (measured) at least two times during the six-month study period. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  74% of the peritoneal dialysis patients who met the inclusion criteria (n=1,246) had at least two documented (mea</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>sured) transferrin saturation values and at least two documented (measured) serum ferritin concentration values during October 2006–March 2007. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Anemia Management CPM IIb —</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> For all anemic patients (he</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>moglobin &lt; 11 g/dL [110 g/L]) or patients prescribed epoetin, at least one serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL and at least one transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% were documented during the six-month study period. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  85% of the adult peritoneal dialysis patients who met the inclusion criteria (n=1,246) had at least one documented transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% and at least one documented se</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>rum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL during October 2006– March 2007. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Anemia Management CPM III —</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> All anemic patients (hemo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>globin &lt; 11 g/dL [110 g/L]) or patients prescribed epoetin, with at least one transferrin saturation  &lt; 20% or at least one serum ferritin concentration &lt; 100 ng/mL during the study period are prescribed intravenous iron; UNLESS the mean transferrin satu</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ration was </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 50% or the mean serum ferritin concentration was </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 800 ng/ml; UNLESS the patient was in the first three months of dialysis and was prescribed a trial dose of oral iron. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000; text-decoration:underline"
>FINDING:</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 41% of the peritoneal dialysis patients who met the inclusion criteria (n=493) were prescribed intravenous iron at least once during October 2006–March 2007. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>D.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  ANEMIA MANAGEMENT TABLES </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-right:10px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Anemia Management Findings for October 2006– March 2007 </SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 19:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Mean hemoglobin values (g/dL) for adult peritoneal dialysis patients, by patient characteristics, October 2006-March 2007. 2007 ESRD CPM Project. </SPAN
></P>
<TABLE style="margin-bottom:5px">
<TR>
<TH style="width:117px; height:56px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Patient  Characteristics </SPAN
></TH>
<TH style="text-align:center; width:36px; height:56px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Mean Hgb (g/dL) </SPAN
></TH>
<TH style="vertical-align:bottom; width:29px; height:56px; border-style: solid none solid solid; border-color: #000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9pt; color:#000000"
>&lt;10 </SPAN
></TH>
<TH style="width:170px; height:56px; border-style: solid solid solid none; border-color: #000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Percent of Patients with hemoglobin values10-11-12-13</SPAN
><SPAN style="font-size:9pt; color:#000000"
></SPAN
><SPAN style="font-size:9pt; color:#000000"
>10.9 11.9 12.9 13.9 14+ </SPAN
></TH>
</TR>
<TR>
<TD style="vertical-align:top; width:117px; height:680px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>TOTAL </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER Male Female RACE American Indian/  Alaska Native Asian/Pacific Islander 12.0 Black or  African American White Other/Unknown ETHNICITY Hispanic Non-Hispanic AGE GROUP (years) 18 - 44 45 - 54 55 - 64 65 - 74 75+ CAUSE of ESRD Diabetes Mellitus Hypertension Glomerulonephritis Other/Unknown DURATION OF DIALYSIS (years) &lt; 0.5 0.5 - 0.9 1.0 - 1.9 2.0 - 2.9 3.0 - 3.9 4.0 + MEAN SERUM ALBUMIN (g/dL) </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 3.5/3.2 BCG/BCP^ &lt; 3.5/3.2 BCG/BCP^ MEAN WEEKLY CREATININE CLEARANCE </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 60 L/week/1.73m</SPAN
><SPAN style="font-size:5.1pt; font-weight:normal; color:#000000"
>2 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt; 60 L/week/1.73m</SPAN
><SPAN style="font-size:5.1pt; font-weight:normal; color:#000000"
>2 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:36px; height:680px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>12.0 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>12.1 11.9 11.8 11.8 12.1 * 12.1 12.0 11.7 12.0 12.2 12.0 12.3 12.0 12.0 12.0 12.1 12.3 12.3 12.1 11.9 11.9 11.7 12.2 11.8 12.3 12.0 </SPAN
></TD>
<TD style="vertical-align:top; width:29px; height:680px; border-style: border-style:solid none solid solid; border-color: #000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>6 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>5 7 * * 10 4 * * 6 11 6 3 * * 4 7 5 7 * * 4 * * 11 4 8 * 6 </SPAN
></TD>
<TD style="vertical-align:top; width:170px; height:680px; border-style: border-style:solid solid solid none; border-color: #000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>12 31 32 13 6 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>11 29 34 15 7 14 33 30 12 4 * * * * * 13 33 33 15 * 13 35 24 13 4 12 29 35 13 7 * * * * * 10 28 37 14 6 13 31 31 13 6 15 27 30 10 6 15 28 31 12 7 10 34 30 17 5 11 34 38 13 * 9 33 33 14 9 13 32 34 13 3 11 27 33 14 7 15 33 28 14 6 10 30 32 13 8 9 25 38 18 8 11 25 34 18 9 10 33 35 13 6 15 36 29 11 * 16 35 29 10 * 13 31 28 11 5 10 30 35 14 7 16 32 27 12 5 9 27 39 15 8 12 33 32 10 </SPAN
><SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
>7 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; margin-left:368px; line-height:11px">
<SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: Percentages may not add up to 100% due to rounding</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>^BCG/BCP = bromcresol green/bromcresol purple laboratory methods</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>*Value suppressed because n &lt; 11</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>E. </SPAN
><SPAN style="font-size:11pt; color:#000000"
>SERUM ALBUMIN TABLE </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:20px">
<SPAN style="font-size:11pt; color:#000000"
>Peritoneal Dialysis Serum Albumin Findings for October 2006-March 2007 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-right:151px; margin-left:144px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 20:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Percent of adult peritoneal dialysis patients with mean serum albumin values </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (BCG/BCP)^ and </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (BCG/BCP) in the U.S., by patient characteristics, October 2006-March 2007. 2007 ESRD CPM Project.</SPAN
></P>
<P style="text-align:left; margin-bottom:8px; text-indent:230px; line-height:16px">
<SPAN style="font-size:10pt; color:#000000"
>                                                             Percent of Patients with Patient  Mean Serum Albumin Characteristics </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:10pt; color:#000000"
> 4.0/3.7 g/dL </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:10pt; color:#000000"
> 3.5/3.2 g/dL </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; color:#000000"
>TOTAL 19 63 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
>GENDER Male 22 64 Female 16 61 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
>RACE American Indian/Alaska Native * * Asian/Pacific Islander 32 69 Black or African American 20 62 White 17 62 Other/Unknown * * </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
>ETHNICITY Hispanic 21 65 Non-Hispanic 19 62 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
>AGE GROUP (years) 18 - 44 31 73 45 - 54 24 70 55 - 64 18 62 65 - 74 8 49 75+ *46 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
>CAUSE of ESRD Diabetes Mellitus 9 51 Hypertension 26 68 Glomerulonephritis 28 76 Other/Unknown 21 64 </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
>DURATION OF DIALYSIS (years) </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
> 0.5 21 62 </SPAN
></P>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
> - 0.9 22 67 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
> - 1.9 21 62 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-family:'sans-serif', 'Arial'; font-size:9pt; font-weight:normal; color:#000000"
> - 2.9 15 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>63 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 3.9 22 63 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> + 17 61 </SPAN
></LI>
</ol>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>MEAN HGB (g/dL) </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 11 2066 &lt; 11 14 49 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>MEAN WEEKLY CREATININE CLEARANCE </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 60 L/week/1.73m</SPAN
><SPAN style="font-size:5.1pt; font-weight:normal; color:#000000"
><Sup>2 </Sup></SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>23 67 &lt; 60 L/week/1.73m</SPAN
><SPAN style="font-size:5.1pt; font-weight:normal; color:#000000"
><Sup>2 </Sup></SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>22 65 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>MODALITY CAPD 20 64 Cycler 20 65 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:10px">
<SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>^ BCG/BCP = bromcresol green/bromcresol purple laboratory methods. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:10px">
<SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>* </SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Value suppressed because n &lt; 11</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:8px; margin-right:18px; line-height:18px">
<SPAN style="font-size:12pt; color:#000000"
>VII. </SPAN
><SPAN style="font-size:12pt; color:#000000"
>PEDIATRIC IN-CENTER HEMODIALYSIS PATIENTS </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All patients aged &lt; 18 years identified as receiving in-center hemodialysis on December 31, 2006 were included in this study (n=720). 681 patients (95%) of this group met the case defini</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tion and were included in the sample for analysis. (See footnote to Table 5 on page 11 for case definition). </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>This section describes the findings for pediatric (aged &lt; 18 years) in-center hemodialysis patients for core indicators related to urea clearance, vascular access, anemia management and serum albumin. </SPAN
></P>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>A. </SPAN
><SPAN style="font-size:12pt; color:#000000"
>CLEARANCE TABLE </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Findings for October-December 2006 (for patients &lt; 18 years) </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; color:#000000"
>TABLE 21:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; font-weight:normal; color:#000000"
>  Mean delivered calculated, single session spKt/V for all pediatric (aged &lt; 18 years) in-center hemodialysis patients and percent of patients with mean single session spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:9.5pt; font-style:italic; font-weight:normal; color:#000000"
> 1.2, by patient characteristics, October-December 2006. 2007 ESRD CPM Project. </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:9.5pt; color:#000000"
>Patient Characteristics Mean spKt/V % spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; color:#000000"
> 1.2 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px">
<SPAN style="font-size:9pt; color:#000000"
>TOTAL 1.62 91 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>GENDER Male 1.57 89 Female 1.69 94 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>RACE American Indian/Alaska Native 1.73 87 Asian/Pacific Islander 1.66 88 Black or African American 1.59 89 White 1.64 92 Other/Unknown * * </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ETHNICITY Hispanic 1.62 92 Non-Hispanic 1.62 90 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>AGE GROUP (years) 0 - 4 1.69 92 5 - 9 1.76 95 10 - 14 1.67 96 15 to &lt;18 1.56 87 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>DIALYSIS SESSION LENGTH (minutes) &lt; 180 1.55 87 180 - 209 1.57 90 210 - 239 1.66 94 240+ 1.72 94 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>DURATION OF DIALYSIS (years) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 0.5 1.47 74 </SPAN
></P>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 0.9 1.58 92 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 1.9 1.63 95 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 2.9 1.67 96 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:-5px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 3.9 1.74 95 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:-5px; margin-right:0px; margin-left:19px; text-indent:-18px; line-height:20px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> + 1.69 95 QUINTILE POST DIALYSIS BODY WEIGHT (kg) </SPAN
></LI>
</ol>
<P style="text-align:left; margin-bottom:-5px; line-height:20px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4.7</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 29.2 1.73 95 </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; line-height:20px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>29.3</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 38.9 1.78 100 </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; line-height:20px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>39.0</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 48.8 1.66 95 </SPAN
></P>
<P style="text-align:left; margin-bottom:-5px; line-height:20px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>48.9</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 61.7 1.57 93 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:20px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>61.8</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> - 141.9 1.41 73 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ACCESS TYPE AV Fistula 1.62 94 AV Graft** 1.73 96 Catheter 1.61 89 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>MEAN HGB (g/dL) </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 11 1.63 93 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 11 1.60 86 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>MEAN SERUM ALBUMIN (g/dL) </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 BCG/BCP^ 1.62 93 &lt; 3.5/3.2 BCG/BCP^ 1.65 83 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:368px; line-height:11px">
<SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>*Value suppressed because n &lt; 11</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>**Includes grafts with and without AVF</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>^BCG/BCP = bromcresol green/bromcresol purple laboratory methods</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-left:368px; line-height:11px">
<SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10. Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by </SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>B. </SPAN
><SPAN style="font-size:12pt; color:#000000"
>VASCULAR ACCESS TABLE </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Findings for October-December 2006 (for patients &lt; 18 years) </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 22: </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>Vascular access type for all pediatric (aged &lt; 18 years) in-center hemodialysis patients on their last hemodialysis session during October-December 2006, by selected patient characteristics. 2007 ESRD CPM Project. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Patient Characteristics          Percent of Patients with                                       AV Fistula  AV Graft**  Catheter </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDE</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>R 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Male 339 5</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>8 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Female 29 7 6</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>RAC</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>E 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>American Indian/Alaska Native * * </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>* 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Asian/Pacific Islander * * </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>* 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Black or African American 32 12 5</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>6 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>White 30 6 6</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Other/Unknown * * </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>* 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>ETHNICIT</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Y 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Hispanic 32 * 6</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Non-Hispanic 31 10 5</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>9 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>AGE GROUP (years</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>) 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt; 12 13* 8</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>12 to &lt;18 37 10 5</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>3 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>DURATION OF DIALYSIS (years</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>) 
</SPAN
></P>
<DL class="unexpected-ListItem" style="margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px; line-height:15px">
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt;</SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.5 12* 86 </SPAN
></DD>

<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 0.9 31 * 67 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 1.9 43 8 49 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 2.9 31 * 61 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 3.9 28 * 61 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> + 38 15 47 </SPAN
></LI>
</ol>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>NOTE:  Percentages may not add up to 100% due to rounding</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*Value suppressed because n &lt; 11</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>**Includes grafts with and without AVF</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>C.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  ANEMIA MANAGEMENT TABLE </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Findings for October-December 2006 (for patients &lt; 18 years) </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 23:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Mean hemoglobin values (g/dL) and distribution of hemoglobin values for all pediatric (aged &lt; 18 years) in-center hemodialysis patients, by patient characteristics, October-December 2006. 2007 ESRD CPM Project. </SPAN
></P>
</DIV>
<TABLE style="margin-bottom:4px">
<CAPTION  style="margin-bottom:4px">
<P style="text-align:left; margin-bottom:7px; line-height:16px">
<SPAN style="font-size:9pt; color:#000000"
>TOTAL 31 8 60 </SPAN
></P>
</CAPTION>
<TR>
<TH style="width:114px; height:56px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Patient  Characteristics </SPAN
></TH>
<TH style="width:37px; height:56px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Mean Hgb (g/dL) </SPAN
></TH>
<TH style="width:201px; height:56px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Percent of Patients with hemoglobin values9-10-11-12-13</SPAN
><SPAN style="font-size:9pt; color:#000000"
></SPAN
><SPAN style="font-size:9pt; color:#000000"
>&lt;9 9.9 10.9 11.9 12.9 13.9 14+ </SPAN
></TH>
</TR>
<TR>
<TD style="vertical-align:top; width:114px; height:591px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>ALL </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>GENDER Male Female RACE American Indian/  Alaska Native Asian/Pacific Islander Black or African  American White Other/Unknown ETHNICITY Hispanic Non-Hispanic AGE GROUP (years) 0 - 4 5 - 9 10 - 14 15 to &lt;18 DURATION OF DIALYSIS (years) &lt; 0.5 0.5 - 0.9 1.0 - 1.9 2.0 - 2.9 3.0 - 3.9 4.0 + ACCESS TYPE AV Fistula AV Graft** Catheter MEAN spKt/V </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 1.2 &lt; 1.2 MEAN SERUM ALBUMIN (g/dL) </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 BCG/BCP^ &lt; 3.5/3.2 BCG/BCP^ </SPAN
></TD>
<TD style="vertical-align:top; width:37px; height:591px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>11.5 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11.6 11.4 11.8 12.3 11.3 11.6 * 11.6 11.5 10.9 10.9 11.5 11.7 11.0 12.0 11.7 11.4 11.3 11.6 12.0 11.8 11.2 11.6 11.0 11.7 10.8 </SPAN
></TD>
<TD style="vertical-align:top; width:201px; height:591px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>8 9 15 26 25 13 4 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>8 7 15 26 26 13 4 9 12 14 27 23 13 * * * * * * * * * * * * * * * 11 11 17 24 21 13 * 7 8 14 28 27 12 3 * * * * * * * 7 9 14 28 28 12 * 9 9 15 25 24 14 4 * * * * * * * 17 * * 29 * * * 8 10 17 26 26 11 * 6 7 13 27 27 16 5 10 18 22 22 14 13 * * * 10 23 31 19 * * * 12 24 29 15 * * * 18 31 23 * * * * * 33 * * * 6 10 13 29 28 11 * * * 9 28 38 13 6 * * * 29 23 21 * 11 13 18 25 18 12 3 7 9 14 28 26 13 3 * * 24 * * * * 6 8 15 27 27 14 4 20 17 15 22 15 9 * </SPAN
></TD>
</TR>
</TABLE>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>* </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Values suppressed because n &lt; 11</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>**Includes grafts with and without AVF</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^ BCG/BCP = bromcresol green/bromcresol purple laboratory methods</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note:   Percentages may not add up to 100% due to rounding</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multipl</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>y 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L)</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>, 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>D.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  SERUM ALBUMIN TABLE </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Findings for October-December 2006 (for patients &lt; 18 years) </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; margin-right:6px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 24:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Percent of all pediatric (aged &lt; 18 years) in-center hemodialysis patients with mean serum albumin values </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (BCG/BCP)^, and </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (BCG/BCP), by patient characteristics, October-December 2006. 2007 ESRD CPM Project.</SPAN
></P>
<TABLE>
<TR>
<TH style="vertical-align:bottom; width:190px; height:47px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:10pt; color:#000000"
>Patient  Characteristics </SPAN
></TH>
<TH colspan=2 style="width:224px; height:47px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:10pt; color:#000000"
>                                                             Percent of Patients with Mean Serum Albumin </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:10pt; color:#000000"
> 4.0/3.7 g/dL </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:10pt; color:#000000"
> 3.5/3.2 g/dL </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:190px; height:21px; border-style: solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>TOTAL </SPAN
></TH>
<TD style="width:121px; height:21px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>49 </SPAN
></TD>
<TD style="width:103px; height:21px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>82 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:190px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDER Male Female </SPAN
></TH>
<TD style="vertical-align:bottom; width:121px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>54 43 </SPAN
></TD>
<TD style="vertical-align:bottom; width:103px; height:54px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>84 78 </SPAN
></TD>
</TR>
<TR>
<TH style="width:190px; height:102px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>RACE American Indian/Alaska Native Asian/Pacific Islander Black or African American White Other/Unknown </SPAN
></TH>
<TD style="vertical-align:bottom; width:121px; height:102px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>* * 47 50 * </SPAN
></TD>
<TD style="vertical-align:bottom; width:103px; height:102px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>82 72 81 83 * </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:190px; height:58px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>ETHNICITY Hispanic Non-Hispanic </SPAN
></TH>
<TD style="vertical-align:bottom; width:121px; height:58px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>55 46 </SPAN
></TD>
<TD style="vertical-align:bottom; width:103px; height:58px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>88 79 </SPAN
></TD>
</TR>
<TR>
<TH style="width:190px; height:85px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>AGE GROUP (years) 0 - 4 5 - 9 10 - 14 15 to &lt;18 </SPAN
></TH>
<TD style="vertical-align:bottom; width:121px; height:85px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>40 45 42 55 </SPAN
></TD>
<TD style="vertical-align:bottom; width:103px; height:85px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>81 80 75 86 </SPAN
></TD>
</TR>
<TR>
<TH style="width:190px; height:115px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>DURATION OF DIALYSIS (years) &lt; 0.5 0.5 - 0.9 1.0 - 1.9 2.0 - 2.9 3.0 - 3.9 4.0 + </SPAN
></TH>
<TD style="vertical-align:bottom; width:121px; height:115px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>39 47 51 56 46 53 </SPAN
></TD>
<TD style="vertical-align:bottom; width:103px; height:115px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>73 83 82 86 80 85 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:190px; height:72px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>ACCESS TYPE AV Fistula AV Graft** Catheter </SPAN
></TH>
<TD style="vertical-align:bottom; width:121px; height:72px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>60 50 43 </SPAN
></TD>
<TD style="vertical-align:bottom; width:103px; height:72px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>90 86 77 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:190px; height:58px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>MEAN spKt/V </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 1.2 &lt; 1.2 </SPAN
></TH>
<TD style="vertical-align:bottom; width:121px; height:58px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>50 36 </SPAN
></TD>
<TD style="vertical-align:bottom; width:103px; height:58px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>83 64 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:bottom; width:190px; height:47px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>MEAN HGB(g/dL) </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥ </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>11 &lt; 11 </SPAN
></TH>
<TD style="vertical-align:bottom; width:121px; height:47px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>56 33 </SPAN
></TD>
<TD style="vertical-align:bottom; width:103px; height:47px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>87 71 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^BCG/BCP = bromcresol green/bromcresol purple laboratory methods</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*Values suppressed because n &lt; 11</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>**Includes grafts with and without AVF</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note:  Percentages may not add up to 100% due to rounding</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:16px; margin-right:52px; line-height:19px">
<SPAN style="font-size:12pt; color:#000000"
>VIII. </SPAN
><SPAN style="font-size:12pt; color:#000000"
>PEDIATRIC PERITONEAL DIALYSIS PATIENTS </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>This is the third year data were collected for pediatric (aged &lt; 18 years) peritoneal dialysis patients. All patients aged &lt; 18 years identified as receiving peritoneal dialysis on December 31, 2006 were included in this study (n = 759). 740 patients (97%) of this group met the case definition and were included in the sample for analysis. (See footnote to Table 6 on pg 11 for case definition). </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>This section describes the national findings for pediatric (aged &lt; 18 years) peritoneal dialysis patients for core indicators re</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lated to peritoneal dialysis clearance, anemia management and serum albumin. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:19px">
<SPAN style="font-size:12pt; color:#000000"
>A.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  CLEARANCE TABLE </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-right:45px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Findings for October 2006 – March 2007 (for patients &lt; 18 years) </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 25:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Description of peritoneal dialysis clearance for pedi</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>atric (aged &lt; 18 years) peritoneal dialysis patients, by modality, October 2006 – March 2007. 2007 ESRD CPM Project.</SPAN
></P>
<TABLE style="margin-bottom:14px">
<TR>
<TD style="width:110px; height:47px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
> Weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; color:#000000"
>urea</SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:78px; height:47px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
> CAPD         Patients^  </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; color:#000000"
> 2.0 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:47px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>CyclerPatients^^  </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; color:#000000"
> 2.1 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:81px; height:47px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>AllPatients^^^ </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; color:#000000"
> 1.8 </SPAN
></TD>
</TR>
<TR>
<TD style="width:110px; height:29px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>% meeting target </SPAN
></TD>
<TD style="text-align:center; width:78px; height:29px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>69% </SPAN
></TD>
<TD style="text-align:center; width:83px; height:29px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>73% </SPAN
></TD>
<TD style="text-align:center; width:81px; height:29px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>87%</SPAN
></TD>
</TR>
<TR>
<TD style="width:110px; height:43px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD Median </SPAN
></TD>
<TD style="text-align:center; width:78px; height:43px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2.20 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.74 2.19 </SPAN
></TD>
<TD style="text-align:center; width:83px; height:43px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2.52 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.74 2.45 </SPAN
></TD>
<TD style="text-align:center; width:81px; height:43px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2.51 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.742.44 </SPAN
></TD>
</TR>
<TR>
<TD style="width:110px; height:61px; border-style: border-style:solid none solid none; border-color: #000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>Weekly creatinine  clearance  (L/week/1.73m</SPAN
><SPAN style="font-size:5.5pt; color:#000000"
>2</SPAN
><SPAN style="font-size:9.5pt; color:#000000"
>) </SPAN
></TD>
<TD style="text-align:center; width:78px; height:61px; border-style: border-style:solid none solid none; border-color: #000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>CAPD Patients  </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; color:#000000"
> 60 </SPAN
></TD>
<TD style="text-align:center; width:83px; height:61px; border-style: border-style:solid none solid none; border-color: #000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#000000"
>Cycler Patients </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; color:#000000"
> 63 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:81px; height:61px; border-style: border-style:solid none solid none; border-color: #000000; border-width:2px 1px 2px 1px"/>
</TR>
<TR>
<TD style="width:110px; height:26px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>% meeting target </SPAN
></TD>
<TD style="text-align:center; width:78px; height:26px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>* </SPAN
></TD>
<TD style="text-align:center; width:83px; height:26px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>25%</SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:81px; height:26px; border-style: border-style:solid none none none; border-color: #000000; border-width:2px 1px 1px 1px"/>
</TR>
<TR>
<TD style="vertical-align:bottom; width:110px; height:32px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD Median </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:78px; height:32px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>55.3 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 29.0 50.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:83px; height:32px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>55.3 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 25.248.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:81px; height:32px"/>
</TR>
</TABLE>
<P style="text-align:; margin-bottom:-5px; margin-right:60px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>*Value suppressed because n &lt; 11. ^For CAPD patients, the delivered PD dose target has been a weekly Kt/V</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 2.0 and a weekly creatinine clearance </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 60 L/week/1.73m</SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
><Sup>2 </Sup></SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
><Sup>urea </Sup></SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^For cycler patients, the target has been a weekly Kt/V</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 2.1 and a weekly  creatinine clearance </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 63 L/week/1.73m</SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
><Sup>2 </Sup></SPAN
><SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
><Sup>urea </Sup></SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^^Using the 2006 KDOQI guidelines and recommendations (29):  For pediatric peritoneal dialysis patients with and without renal kidney function:  weekly KtV</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 1.8. </SPAN
></P>
<P style="text-align:left; margin-bottom:4px; margin-left:52px">
<SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>urea </SPAN
></P>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>B.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  ANEMIA MANAGEMENT TABLE </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; margin-right:47px; line-height:18px">
<SPAN style="font-size:11pt; color:#000000"
>Findings for October 2006- March 2007 (for patients &lt; 18 years) </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 26</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>: Mean hemoglobin values (g/dL) and distribution of mean hemoglobin categories for pediatric (aged &lt; 18 years) peritoneal dialysis patients, by patient characteristics, October 2006 – March 2007. 2007 ESRD CPM Project. </SPAN
></P>
<TABLE style="margin-bottom:5px">
<TR>
<TH style="width:114px; height:56px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Patient  Characteristics </SPAN
></TH>
<TH style="width:38px; height:56px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Mean Hgb (g/dL) </SPAN
></TH>
<TH style="width:201px; height:56px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Percent of Patients with hemoglobin values9-10-11-12-13</SPAN
><SPAN style="font-size:9pt; color:#000000"
></SPAN
><SPAN style="font-size:9pt; color:#000000"
>&lt;9 9.9 10.9 11.9 12.9 13.9 14+ </SPAN
></TH>
</TR>
<TR>
<TD style="vertical-align:top; width:114px; height:651px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>ALL </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>GENDER Male Female RACE American Indian/  Alaska Native Asian/Pacific Islander Black or African  American White Other/Unknown ETHNICITY Hispanic Non-Hispanic AGE GROUP (years) 0 - 4 5 - 9 10 - 14 15 to &lt;18 CAUSE OF ESRD Congenital/Urologic Other Causes Combined DURATION OF DIALYSIS (years) &lt; 0.5 0.5 - 0.9 1.0 - 1.9 2.0 - 2.9 3.0 - 3.9 4.0 + MEAN WEEKLY Kt/V</SPAN
><SPAN style="font-size:5.5pt; color:#000000"
>urea </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 2.0 &lt; 2.0 MEAN SERUM ALBUMIN (g/dL) </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 BCG/BCP^ &lt; 3.5/3.2 BCG/BCP^ </SPAN
></TD>
<TD style="vertical-align:top; width:38px; height:651px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>11.6 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>11.6 11.7 11.4 11.6 11.4 11.7 * 11.8 11.5 11.5 11.3 11.8 11.8 11.7 11.6 11.8 11.8 11.6 11.5 11.2 11.4 11.7 11.6 11.8 11.3 </SPAN
></TD>
<TD style="vertical-align:top; width:201px; height:651px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:8.5pt; color:#000000"
>4 8 18 31 24 11 4 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>4 9 17 34 24 9 4 4 7 19 27 25 13 5 * * * * * * * * * * * * * * 7 8 21 30 23 10 * 3 8 17 31 25 11 6 * * * * * * * * 5 20 27 28 12 6 5 9 17 33 22 10 4 * 9 22 30 20 10 * * 12 16 33 24 * * * 6 16 31 26 12 5 * 6 17 29 26 13 6 * 6 17 31 28 10 * 4 8 18 31 22 11 5 * 7 14 29 27 13 * * 8 21 23 24 14 8 * * 18 38 23 8 * * * * 37 27 * * * * 26 29 29 * * * 9 22 29 19 11 * 3 6 18 32 28 10 4 * 12 18 29 21 11 * 2 6 16 31 27 12 5 7 10 20 32 20 8 * </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; margin-left:368px; line-height:11px">
<SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>*Value suppressed because n &lt; 1</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>1 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>^ BCG/BCP = bromcresol green/bromcresol purple laboratory method</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>s 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: Percentages may not add up to 100% due to rounding</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:20px">
<SPAN style="font-size:12pt; color:#000000"
>C.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  SERUM ALBUMIN TABLE </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:11pt; color:#000000"
>Findings for October 2006 -  March 2007 (for patients &lt; 18 years) </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; margin-right:142px; margin-left:144px; line-height:16px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; color:#000000"
>TABLE 27:</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
>  Percent of pediatric (aged &lt; 18 years) peritoneal dialysis patients with mean serum albumin values </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (BCG/BCP)^ and </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:10pt; font-style:italic; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (BCG/BCP) in the U.S., by patient characteristics, October 2006 – March 2007. 2007 ESRD CPM Project. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:10pt; color:#000000"
>Patient  Percent of Patients with Mean Serum Albumin Characteristics </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:10pt; color:#000000"
> 4.0/3.7 g/dL </SPAN
><SPAN style="font-size:10pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:10pt; color:#000000"
> 3.5/3.2 g/dL </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; color:#000000"
>TOTAL 27 64 </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>GENDE</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>R 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Male 29 6</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>5 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Female 25 6</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>3 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>RAC</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>E 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>American Indian/Alaska Native * </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>* 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Asian/Pacific Islander * </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>* 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Black or African American 23 5</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>8 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>White 29 6</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>7 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Other/Uknown * </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>* 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>ETHNICIT</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Y 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Hispanic 36 7</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>3 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Non-Hispanic 23 6</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>0 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>AGE GROUP (years</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>) 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>0 - 4 20 5</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>5 - 9 20 5</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>9 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>10 - 14 29 6</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>9 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>15 to &lt;18 37 7</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4 
</SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>CAUSE of ESR</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>D 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Congenital/Urologic 28 6</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4 
</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Other Causes Combined 27 6</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>4 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>DURATION OF DIALYSIS (years</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>) 
</SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.5 26 60 </SPAN
></P>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 0.9 34 68 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 1.9 30 63 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 2.9 24 63 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> - 3.9 29 69 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:0px; margin-left:20px; text-indent:-19px; line-height:14px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> + 20 67 </SPAN
></LI>
</ol>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>MEAN HGB (g/dL) </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 11 3168 &lt; 11 19 55 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>MEAN WEEKLY Kt/V</SPAN
><SPAN style="font-size:5.1pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 2.0 28 65 </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>&lt;</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 2.0 33 71 </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>MODALITY CAPD * 56 Cycler 29 67 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^ BCG/BCP = bromcresol green/bromcresol purple laboratory methods </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>* </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Value suppressed because n &lt; 11</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>IX.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  References </SPAN
></P>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Renal Physicians Association.  Clinical practice guideline on adequacy of hemodialysis:  Clinical practice guideline, number 1. December 1993 (pamphlet) </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>National Kidney Foundation.  K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy, 2000. Am J Kidney Dis 37:S7-S64, 2001 (suppl 1) </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>National Kidney Foundation.  K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy, 2000. Am J Kidney Dis 37:S65-S136, 2001 (suppl 1) </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>National Kidney Foundation.  K/DOQI Clinical Practice Guidelines for Vascular Access, 2000. Am J Kidney Dis 37:S137-S181, 2001 (suppl 1) </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease , 2000. Am J Kidney Dis 37:S182-S238, 2001 (suppl 1) </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialy</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>sis. N Engl J Med 329:1001-1006, 1993 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, et al:  Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 3:1613-1622, 1993 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Soucie JM, McClellan WM:  Early death in dialysis patients: Risk factors and impact on incidence and mortality rates. J Am Soc Nephrol 7:2169-2175, 1996 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Blagg CR, Liedtke RJ, Batjer JD, Racoosin B, Sawyer TK, Wick MJ, et al:  Serum albumin concentra-tion-related Health Care Financing Administration quality assurance criterion is method-dependent: revision is necessary. Am J Kidney Dis 21:138-144,1993 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure, 2000. Guideline No. 3. Am J Kidney Dis 35:S20-S21, 2000 (suppl 2) </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>U.S. Renal Data System, USRDS 2007 Annual Data Re</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>port:  Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2007 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2006 ESRD facility survey (CMS-2744) data, Centers for Medicare &amp; Medicaid Services, Office of Clinical Standards and Quality (report) </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Lohr KN, Schroeder SA: A strategy for quality assurance in Medicare. N Engl J Med 322:707-712, 1990 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Gagel BJ</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>:	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Health Care Quality Improvement Program: A New Approach.  Health Care Financ Rev 16(4):15-23, 1995 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Vladeck BC</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>:	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  From the HCFA ESRD Core Indicators Project. JAMA 273:1896, 1995 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy. Am J Kidney Dis 30:S15-S66, September 1997 (suppl 2) </SPAN
></LI>
</ol>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>NKF-DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy.  Am J Kidney Dis 30:S67-S136, September 1997 (suppl 2) </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>NKF-DOQI Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis 30:S150-S191, October 1997 (suppl 3) </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>NKF-DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. Am J Kidney Dis 30:S192-S240, October 1997 (suppl 3) </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Health Care Financing Administration. 1994 Core Indica</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tors Project Initial Results.  Opportunities to Improve Care for Adult In-Center Hemodialysis Patients. Department of Health and Human Services, Health Care Financing Ad</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ministration, Health Standards and Quality Bureau, Baltimore, Maryland, December 1994 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Health Care Financing Administration. 1995 Annual Report, End Stage Renal Disease Core Indicators Project.  Depart</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ment of Health and Human Services, Health Care Financ</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ing Administration, Health Standards and Quality Bureau, Baltimore, Maryland, December 1995 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Health Care Financing Administration</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>.	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> Highlights from the 1995 ESRD Core Indicators Project for Peritoneal Dialysis Patients. Department of Health and Human Services, Health Care Financing Administration, Health Standards and Quali</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>ty Bureau, Baltimore, Maryland, December 1995 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Health Care Financing Administration</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>.	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  1996 Annual Report, End Stage Renal Disease Core Indicators Project. Department of Health and Human Services, Health Care Financing Administration, Health Standards and Quality Bureau, Baltimore, Maryland, January 1997 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Health Care Financing Administration</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>.	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  1997 Annual Report, End Stage Renal Disease Core Indicators Project. Department of Health and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality, Baltimore, Maryland, December 1997 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Health Care Financing Administration</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>.	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  1998 Annual Report, End Stage Renal Disease Core Indicators Project. Department of Health and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality, Baltimore, Maryland, December 1998 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Health Care Financing Administration. 1999 Annual Report, End Stage Renal Disease Clinical Performance Measures Project.  Department of Health and Human Services, Health Care Financing Administration, Office of Clinical Standards and Quality, Baltimore, Maryland, December 1999 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Daugirdas JT:  Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 4:1205-1213, 1993 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Norusis MJ</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>:	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  SPSS for Windows Advanced Statistics Release 10.0. Chicago, IL, USA, 2001 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:35px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>National Kidney Foundation. KDOQI Clinical Practice Guide</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>lines and Clinical Practice Recommendations for 2006 Updates:  Hemodialysis Adequacy, Peritoneal Dialysis Adequacy and Vascular Access. Am J Kidney Dis 48:S1-S322, 2006 (suppl 1). </SPAN
></LI>
</ol>
</DIV>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:20px; margin-left:24px; text-indent:-23px">
<SPAN style="font-size:12pt; color:#000000"
>X</SPAN
><SPAN style="font-size:12pt; color:#000000"
>.	</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  List of Tables and Figures </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:16px; margin-left:343px; text-indent:-342px">
<SPAN style="font-size:12pt; color:#000000"
>Tabl</SPAN
><SPAN style="font-size:12pt; color:#000000"
>e 	</SPAN
><SPAN style="font-size:12pt; color:#000000"
>Title Page </SPAN
></P>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Number of adult in-center hemodialysis patients in each Network in December 2006, sample size and response rate for the 2007 ESRD CPM Project. 8 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Characteristics of adult in-center hemodialysis patients in the 2007 ESRD CPM Project compared to those of all in-center hemodialysis patients in the U.S. in 2005. 9 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Number of adult peritoneal dialysis patients in each Network in December 2006, sample size and response rate for the 2007 ESRD CPM Project. 9 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Characteristics of adult peritoneal dialysis patients in the 2007 ESRD CPM Project compared to those of all peritoneal dialysis patients in the U.S. in 2005. 10 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Characteristics of pediatric (aged &lt; 18 years) in-center hemodialysis patients in the 2007 ESRD CPM Project. 11 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Characteristics of pediatric (aged &lt; 18 years) peritoneal dialysis patients in the 2007 ESRD CPM Project. 11 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean delivered calculated, single session spKt/V and percent of adult in-center hemodialysis patients with mean delivered calculated, single session spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2 and </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.3 by patient characteristics, October-December 2006. 2007 ESRD CPM Project. 23 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Percent of adult in-center hemodialysis patients receiving dialysis with a mean delivered, single session spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2, by  gender, race, ethnicity, body weight, dialysis session length, and Network, October-December 2006. 2007 ESRD CPM Project. 24 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Vascular access type for incident and all adult in-center hemodialysis patients during the last hemodialysis session of the study period, by selected patient characteristics, October-December 2006. 2007 ESRD CPM Project. 25 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Percent of all adult in-center hemodialysis patients with an AV fistula access on their last hemodialysis session during October–December 2006, by gender, race, ethnicity, age, cause of ESRD, and Network. 2007 ESRD CPM Project. 26 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Percent of all adult in-center hemodialysis patients with a catheter access on their last hemodialysis session during October–December 2006, by gender, race, ethnicity, age, cause of ESRD, and Network. 2007 ESRD CPM Project. 27 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Reasons for catheter placement in adult in-center hemodialysis patients using catheters on their last hemodialysis session during October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. 27 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Mean hemoglobin values (g/dL</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>)  	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>for adult in-center hemodialysis patients in the U.S., by patient characteristics, October–December 2006. 2007 ESRD CPM Project. 28 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Percent of all adult in-center hemodialysis patients with mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL, by gender, race, ethnicity, age, access type, mean serum albumin, and Network, October-December 2006. 2007 ESRD CPM Project. 29 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Regional variation for various anemia management measures for adult in-center hemodialysis patients including the percent of patients with mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL, mean hemoglobin (g/dL), and mean serum albumin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0 (BCG) for these patients nationally and by Network, October-December 2006. 2007 ESRD CPM Project. 30 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Percent of adult in-center hemodialysis patients with mean serum albumin values </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (BCG/BCP) and </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (BCG/BCP) in the U.S., by patient characteristics, October-December 2006. 2007 ESRD CPM Project. 31 </SPAN
></LI>
</ol>
<TABLE style="margin-bottom:0px">
<TR>
<TH colspan=2 style="width:664px; height:36px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2007 ESRD CLINICAL PERFORMANCE MEASURES PROJECT </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>TABLES AND FIGURES </SPAN
></TH>
<TH style="text-align:center; width:56px; height:36px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>43 </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:192px; height:37px">
<SPAN style="font-size:12pt; color:#000000"
>Table </SPAN
></TH>
<TD style="text-align:center; width:472px; height:37px">
<SPAN style="font-size:12pt; color:#000000"
>Title</SPAN
></TD>
<TD style="text-align:right; width:56px; height:37px">
<SPAN style="font-size:12pt; color:#000000"
> Page </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:664px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>17. Percent of adult CAPD patients with mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD weekly adequacy values meeting 2000 NKF-K/DOQI guidelines and median adequacy values, by transporter type (4 hr. D/P Cr Ratio), October 2006–March 2007. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>33 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:664px; height:46px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>18. Percent of adult cycler patients with mean </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> SD weekly adequacy values meeting 2000 NKF-K/DOQI guidelines and median adequacy values, October 2006–March 2007. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:46px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>33 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:664px; height:45px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>19. Mean hemoglobin values (g/dL) for adult peritoneal dialysis patients, by patient characteristics, October 2006-March 2007. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:45px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>34 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:664px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>20. Percent of adult peritoneal dialysis patients with mean serum albumin values </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (BCG/BCP) and </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (BCG/BCP) in the U.S., by patient characteristics, October 2006-March 2007. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>35 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:664px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>21. Mean delivered calculated, single session spKt/V for all pediatric (aged &lt; 18 years) in-center hemodialysis patients and percent of patients with mean single session spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2, by patient characteristics, October-December 2006. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>36 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:664px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>22. Vascular access type for all pediatric (aged &lt; 18 years) in-center hemodialysis patients on their last hemodialysis session during October-December 2006, by selected patient characteristics. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>37 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:664px; height:46px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>23. Mean hemoglobin values (g/dL) and distribution of hemoglobin values for all pediatric (aged &lt; 18 years) in-center hemodialysis patients, by patient characteristics, October-December 2006. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:46px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>37 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:664px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>24. Percent of all pediatric (aged &lt; 18 years) in-center hemodialysis patients with mean serum albumin values </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (BCG/BCP), and </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (BCG/BCP), by patient characteristics, October-December 2006. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>38 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:664px; height:46px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>25. Description of peritoneal dialysis clearance for pediatric (aged &lt; 18 years) peritoneal dialysis patients, by modality, October 2006 – March 2007. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:46px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>39 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:664px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>26. Mean hemoglobin values (g/dL) and distribution of mean hemoglobin categories for pediatric (aged &lt; 18 years) peritoneal dialysis patients, by patient characteristics, October 2006 – March 2007. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:61px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>39 </SPAN
></TD>
</TR>
<TR>
<TH colspan=2 style="vertical-align:bottom; width:664px; height:51px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>27. Percent of pediatric (aged &lt; 18 years) peritoneal dialysis patients with mean serum albumin values </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (BCG/BCP) and </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (BCG/BCP) in the U.S., by patient characteristics, October 2006 – March 2007. 2007 ESRD CPM Project. </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:56px; height:51px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>40 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:16px; margin-left:672px; text-indent:-671px">
<SPAN style="font-size:12pt; color:#000000"
>Figure Titl</SPAN
><SPAN style="font-size:12pt; color:#000000"
>e 	</SPAN
><SPAN style="font-size:12pt; color:#000000"
>Page </SPAN
></P>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Vascular access type for all adult in-center hemodialysis patients on their last hemodialysis session during the study period. 2007 ESRD CPM Project. 16 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Percent of adult peritoneal dialysis patients with total solute clearance for urea and creatinine measured at least once during the study period (PD Adequacy CPM I) and with total solute clearance calculated in a standard way (PD Adequacy CPM II), October 2006-March 2007 compared  to previous study periods. 2007 ESRD CPM Project. 16 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Percent of adult peritoneal dialysis patients meeting 1997 NKF-DOQI guidelines for weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>and weekly creatinine clearance (PD Adequacy CPM III). 2007 ESRD CPM Project. 16 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Percent of adult in-center hemodialysis patients with mean delivered calculated, single session single pool (sp)Kt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2 in October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. 16 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Percent of adult in-center hemodialysis patients with mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL, October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. 17 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Distribution of mean hemoglobin values for adult in-center hemodialysis patients, October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. 17 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Percent of adult peritoneal dialysis patients with mean hemoglobin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 11 g/dL, October 2006-March 2007 compared to previous study periods. 2007 ESRD CPM Project. 17 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Distribution of mean hemoglobin values for adult peritoneal dialysis patients, October 2006-March 2007 compared to previous study periods. 2007 ESRD CPM Project. 17 </SPAN
></LI>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Distribution of mean delivered calculated, single session spKt/V values for pediatric (aged &lt; 18 years)</SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:0px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> in-center hemodialysis patients, October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. 18 </SPAN
></LI>
</ol>
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Vascular access type for pediatric (aged &lt; 18 years) in-center hemodialysis patients on their last hemodialysis session during the study period, October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. 18 </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:16px; margin-left:24px; text-indent:-23px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Distribution of mean hemoglobin values for pediatric (age</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>d  	</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>&lt; 18 years) in-center hemodialysis patients, October-December 2006 compared to previous study periods. 2007 ESRD CPM Project. 18 </SPAN
></LI>
</ol>
<P style="text-align:justify; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>Appendix 1.  Centers for Medicare &amp; Medicaid Services (CMS) Offices and ESRD Networks </SPAN
></P>
<P style="text-align:; margin-bottom:-15px; margin-right:19px; margin-left:245px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 3 ESRD Network Organization No. 13 </SPAN
></P>
<DIV class="Sect">
<P style="text-align:justify; margin-bottom:-5px">
<SPAN style="font-size:12pt; color:#000000"
>CMS Offices </SPAN
></P>
</DIV>
<P style="text-align:; margin-bottom:8px; margin-left:245px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>TransAtlantic Renal Council 4200 Perimeter Center Drive, Suite 102 </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Centers for Medicare &amp; Medicaid Services Office of Clinical Standards &amp; Quality Quality Measurement and Health Assessment </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:24px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Group Mailstop S3-02-01 7500 Security Boulevard Baltimore, MD 21244 </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(410)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 786-6940 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Centers for Medicare &amp; Medicaid Services </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
></SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:24px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Region I Division of Clinical Standards and Quality, Clinical Standards Branch Room 2275 JFK Federal Building Boston, MA 02203-0003 </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(617)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 565-3136 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Centers for Medicare &amp; Medicaid Services </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
></SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:24px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Region VI Division of Clinical Standards and Quality Room 714 1301 Young Street Dallas, TX 75202 </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(214)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 767-4443 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Centers for Medicare &amp; Medicaid Services </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
></SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:24px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Region VII Division of Clinical Standards and Quality, Medical Review Branch Richard Bolling Federal Building 60l East l2th Street, Room 242 Kansas City, MO 64106-2808 </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(816)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 426-5746 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Centers for Medicare &amp; Medicaid Services </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
></SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:24px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Region X Division of Clinical Standards and Quality 2201 Sixth Avenue, Mail Stop (RX-42) Seattle, WA 98121-2500 </SPAN
></P>
<P style="text-align:left; margin-bottom:25px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(206)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 615-2317 </SPAN
></P>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>ESRD Networks </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 1 ESRD Network of New England, Inc. 30 Hazel Terrace Woodbridge, CT 06525 Region I: ME, NH, VT, MA, CT, RI </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(203)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 387-9332 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-right:53px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 2 CKD Network of New York, Inc. 1979 Marcus Avenue, Suite 105 Lake Success, NY 11042-1002 Region I: NY </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(516) 209-5578 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Cranbury Gates Office Park 109 South Main Street, Suite 21 Cranbury, NJ 08512-3174 Region I: NJ, PR, VI </SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(609)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 490-0310 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 4 40 24</SPAN
><SPAN style="font-size:5pt; font-weight:normal; color:#000000"
><Sup>th</Sup></SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> Street, Suite 410 Pittsburgh, PA 15222 Region: DE, PA </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(412)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 325-2250 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 5 Mid-Atlantic Renal Coalition 1527 Huguenot Road Midlothian, VA 23113 Region I: DC, MD, VA, WV </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(804)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 794-3757 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 6 Southeastern Kidney Council, Inc. 1000 St. Albans Drive, Suite 270 Raleigh, NC 27609 Region VI: GA, NC, SC </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(919)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 855-0882 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 7 FMQAI: The Florida ESRD Network 5201 West Kennedy Boulevard, Suite 900 Tampa, FL  33609 Region: FL </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(813)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 383-1530 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; margin-right:53px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 8 Network Eight, Inc. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-right:95px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>P.O. </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Box 321475 Jackson, MS  39232-1475 Region VI: AL, MS, TN </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(601)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 936-9260 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 9 &amp; 10 The Renal Network, Inc. 911 East 86th Street, Suite 202 Indianapolis, IN 46240-1858 Region VII: KY, IN, OH, IL </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(317)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 257-8265 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 11 Renal Network of the Upper Midwest, Inc. 1360 Energy Park Drive, Suite 200 St. Paul, MN  55108 Region: MI, MN, ND, SD, WI </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(651)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 644-9877 </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 12 Heartland Kidney Network 7505 NW Tiffany Springs Parkway, Suite 230 Kansas City, MO 64153 Region VII: MO, IA, NE, KS </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(816) 880-9990 </SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Oklahoma City, OK  73112-2314 Region: AR, LA, OK </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(405)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 942-6000 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 14 ESRD Network of Texas, Inc. 4040 McEwen, Suite 350 Dallas, TX 75244-5015 Region VI: TX </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(972)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 503-3215 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 15 Intermountain ESRD Network, Inc. 1301 Pennsylvania Street, Suite 750 Denver, CO 80203-5012 Region X: NM, CO, WY, UT, AZ, NV </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(303)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 831-8818 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 16 Northwest Renal Network 4702 42nd Avenue, SW Seattle, WA 98116 Region X: MT, AK, ID, OR, WA </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(206)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 923-0714 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 17 Western Pacific Renal Network, LLC 505 San Marin Drive, Building A, Suite 300 Novata, CA  94945 Region X: No. CA, HI, Mariana Isl., GU, AS </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(415)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 897-2400 </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>ESRD Network Organization No. 18 Southern California Renal Disease Council, </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; text-indent:24px; line-height:14px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>Inc. 6255 Sunset Boulevard, Suite 2211 Los Angeles, CA 90028 Region X: So. CA </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
>(323)</SPAN
><SPAN style="font-size:8.5pt; font-weight:normal; color:#000000"
> 962-2020 </SPAN
></P>
</DIV>
<IMG width=743 height=936 style="display:block; float:none; text-align:center; margin-bottom:0px" src="images/ESRDCPMYear2007Report_img_14.jpg">
<DIV class="Sect">
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:12pt; color:#000000"
>XI. </SPAN
><SPAN style="font-size:12pt; color:#000000"
>Appendices </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>Appendix 2. ESRD Clinical Performance Measures (CPMs) for 2007 Data Collection Effort </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Study period for HD patients is Oct, Nov, Dec 2006; for PD patients is Oct, Nov, Dec 2006 and Jan, Feb, Mar 2007. </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:12pt; color:#000000"
>Hemodialysis (HD) Adequacy </SPAN
></P>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>1.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  HD Adequacy CPM I:  Monthly Measurement of Delivered Hemodialysis Dose. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>HD Adequacy Guideline 1: Regular Measurement of the Delivered Dose of Hemodialysis (Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The dialysis care team should routinely measure and monitor the delivered dose of hemodialysis</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>HD Adequacy Guideline 6: Frequency of Measurement of Hemodialysis Adequacy (Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The delivered dose of hemodialysis should be measured at least once a month in all adult and pediatric hemodialysis patients. Th</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>e 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>frequency of measurement of the delivered dose of hemodialysis should be increased when</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>: 
</SPAN
></P>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Patients are noncompliant with their hemodialysis prescriptions (missed treatments, late for treatments, early sign-off from hemodialysis treatments, etc.). </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Frequent problems are noted in delivery of the prescribed dose of hemodialysis (such as variably poor blood flows, or treatment interruptions because of hypotension or angina pectoris). </SPAN
></LI>
<LI style="list-style-type:decimal; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Wide variability in urea kinetic modeling results is observed in the absence of prescription changes. </SPAN
></LI>
<DIV class="Sect">
<DL class="unexpected-ListItem" style="margin-right:0px; margin-left:0px; text-indent:0px; line-height:15px">
<DT style="list-style-type:decimal; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>4. </SPAN
></DT>
<DD style="list-style-type:decimal; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The hemodialysis prescription is modified. </SPAN
></DD>

</DIV>
</ol>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Number of patients in denominator with documented monthly adequacy measurements (URR or spKt/V) during the study period. (The study period for HD patients is Oct, Nov, Dec 2006). </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) HD patients in the sample for analysis. </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>2.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  HD Adequacy CPM II:  Method of Measurement of Delivered Hemodialysis Dose. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>HD Adequacy Guideline 2: Method of Measurement of Delivered Dose of Hemodialysis (Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The delivered dose of hemodialysis in adult and pediatric patients should be measured using formal urea kinetic modeling (UKM)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>, 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>employing the single-pool, variable volume model</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Number of patients in denominator for whom delivered HD dose was calculated using formal urea kinetic modeling or Daugirdas II during the study period. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) HD patients in the sample for analysis. </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>3.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  HD Adequacy CPM III:  Minimum Delivered Hemodialysis Dose. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>HD Adequacy Guideline 4: Minimum Delivered Dose of Hemodialysis (Adults-Evidence, Children-Opinion). The dialysis care team should deliver a spKt/V of at least 1.2 (single-pool, variable volume) for both adult and pediatric hemodialysis patients. For those using the urea reduction ratio (URR), the delivered dose should be equivalent to a spKt/V of 1.2, i.e., an average URR of 65%; however URR can vary substantially as a function of fluid removal. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Number of patients in denominator whose average delivered dose of HD (calculated from data points on the data collection form) was a spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 1.2 during the study period. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:29px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>18 years old) HD patients in the sample for analysis who have been on HD for six months or more and dialyzing three times per week. </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:12pt; color:#000000"
>Peritoneal Dialysis (PD) Adequacy </SPAN
></P>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>4.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  PD Adequacy CPM I:  Measurement of Total Solute Clearance at Regular Intervals. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>PD Adequacy Guideline 4: Measures of Peritoneal Dialysis Dose and Total Solute Clearance (Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Both total weekly creatinine clearance normalized to 1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> body surface area (BSA) and total weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>should be used t</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>o 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>measure delivered peritoneal dialysis doses</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>PD Adequacy Guideline 11: Dialysate and Urine Collections (Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Two to three total solute removal measurements are required during the first six months of peritoneal dialysis (See Guideline 3)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>After six months, if the dialysis prescription is unchanged: </SPAN
></P>
</DIV>
<ol style="list-style-type:decimal">
<LI style="list-style-type:decimal; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Perform both complete dialysate and urine collections every four months; and </SPAN
></LI>
<LI style="list-style-type:decimal; margin-right:0px; margin-left:0px; text-indent:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Perform urine collections every two months until the renal weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>is &lt;0.1</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Thereafter, urine collections are no longer necessary, as the residual renal function contribution to total Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> becomes negligibl</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>e 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(See Guideline 5)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></LI>
</ol>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Number of patients in denominator with total solute clearance for urea and creatinine measured at least once in a 6 month time period. (The study period for PD patients is Oct, Nov, Dec 2006 and Jan, Feb, Mar 2007). </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) PD patients in sample for analysis, excluding tidal dialysis patients. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>5.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  PD Adequacy CPM II:  Calculate Weekly Kt/V</SPAN
><SPAN style="font-size:6pt; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:12pt; color:#000000"
>and Creatinine Clearance in a Standard Way. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>PD Adequacy Guideline 4: Measures of Peritoneal Dialysis Dose and Total Solute Clearance (Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Both total weekly creatinine clearance normalized to 1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> body surface area (BSA) and total weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>should be used t</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>o 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>measure delivered peritoneal dialysis doses</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>PD Adequacy Guideline 6: Assessing Residual Renal Function (Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Residual renal function (RRF), which can provide a significant component of total solute and water removal, should be assessed b</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>y 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>measuring the renal component of Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> and estimating the patient’s glomerular filtration rate (GFR) by calculating the mean o</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>f 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>urea and creatinine clearance</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>PD Adequacy Guideline 9: Estimating Total Body Water and Body Surface Area (Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>V (total body water) should be estimated by either the Watson or Hume method in adults using actual body weight</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Watson method</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>: 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For Men: V (liters) = 2.447 + 0.3362*Wt(kg) + 0.1074*Ht(cm) - 0.09516*Age(years</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For Women: V = -2.097 + 0.2466*Wt + 0.1069*H</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>t 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Hume method</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>: 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For Men: V = -14.012934 + 0.296785*Wt + 0.192786*H</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>t 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For Women: V = -35.270121 + 0.183809*Wt + 0.344547*H</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>t 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>BSA should be estimated by either  the DuBois and DuBois method, the Gehan and George method, or the Haycock method usin</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>g 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>actual body weight</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For all formulae, Wt is in kg and Ht is in cm</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>: 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>DuBois and DuBois method: BSA (m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) = 0.007184*Wt</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>0.425</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>*Ht</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>0.72<SPAN style="font-size:5.5pt; font-weight:normal"
>5 
</SPAN
></Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Gehan and George method: BSA (m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) = 0.0235*Wt</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>0.51456</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>*Ht</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>0.4224<SPAN style="font-size:5.5pt; font-weight:normal"
>6 
</SPAN
></Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Haycock method: BSA (m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) = 0.024265*Wt</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>0.5378</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>*Ht</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>0.396<SPAN style="font-size:5.5pt; font-weight:normal"
>4 
</SPAN
></Sup></SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of patients in denominator with all of the following: </SPAN
></P>
</DIV>
<dl>
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>a. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Weekly creatinine clearance normalized to 1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> body surface area (BSA) and total weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea </Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>used to measure delivered PD dose; and </SPAN
></DD>

<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>b.</SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>  Residual renal function (unless negligible*) is assessed by measuring the renal component of Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> and estimating the patient’s glomerular filtration rate (GFR) by calculating the mean of urea and creatinine clearance; and </SPAN
></DD>

<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>c. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Total body water (V) estimated by either the Watson or Hume method using actual body weight, and BSA estimated  by either the DuBois and DuBois method, the Gehan and George method, or the Haycock method of using actual body weight, during the study period. </SPAN
></DD>

</dl>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>*</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> negligible = &lt; 200 mL urine in 24 hours. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) PD patients in the sample for analysis, excluding tidal dialysis patients. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>6.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  PD Adequacy CPM III:  Delivered Dose of Peritoneal Dialysis. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>PD Adequacy Guideline 15: Weekly Dose of CAPD (Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For CAPD, the delivered peritoneal dialysis dose should be a total Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least 2.0 per week and a total creatinine clearanc</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>e 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>(CrCl) of at least 60 L/week/1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>PD Adequacy Guideline 16: Weekly Dose of NIPD and CCPD (Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For NIPD, the weekly delivered peritoneal dialysis dose should be a total Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least 2.2 and a weekly total CrCL of at leas</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>t 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>66 L/1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For CCPD, the weekly delivered peritoneal dialysis dose should be a total Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least 2.1 and a weekly total CrCl of at leas</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>t 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>63 L/1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<dl>
<DT style="list-style-type:none; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>a. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For CAPD patients in the denominator, the delivered PD dose was a weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least 2.0 and a weekly CrCl of at least 60 L/week/1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> or evidence that the prescription was changed according to NKF-K/DOQI recommendations, during the study period. </SPAN
></DD>

<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>b. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>For cycler patients in the denominator without a daytime dwell (NIPD), the delivered PD dose was a weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least </SPAN
></DD>

</dl>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>2.2</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> and a weekly CrCl of at least 66 L/week/1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2</Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> or evidence that the prescription was changed according to NKF-K/DOQI recommendations, during the study period.  For cycler patients in the denominator with a daytime dwell (CCPD), the delivered PD dose was a weekly Kt/V</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sub>urea</Sub></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> of at least 2.1 and a weekly CrCl of at least 63 L/week/1.73 m</SPAN
><SPAN style="font-size:5.5pt; font-weight:normal; color:#000000"
><Sup>2 </Sup></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> or evidence that the prescription was changed according to NKF-K/DOQI recommendations, during the study period. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:29px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) PD patients in the sample for analysis, excluding tidal dialysis patients. </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:12pt; color:#000000"
>Vascular Access </SPAN
></P>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>7. </SPAN
><SPAN style="font-size:12pt; color:#000000"
>Vascular Access CPM I:  Maximizing Placement of Arterial Venous Fistulae (AVF). </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Vascular Access Guideline 29A: Goals of Access Placement-Maximizing Primary Arterial Venous Fistulae (Opinion).   Primary arterial venous fistulae (AVF) should be constructed in at least 50% of all new patients electing to receive hemodialysis as their initial form of renal replacement therapy. Ultimately, 40% of prevalent patients should have a native AV fistula. (See Guideline 3, Selection of Permanent Vascular Access and Order of Preference of AV Fistulae). </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<dl>
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>a. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of incident patients in the denominator who were dialyzed using an AVF during their last HD treatment  during the study period. (The study period for HD patients is Oct, Nov, Dec 2006). </SPAN
></DD>

<DT style="list-style-type:none; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>b. </SPAN
></DT>
<DD style="list-style-type:none; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of prevalent patients in the denominator who were dialyzed using an AVF during their last HD treatment during the study period. </SPAN
></DD>

</dl>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
</DIV>
<dl>
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>a. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Incident adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) HD patients (defined as those patients initiating their most recent course of HD on or between Jan 1 and Aug 31, 2006) in the sample for analysis. </SPAN
></DD>

<DT style="list-style-type:none; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>b. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Prevalent adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) HD patients in the sample for analysis. </SPAN
></DD>

</dl>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>8. </SPAN
><SPAN style="font-size:12pt; color:#000000"
>Vascular Access CPM II:  Minimizing Use of Catheters as Chronic Dialysis Access. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Vascular Access Guideline 30A: Goals of Access Placement- Use of Catheters for Chronic Dialysis (Opinion). Less than 10% of chronic maintenance hemodialysis patients should be maintained on catheters as their permanent chronic dialysis access. In this context, chronic catheter access is defined as the use of a dialysis catheter for more than three months in the absence of a maturing permanent access. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of patients in the denominator who were dialyzed with a chronic catheter continuously for 90 days or longer prior to the last HD session during the study period. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) patients in the sample for analysis. </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>9. </SPAN
><SPAN style="font-size:12pt; color:#000000"
>Vascular Access CPM III:  Surveillance of Arterial Venous Grafts for Stenosis. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Vascular Access Guideline 10: Surveillance of Dialysis AV Grafts for Stenosis (Evidence/Opinion). Physical examination of an access graft should be performed weekly and should include, but not be limited to, inspection and palpation for pulse and thrill at the arterial, mid, and venous sections of the graft (Opinion). Dialysis arterial venous graft accesses should be surveyed for hemodynamically significant stenosis. The DOQI Work Group recommends an organized surveillance approach with regular assessment of clinical parameters of the arterial venous access and dialysis adequacy. Data from the surveillance tests, clinical assessment, and dialysis adequacy measurements should be collected and maintained for each patient’s access and made available to all staff. The data should be tabulated and tracked within each dialysis center as part of a Quality Assurance/ Continuous Quality Improvement (QA/CQI) program (Opinion). Prospective surveillance of arterial venous grafts for hemodynamically significant stenosis, when combined with correction, improves patency and decreases the incidence of thrombo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>sis (Evidence). Techniques, not mutually exclusive, that can be used to survey for stenosis in arterial venous grafts include: </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>A. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Intra-access flow (Evidence</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>B. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Static venous pressures (Evidence</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>C. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Dynamic venous pressures (Evidence</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Other studies or information that can be useful in detecting arterial venous graft stenosis include</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>: 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>D. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Measurement of access recirculation using urea concentrations (See Guideline 12) (Evidence</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>E. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Measurement of recirculation using dilution flow techniques (nonurea-based) (Evidence) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>F. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Unexplained decreases in the measured amount of hemodialysis delivered (URR, Kt/V) (Evidence) </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>G. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Physical findings of persistent swelling of the arm, clotting of the graft, prolonged bleeding after needle withdrawal, or altere</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>d 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>characteristics of pulse or thrill in a graft (Evidence/Opinion</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>H. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Elevated negative arterial pre-pump pressures that prevent increasing to acceptable blood flow (Evidence/Opinion</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>I. </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Doppler ultrasound (Evidence/Opinion</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>) 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Persistent abnormalities in any of these parameters should prompt referral for venography (Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of patients in the denominator whose AV graft was routinely surveyed (screened) for the presence of stenosis during the study period by one of the following methods and with the stated frequency:  Color-flow Doppler at least once every 3 months; Static venous pressure at least once every 2 weeks; Dynamic venous pressure every HD session; Dilution technique at least once every 3 months. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:29px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) patients in the sample for analysis who were on HD continuously during the study period and who were dialyzed through an arterial venous graft during their last HD session during the study period. </SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-size:12pt; color:#000000"
>Anemia Management </SPAN
></P>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>10.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  Anemia Management CPM I: Target Hemoglobin for Epoetin Therapy. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 4: Target Hemoglobin (Hgb) for Epoetin Therapy (Evidence/Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The target range for hemoglobin should be 11-12 g/dL (110-120 g/L) (Evidence). This target is for epoetin therapy and is not a</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>n 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>indication for blood transfusion therapy (Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Number of patients in denominator with documented mean Hgb of 11-12 g/dL (110-120 g/L) during the study period. (The study period for HD patients is Oct, Nov, Dec 2006 and Oct, Nov, Dec 2006 and Jan, Feb, Mar 2007 for PD patients). </SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:16px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) HD or PD patients in the sample for analysis, exclude patients with mean Hgb  &gt; 12 g/dL (120 g/L) who are not prescribed epoetin at any time during the study period. </SPAN
></P>
<P style="text-align:left; margin-bottom:0px; margin-right:46px; line-height:19px">
<SPAN style="font-size:12pt; color:#000000"
>11.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  Anemia Management CPM IIa:  Assessment of Iron Stores among Anemic Patients or Patients Prescribed Epoetin. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 5: Assessment of Iron Status (Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Iron status should be monitored by the percent transferrin saturation and the serum ferritin concentration</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 6A: Target Iron Level (Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Chronic renal failure patients should have sufficient iron to achieve and maintain a Hgb of 11 to 12 g/dL (110-120 g/L)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 7A: Monitoring Iron Status (Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>During the initiation of epoetin therapy and while increasing the epoetin dose in order to achieve an increase in hematocrit/hemo</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>globin, the transferrin saturation and the serum ferritin concentration should be checked every month in patients not receivin</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>g 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>intravenous iron, and at least once every 3 months in patients receiving intravenous iron, until target hematocrit/hemoglobin i</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>s 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>reached</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 7B: Monitoring Iron Status (Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Following attainment of the target hematocrit/hemoglobin, transferrin saturation and serum ferritin concentration should be deter</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>mined at least once every 3 months</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<dl>
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>a. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of HD patients in the denominator with at least one documented transferrin saturation and serum ferritin concentra</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tion result every three months</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></DD>

<DT style="list-style-type:none; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>b. </SPAN
></DT>
<DD style="list-style-type:none; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of PD patients in the denominator with at least two documented transferrin saturation and serum ferritin concentra</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>tion results over the six-month study period</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>[Note: Not directly comparable to Numerator “a”, but most feasible given probable frequency of visits for PD patients.</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>] 
</SPAN
></DD>

</dl>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
</DIV>
<dl>
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>a. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) HD patients included in the sample for analysis, if first monthly Hgb is &lt; 11 g/dL (110 g/L) for at least one of the study months or if prescribed epoetin at any time during the study period regardless of Hgb. </SPAN
></DD>

<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>b. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) PD patients included in the sample for analysis, if first monthly Hgb is &lt; 11 g/dL (110 g/L) for at least one of the two-month periods during the six-month study period or if prescribed epoetin at any time during the study period regardless of Hgb. </SPAN
></DD>

</dl>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>12.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  Anemia Management CPM IIb:  Maintenance of Iron Stores-Target. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 6B: Target Iron Level (Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>To achieve and maintain target Hgb of 11-12 g/dL (110-120 g/L) , sufficient iron should be administered to maintain a transferri</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>n 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>saturation of </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20%, and a serum ferritin concentration of </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>100 ng/mL</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<dl>
<DT style="list-style-type:none; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>a. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of HD patients in the denominator with at least one documented transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% and at least one documented serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL during a three-month period. </SPAN
></DD>

<DT style="list-style-type:none; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>b. </SPAN
></DT>
<DD style="list-style-type:none; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of PD patients in the denominator with at least one documented transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 20% and at least on</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>e 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>documented serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 100 ng/mL during the six-month study period</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>[Note: Not directly comparable to Numerator “a”, but most feasible given probable frequency of visits for PD patients.</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>] 
</SPAN
></DD>

</dl>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
</DIV>
<dl>
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>a. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) HD patients included in sample, if first monthly Hgb is &lt; 11 g/dL (110 g/L) for at least one of the study months or if prescribed epoetin at any time during the study period regardless of Hgb. </SPAN
></DD>

<DT style="list-style-type:none; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>b. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:16px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) PD patients included in sample, if first monthly Hgb is &lt; 11 g/dL (110 g/L) for at least one of the two-month periods during the six-month study period or if prescribed epoetin at any time during the study period regardless of Hgb. </SPAN
></DD>

</dl>
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:12pt; color:#000000"
>13.</SPAN
><SPAN style="font-size:12pt; color:#000000"
>  Anemia Management CPM III:  Administration of Supplemental Iron. </SPAN
></P>
<P style="text-align:left; margin-bottom:8px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 8A: Administration of Supplemental Iron (Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Supplemental iron should be administered to prevent iron deficiency and to maintain adequate iron stores so that chronic rena</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>l 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>failure patients can achieve and maintain a Hgb of 11 to 12 g/dL (110-120 g/L) in conjunction with epoetin therapy</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 8C: Administration of Supplemental Iron (Evidence/Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The adult pre-dialysis, home hemodialysis, and peritoneal dialysis patient may not be able to maintain adequate iron status wit</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>h 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>oral iron.Therefore, 500 to 1000 mg of iron dextran may be administered intravenously in a single infusion, and repeated as needed</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>, 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>after an initial one-time test dose of 25 mg</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 8D: Administration of Supplemental Iron (Opinion/Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>A trial of oral iron is acceptable in the hemodialysis patient, but is unlikely to maintain the transferrin saturation &gt; 20%, serum ferriti</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>n 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>concentration &gt; 100 ng/mL, and Hgb at 11-12 g/dL (110-120 g/L)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 8G: Administration of Supplemental Iron (Opinion/Evidence)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Most patients will achieve a Hgb 11 to 12 g/dL (110-120 g/L) with transferrin saturation and serum ferritin concentration  &lt; 50% an</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>d 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>&lt; 800 ng/mL, respectively. In patients in whom transferrin saturation is </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 50% and/or serum ferritin concentration is </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 800 ng/mL</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>, 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>intravenous iron should be withheld for up to three months, at which time the iron parameters should be re-measured befor</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>e 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>intravenous iron is resumed.When the transferrin saturation and serum ferritin concentration have fallen to &lt; 50% and &lt; 800 ng/mL</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>, 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>respectively, intravenous iron can be resumed at a dose reduced by one-third to one-half</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Anemia Management Guideline 8H: Administration of Supplemental Iron (Opinion)</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>It is anticipated that once optimal hematocrit/hemoglobin and iron stores are achieved, the required maintenance dose of intrave</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
></SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>nous iron may vary from 25 to 100 mg/week for hemodialysis patients. The goal is to provide a weekly dose of intravenous iron i</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>n 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>hemodialysis patients that will allow the patient to maintain the target hematocrit/hemoglobin at a safe and stable iron level. Th</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>e 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>maintenance iron status should be monitored by measuring the transferrin saturation and serum ferritin concentration every thre</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>e 
</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>months</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Numerator: </SPAN
></P>
</DIV>
<dl>
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>a. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of HD patients in the denominator prescribed intravenous iron in at least one of the study months. </SPAN
></DD>

<DT style="list-style-type:none; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>b. </SPAN
></DT>
<DD style="list-style-type:none; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>The number of PD patients in denominator prescribed intravenous iron in at least one of the two-month periods during the six-month study period </SPAN
></DD>

</dl>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:15px">
<SPAN style="font-size:9.5pt; color:#000000"
>Denominator: </SPAN
></P>
</DIV>
<dl>
<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>a. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) HD patients included in the sample for analysis if first monthly Hgb &lt; 11 g/dL (110 g/L) for at least one month out of a three-month period or prescribed epoetin at any time during the study period regardless of  Hgb level, with at least one transferrin saturation &lt; 20% or at least one serum ferritin concentration &lt; 100 ng/mL.  EXCLUDE patients with mean transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 50% or mean serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 800 ng/mL and EXCLUDE patients in first three months of dialysis and prescribed oral iron. </SPAN
></DD>

<DT style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>b. </SPAN
></DT>
<DD style="list-style-type:none; margin-bottom:0px; margin-right:0px; margin-left:0px; text-indent:0px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>All adult (</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 18 years old) PD patients included in the sample for analysis if the first Hgb in a two-month period &lt; 11 g/dL (110 g/L) for at least one of the two-month periods during the six-month study period or prescribed epoetin at any time during the study period regardless of Hgb level, with at least one transferrin saturation &lt; 20% or at least one serum ferritin concentration &lt; 100 ng/ mL.  EXCLUDE patients with mean transferrin saturation </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 50% or mean serum ferritin concentration </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000; text-decoration:underline"
>&gt;</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
> 800 ng/mL and EXCLUDE patients in first three months of dialysis and prescribed oral iron. </SPAN
></DD>

</dl>
<IMG width=680 height=919 style="display:block; float:none; text-align:center; margin-bottom:9px" src="images/ESRDCPMYear2007Report_img_15.jpg">
<DIV class="Sect">
<P style="margin-bottom:0px">
<SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style=" font-weight:normal"
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 820 (Rev 2/8/06) </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 820 (Rev 2/8/06) </SPAN
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 820 (Rev 2/8/06) </SPAN
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 820 (Rev 2/8/06) </SPAN
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 820 (Rev 2/8/06) </SPAN
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 820 (Rev 2/8/06) </SPAN
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 821 (Rev 2/8/06) </SPAN
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 821 (Rev 2/8/06) </SPAN
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 821 (Rev 2/8/06) </SPAN
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 821 (Rev 2/8/06) </SPAN
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 821 (Rev 2/8/06) </SPAN
></SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:7pt; font-weight:normal; color:#000000"
>CMS - 821 (Rev 2/8/06) </SPAN
></P>
</DIV>
<IMG width=680 height=852 style="display:block; float:none; text-align:center; margin-bottom:0px" src="images/ESRDCPMYear2007Report_img_16.jpg">
<IMG width=696 height=728 style="display:block; float:none; text-align:center; margin-bottom:231px" src="images/ESRDCPMYear2007Report_img_17.jpg">
<IMG width=671 height=936 style="display:block; float:none; text-align:center; margin-bottom:13px" src="images/ESRDCPMYear2007Report_img_18.jpg">
<IMG width=695 height=917 style="display:block; float:none; text-align:center; margin-bottom:42px" src="images/ESRDCPMYear2007Report_img_19.jpg">
<IMG width=691 height=933 style="display:block; float:none; text-align:center; margin-bottom:15px" src="images/ESRDCPMYear2007Report_img_20.jpg">
<IMG width=679 height=909 style="display:block; float:none; text-align:center; margin-bottom:15px" src="images/ESRDCPMYear2007Report_img_21.jpg">
<IMG width=693 height=856 style="display:block; float:none; text-align:center; margin-bottom:103px" src="images/ESRDCPMYear2007Report_img_22.jpg">
<IMG width=669 height=913 style="display:block; float:none; text-align:center; margin-bottom:39px" src="images/ESRDCPMYear2007Report_img_23.jpg">
<IMG width=671 height=913 style="display:block; float:none; text-align:center; margin-bottom:35px" src="images/ESRDCPMYear2007Report_img_24.jpg">
<IMG width=671 height=908 style="display:block; float:none; text-align:center; margin-bottom:41px" src="images/ESRDCPMYear2007Report_img_25.jpg">
<IMG width=695 height=920 style="display:block; float:none; text-align:center; margin-bottom:39px" src="images/ESRDCPMYear2007Report_img_26.jpg">
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>APPENDIX 5 </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:11.4pt; color:#211D1E"
>2007 NATIONAL CPM DATA COLLECTION – NATIONAL AND NETWORK PROFILES</SPAN
></P>
<P style="text-align:left; margin-bottom:8px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:11.4pt; color:#211D1E"
>for Adult (aged </SPAN
><SPAN style="font-size:11.4pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:11.4pt; color:#211D1E"
> 18 years)  In-Center Hemodialysis Patients </SPAN
></P>
<TABLE style="text-align:left; margin-bottom:12px">
<TR>
<TH style="vertical-align:bottom; width:156px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>Network </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>4 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>5 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>6 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>7 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>8 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>9 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>10 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>11 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:43px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>12 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:38px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>13 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>14 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>15 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:38px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>16 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>17 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>18 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>U.S. </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:156px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
># Patients in sample </SPAN
></TH>
<TD style="text-align:center; width:39px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>484 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>486 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>487 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>485 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>488 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>490 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>483 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>488 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>484 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>479 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>481 </SPAN
></TD>
<TD style="text-align:center; width:43px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>476 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>487 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>485 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>487 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>480 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>495 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>495 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:18px; border-style:solid; border-color:#000000; border-width:2px 1px 2px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>8740 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:156px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
># Facilities in sample </SPAN
></TH>
<TD style="text-align:center; width:39px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>138 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>178 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>130 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>196 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>219 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>295 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>212 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>224 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>243 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>154 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>236 </SPAN
></TD>
<TD style="text-align:center; width:43px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>188 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>200 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>266 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>177 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>117 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>147 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>198 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:17px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>3518 </SPAN
></TD>
</TR>
</TABLE>
<P style="margin-bottom:8px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>DIALYSIS ADEQUACY</SPAN
></P>
<TABLE style="text-align:left; margin-bottom:12px">
<TR>
<TH style="vertical-align:middle; width:158px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with mean singlesession spKt/V </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
> 1.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:38px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>95 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>92 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:42px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:38px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>95 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>87 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>87 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:47px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>90 </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:30px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>Median spKt/V </SPAN
></TH>
<TD style="text-align:center; width:38px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.56 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.55 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.56 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.58 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.52 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.54 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.54 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.53 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.57 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.59 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.53 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.53 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.49 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.62 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.57 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.58 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.50 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>1.53 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>1.55 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with meanURR </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
> 65% </SPAN
></TH>
<TD style="text-align:center; width:38px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>87 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>86 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>85 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>87 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>85 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>85 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>84 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>87 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:30px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>Median URR % </SPAN
></TH>
<TD style="text-align:center; width:38px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>74 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>74 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>74 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>74 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>74 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>74 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>73 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>Median dialysis sessionlength (min) </SPAN
></TH>
<TD style="text-align:center; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>210 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>210 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>211 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>225 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>210 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>216 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>210 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>220 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>225 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>215 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>210 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>215 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>216 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>233 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>215 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>229 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>198 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>196 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>213 </SPAN
></TD>
</TR>
</TABLE>
<P style="margin-bottom:12px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>VASCULAR ACCESS</SPAN
></P>
</DIV>
<TABLE style="text-align:right; margin-bottom:7px">
<TR>
<TH style="vertical-align:middle; width:157px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Prevalent Ptswith AVF^ </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:38px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>57 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>47 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>44 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>43 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>38 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>41 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>44 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>42 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>44 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>42 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>40 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:42px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>45 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:38px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>36 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>42 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>55 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>61 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>53 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>51 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:42px; height:45px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>45 </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:157px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Incident Ptswith AVF </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>54 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>43 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>38 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>34 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>38 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>32 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>40 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>47 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>52 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>29 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>34 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:42px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>36 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>36 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>44 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>43 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>56 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>43 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>42 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:42px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>41 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:157px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Prevalent Ptswith Graft with AVF </SPAN
></TH>
<TD style="text-align:center; width:38px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:40px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:40px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:41px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:39px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>2 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:41px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:39px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:41px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:40px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:42px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:38px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:41px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:39px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:41px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>* </SPAN
></TD>
<TD style="text-align:center; width:40px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:50px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>2 </SPAN
></TD>
</TR>
<TR>
<TH style="width:157px; height:44px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Prevalent Pts withGraft without AVF </SPAN
></TH>
<TD style="text-align:center; width:38px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>15 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>25 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>20 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>23 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>29 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>30 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>22 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>31 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>22 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>24 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>23 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>21 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>32 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>13 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>15 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>22 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:44px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>24 </SPAN
></TD>
</TR>
<TR>
<TH style="width:157px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with AVG andstenosis monitoring </SPAN
></TH>
<TD style="text-align:center; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>58 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>55 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>66 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>77 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>57 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>61 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>70 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>71 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>60 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>63 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>99 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>78 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>77 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>70 </SPAN
></TD>
</TR>
<TR>
<TH style="width:157px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Prevalent Ptswith catheter </SPAN
></TH>
<TD style="text-align:center; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>27 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>27 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>35 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>32 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>30 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>33 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>25 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>32 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>33 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>35 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>32 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>36 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>24 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>30 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>22 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>23 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>20 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>29 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:157px; height:44px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Prevalent Pts withcatheter </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
> 90 days </SPAN
></TH>
<TD style="text-align:center; width:38px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>20 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>20 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>23 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>20 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>17 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>24 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>25 </SPAN
></TD>
<TD style="text-align:center; width:38px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>29 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>18 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>23 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>16 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>17 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>18 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:44px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>22 </SPAN
></TD>
</TR>
</TABLE>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>Value suppressed because n &lt; 1</SPAN
><SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>1
</SPAN
><SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>*^ CMS has set a goal to have </SPAN
><SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
> 66% of prevalent hemodialysis patients using an AV Fistula as their access by the year 2010</SPAN
><SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>. 
</SPAN
></P>
</DIV>
<DIV class="Sect">
<P style="margin-bottom:0px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>APPENDIX 5 </SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:11.4pt; color:#211D1E"
>2007 NATIONAL CPM DATA COLLECTION – NATIONAL AND NETWORK PROFILES (CONT.)</SPAN
></P>
<P style="margin-bottom:8px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:11.4pt; color:#211D1E"
>for Adult (aged </SPAN
><SPAN style="font-size:11.4pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:11.4pt; color:#211D1E"
> 18 years)  In-Center Hemodialysis Patients </SPAN
></P>
<TABLE style="text-align:left; margin-bottom:9px">
<TR>
<TH style="vertical-align:middle; width:156px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>Network </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:42px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>4 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:38px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>5 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:42px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>6 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>7 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:42px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>8 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:38px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>9 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>10 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>11 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:42px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>12 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:38px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>13 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>14 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>15 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:38px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>16 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>17 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>18 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>U.S. </SPAN
></TH>
</TR>
</TABLE>
<P style="margin-bottom:16px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>ANEMIA MANAGEMENT</SPAN
></P>
<TABLE style="text-align:left; margin-bottom:4px">
<TR>
<TH style="vertical-align:middle; width:157px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>Median Hgb (g/dL) </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>11.9 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.0 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.0 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.0 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.0 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>11.9 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>11.9 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.0 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:42px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>11.9 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:38px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.0 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>12.1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:29px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>12.1 </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:157px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with meanHgb </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
> 11 g/dL </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>84 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>84 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>79 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>81 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>85 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:42px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>81 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>86 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>86 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>87 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>85 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>85 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>84 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:157px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts^ withmean Hgb 11-12.0 </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>36 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>32 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>34 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>34 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>32 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>31 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>30 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>33 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>38 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>31 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>35 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:42px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>35 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>33 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>33 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>33 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>35 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>33 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>30 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>33 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:157px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with meanHgb &lt; 10 g/dL </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>7 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>7 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>7 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:42px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:45px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>5 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:justify; margin-bottom:12px; margin-right:58px; line-height:10px">
<SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>^ Excludes pts. with mean Hgb &gt; 12 g/dL (120 g/L) who are not prescribed ESA at anytime during the study period.</SPAN
><SPAN style="font-size:6.1pt; font-weight:normal; color:#211D1E"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10. </SPAN
></P>
<P style="text-align:justify; margin-bottom:16px; margin-left:394px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>IRON MANAGEMENT</SPAN
></P>
</DIV>
<TABLE style="margin-bottom:0px">
<TR>
<TH style="vertical-align:middle; width:158px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with meanTSAT </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
> 20% </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>80 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>79 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>76 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>78 </SPAN
></TH>
<TH style="text-align:right; vertical-align:bottom; width:39px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>80 </SPAN
></TH>
<TH style="text-align:right; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TH>
<TH style="text-align:right; vertical-align:bottom; width:41px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>78 </SPAN
></TH>
<TH style="text-align:right; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>78 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>78 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>79 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TH>
<TH style="text-align:right; vertical-align:bottom; width:39px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>81 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>77 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>74 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>78 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>79 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:42px; height:42px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>79 </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:33px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>Median TSAT % </SPAN
></TH>
<TD style="text-align:center; width:39px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>27 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:right; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>27 </SPAN
></TD>
<TD style="text-align:right; width:41px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>25 </SPAN
></TD>
<TD style="text-align:right; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>25 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>25 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>27 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>24 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>26 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:33px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>27 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:33px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>26 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:44px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with meanFerritin </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
> 100 ng/mL </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>95 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>95 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>94 </SPAN
></TD>
<TD style="text-align:right; vertical-align:bottom; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>94 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>93 </SPAN
></TD>
<TD style="text-align:right; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>93 </SPAN
></TD>
<TD style="text-align:right; vertical-align:bottom; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>95 </SPAN
></TD>
<TD style="text-align:right; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>95 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>96 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>96 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>96 </SPAN
></TD>
<TD style="text-align:right; vertical-align:bottom; width:39px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>96 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>97 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>93 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>93 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>94 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:44px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>96 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:42px; height:44px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>95 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:28px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>Median ferritin ng/mL </SPAN
></TH>
<TD style="text-align:center; width:39px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>534 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>466 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>523 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>538 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>529 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>539 </SPAN
></TD>
<TD style="text-align:right; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>530 </SPAN
></TD>
<TD style="text-align:right; width:41px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>476 </SPAN
></TD>
<TD style="text-align:right; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>536 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>493 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>481 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>500 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>556 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>520 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>476 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>445 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>536 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:28px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>564 </SPAN
></TD>
<TD style="text-align:center; width:42px; height:28px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>529 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts prescribedIV Iron </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>68 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>65 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>71 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>71 </SPAN
></TD>
<TD style="text-align:right; vertical-align:bottom; width:39px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>63 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>69 </SPAN
></TD>
<TD style="text-align:right; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>69 </SPAN
></TD>
<TD style="text-align:right; vertical-align:bottom; width:41px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:right; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>75 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:right; vertical-align:bottom; width:39px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>73 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>65 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>72 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>64 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>68 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:42px; height:49px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>70 </SPAN
></TD>
</TR>
</TABLE>
<DIV class="Sect">
<P style="text-align:left; margin-bottom:0px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>APPENDIX 5</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:11.4pt; color:#211D1E"
>2007 NATIONAL CPM DATA COLLECTION – NATIONAL AND NETWORK PROFILES (cont.)</SPAN
></P>
<P style="text-align:left; margin-bottom:8px">
<SPAN style="font-family:'serif', 'Times', serif; font-size:11.4pt; color:#211D1E"
>for Adult (aged </SPAN
><SPAN style="font-size:11.4pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-family:'serif', 'Times', serif; font-size:11.4pt; color:#211D1E"
> 18 years)  In-Center Hemodialysis Patients </SPAN
></P>
<TABLE style="text-align:left; margin-bottom:9px">
<TR>
<TH style="vertical-align:middle; width:156px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>Network </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:42px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>4 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:38px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>5 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:42px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>6 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>7 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:42px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>8 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>9 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>10 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>11 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:42px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>12 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:38px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>13 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>14 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>15 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:38px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>16 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>17 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>18 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>U.S. </SPAN
></TH>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:16px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>ALBUMIN </SPAN
></P>
<TABLE style="text-align:left; margin-bottom:4px">
<TR>
<TH style="vertical-align:middle; width:158px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with meanserum alb </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
> 4.0/3.7g/dL (BCG/BCP)^^ </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:38px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>31 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>34 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>30 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>30 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>36 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>34 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>34 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>31 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>31 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>37 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>29 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:42px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>27 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:38px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>34 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:41px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>34 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>36 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>34 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>40 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:39px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>40 </SPAN
></TH>
<TH style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:2px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>34 </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with meanserum alb </SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>≥</SPAN
><SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
> 3.5/3.2g/dL (BCG/BCP)^^ </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>79 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>77 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>80 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>78 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>77 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>86 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>75 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:42px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>76 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>80 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>86 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>81 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>84 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:60px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>81 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>Median serumBCG albumin (g/dL) </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:42px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>3.8 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>Median serumBCP albumin (g/dL) </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.3 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.7 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.7 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:42px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.3 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:38px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.9 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:41px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:39px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>3.6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:bottom; width:40px; height:43px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>3.5 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>^^ BCG/BCP - Bromcresol Green/Bromcresol Purple Laboratory Methods</SPAN
></P>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>Value suppressed because n &lt; 1</SPAN
><SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>1
</SPAN
><SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>*Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>. 
</SPAN
></P>
</DIV>
<P style="text-align:left; margin-bottom:16px; margin-left:429px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>CALCIUM </SPAN
></P>
<DIV class="Sect">
<TABLE style="margin-bottom:14px">
<TR>
<TH style="vertical-align:middle; width:158px; height:30px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>Median Calcium </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.3 </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.4 </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.4 </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.4 </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:41px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.3 </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.2 </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:39px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>9.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:30px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>9.3 </SPAN
></TH>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with adjustedcalcium 8.4 - 10.2 (mg/dL) </SPAN
></TH>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>84 </SPAN
></TD>
<TD style="text-align:right; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>85 </SPAN
></TD>
<TD style="text-align:right; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>84 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>86 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>84 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>80 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>81 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>85 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>85 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>83 </SPAN
></TD>
</TR>
<TR>
<TH style="vertical-align:middle; width:158px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with monthlycalcium reported </SPAN
></TH>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>93 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>87 </SPAN
></TD>
<TD style="text-align:right; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:right; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>90 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>92 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>86 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>92 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>89 </SPAN
></TD>
</TR>
</TABLE>
<P style="margin-bottom:16px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>PHOSPHORUS </SPAN
></P>
<TABLE style="text-align:right; margin-bottom:4px">
<TR>
<TH style="width:162px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>MedianPhosphorus </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:35px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.0 </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:39px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.4 </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:39px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.4 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.1 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.1 </SPAN
></TH>
<TH style="text-align:right; vertical-align:middle; width:39px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.4 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:39px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.4 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.2 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.3 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:40px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>5.4 </SPAN
></TH>
<TH style="text-align:center; vertical-align:middle; width:41px; height:48px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>5.2 </SPAN
></TH>
</TR>
<TR>
<TH style="width:162px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with mean phosphorus3.5 - 5.5 (mg/dL) </SPAN
></TH>
<TD style="text-align:center; width:35px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>55 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>52 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>49 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>58 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>51 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>51 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>53 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>48 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>53 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>52 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>57 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>56 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>52 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>48 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>51 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>54 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>52 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:46px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>50 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:46px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>52 </SPAN
></TD>
</TR>
<TR>
<TH style="width:162px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>% Pts with monthlyphosphorus reported </SPAN
></TH>
<TD style="text-align:center; width:35px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>92 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>87 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>82 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>83 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>90 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>89 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TD>
<TD style="text-align:right; width:39px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>92 </SPAN
></TD>
<TD style="text-align:center; width:39px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>88 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>87 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>90 </SPAN
></TD>
<TD style="text-align:center; width:40px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#211D1E"
>91 </SPAN
></TD>
<TD style="text-align:center; width:41px; height:42px; border-style:solid; border-color:#000000; border-width:1px 1px 5px 1px">
<SPAN style="font-size:9.5pt; color:#211D1E"
>89 </SPAN
></TD>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; margin-left:373px; line-height:11px">
<SPAN style="font-size:6.6pt; font-weight:normal; color:#211D1E"
>Note: To convert calcium conventional units of mg/dL to SI units (mg/L), multiply by 10.Note: To convert phosphorus conventional units of mg/dL to SI units (mg/L), multiply by 10. </SPAN
></P>
</DIV>
<P style="text-align:justify; margin-bottom:4px; margin-left:8px; line-height:16px">
<SPAN style="font-size:10pt; color:#000000"
>Appendix 6. 2007 ESRD Outcome Comparison Tool —Adult In-Center Hemodialysis Patients — National Data are from October - December  2006 </SPAN
></P>
<P style="text-align:justify; margin-bottom:12px; margin-right:5px; margin-left:7px; line-height:15px">
<SPAN style="font-size:9.5pt; font-weight:normal; color:#000000"
>Enter your Network data from Appendix 5 and use this tool to document and compare your facility outcomes to the national data and your Network data. </SPAN
></P>
<TABLE style="margin-bottom:5px">
<TR>
<TD style="vertical-align:top; width:433px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; width:95px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>U.S.</SPAN
></TD>
<TD style="text-align:center; width:97px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>     Network  </SPAN
></TD>
<TD style="text-align:center; width:94px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>Facility </SPAN
></TD>
</TR>
<TR>
<TD style="width:433px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>ADEQUACY OF DIALYSIS </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:95px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:97px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with a mean spKt/V &gt; 1.2 </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>90% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD spKt/V </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>1.55 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.27 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD dialysis session length (minutes) </SPAN
></TD>
<TD style="text-align:center; width:95px; height:23px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>217 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 32 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:23px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD URR (%) </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>72.0 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 7</SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:20px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
> VASCULAR ACCESS </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:95px; height:20px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:97px; height:20px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:20px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of prevalent patients dialyzed with an AV fistula^ </SPAN
></TD>
<TD style="text-align:center; width:95px; height:22px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>45% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of incident patients dialyzed with an AV fistula </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>41% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of prevalent patients dialyzed with an AV Graft^^ </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>26% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of prevalent patients dialyzed with a catheter </SPAN
></TD>
<TD style="text-align:center; width:95px; height:22px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>29% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of prevalent patients dialyzed with a catheter </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 90 days </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>22% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>ANEMIA MANAGEMENT </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean Hgb &gt; 11.0 g/dL </SPAN
></TD>
<TD style="text-align:center; width:95px; height:22px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>84% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients^^^ with mean Hgb 11.0 – 12.0 g/dL </SPAN
></TD>
<TD style="text-align:center; width:95px; height:22px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>33% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean Hgb &lt; 10.0 g/dL </SPAN
></TD>
<TD style="text-align:center; width:95px; height:22px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>5% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD Hgb (g/dL) </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>12.0 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 1.2 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean TSAT &gt; 20% </SPAN
></TD>
<TD style="text-align:center; width:95px; height:23px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>79% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:23px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="vertical-align:top; width:433px; height:20px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD TSAT (%) </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:95px; height:20px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>28 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 11.2 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:20px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:20px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean serum ferritin concentration &gt; 100 ng/mL </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>95% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD serum ferritin concentration (ng/mL) </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>583 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 387 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients prescribed IV iron </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>70%</SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
> SERUM ALBUMIN </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:95px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:97px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean serum albumin &gt; 4.0/3.7 g/dL (BCG/BCP) </SPAN
></TD>
<TD style="text-align:center; width:95px; height:23px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>34% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:23px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean serum albumin &gt; 3.5/3.2 g/dL (BCG/BCP) </SPAN
></TD>
<TD style="text-align:center; width:95px; height:22px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>81% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD serum albumin (g/dL)</SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:20px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> BCG </SPAN
></TD>
<TD style="text-align:center; width:95px; height:20px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>3.8 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.4</SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:20px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:20px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> BCP </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>3.5 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>CALCIUM </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:95px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:97px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with adjusted calcium 8.4 – 10.2 mg/dL </SPAN
></TD>
<TD style="text-align:center; width:95px; height:23px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>83% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:23px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:23px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:20px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with monthly calcium reported </SPAN
></TD>
<TD style="text-align:center; width:95px; height:20px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>89% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:20px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:20px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:20px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD calcium (mg/dL) </SPAN
></TD>
<TD style="text-align:center; width:95px; height:20px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>9.2 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.7 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:20px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:20px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>PHOSPHORUS </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:95px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:97px; height:22px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:22px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean phosphorus 3.5 – 5.5 mg/dL </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>52% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with monthly phosphorus reported </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>89% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TD style="width:433px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD phosphorus (mg/dL) </SPAN
></TD>
<TD style="text-align:center; width:95px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>5.4 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 1.5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:97px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; vertical-align:top; width:94px; height:21px; border-style:solid; border-color:#000000; border-width:1px 1px 1px 1px"/>
</TR>
</TABLE>
<P style="text-align:left; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^ CMS has set a goal to have </SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 66% of prevalent hemodialysis patients using an AV Fistula as their access by the year 2010</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^ Includes grafts with and without AVF</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^^ Excludes pts. with mean Hgb &gt; 12 g/dL (120 g/L) who are not prescribed ESA at anytime during the study period</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert calcium conventional units of mg/dL to SI units (mg/L), multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert phosphorus conventional units of mg/dL to SI units (mg/L), multiply by 10</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>. 
</SPAN
></P>
<P style="text-align:justify; margin-bottom:8px; margin-left:8px; line-height:16px">
<SPAN style="font-size:10pt; color:#000000"
>Appendix 7. 2007 ESRD Outcome Comparison Tool —Adult Peritoneal Dialysis Patients — National Data are from October 2006 - March 2007 </SPAN
></P>
<P style="text-align:justify; margin-bottom:40px; margin-left:8px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Use this tool to document and compare your facility outcomes to the national data.</SPAN
></P>
<TABLE style="margin-bottom:12px">
<TR>
<TH colspan=2 style="width:582px; height:14px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>              U.S.</SPAN
></TH>
<TH style="text-align:center; width:83px; height:14px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>            Facility </SPAN
></TH>
</TR>
<TR>
<TH colspan=2 style="vertical-align:bottom; width:582px; height:22px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>ADEQUACY OF DIALYSIS^ </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:83px; height:22px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH colspan=2 style="vertical-align:middle; width:582px; height:26px; border-style: solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients measured for adequacy at least once during the six month </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:83px; height:26px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:bottom; width:447px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>study period (both weekly Kt/V and weekly creatinine clearance measured) </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:135px; height:16px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>84% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:16px"/>
</TR>
<TR>
<TH style="width:447px; height:6px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:5.1pt; font-weight:normal; color:#000000"
>urea</SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:135px; height:6px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; vertical-align:top; width:83px; height:6px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:bottom; width:447px; height:17px; border-style: solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of peritoneal dialysis patients with mean weekly Kt/V</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 1.7 </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:135px; height:17px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>85% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:17px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="width:447px; height:6px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:5.1pt; font-weight:normal; color:#000000"
>urea </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:135px; height:6px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; vertical-align:top; width:83px; height:6px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:bottom; width:447px; height:17px; border-style: solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD weekly Kt/V for CAPD patients </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:135px; height:17px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2.31 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.65 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:17px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="width:447px; height:8px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:5.1pt; font-weight:normal; color:#000000"
>urea</SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:135px; height:8px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; vertical-align:top; width:83px; height:8px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:bottom; width:447px; height:15px; border-style: solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD weekly Kt/V for Cycler patients^^ </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:135px; height:15px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2.22 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.64 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:15px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="width:447px; height:7px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:5.1pt; font-weight:normal; color:#000000"
>urea</SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:135px; height:7px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; vertical-align:top; width:83px; height:7px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:bottom; width:447px; height:16px; border-style: solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD weekly Kt/V for all peritoneal dialysis patients </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:135px; height:16px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>2.24 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.64 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:16px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="width:447px; height:6px; border-style: none none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:5.1pt; font-weight:normal; color:#000000"
>urea</SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:135px; height:6px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; vertical-align:top; width:83px; height:6px; border-style: border-style:none none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>ANEMIA MANAGEMENT </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean Hgb </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 11.0 g/dL </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>82% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients^^^ with mean Hgb 11.0 - 12.0 g/dL </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>35% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean Hgb &lt; 10.0 g/dL </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>6% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD Hgb (g/dL) </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>12.0 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 1.3 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean TSAT </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 20% </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>85% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD TSAT (%) </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>30 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 11 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean serum ferritin concentration </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 100 ng/mL </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>90% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD serum ferritin concentration (ng/mL) </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>477 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 398 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:24px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients prescribed IV iron </SPAN
></TH>
<TD style="text-align:center; width:135px; height:24px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>29% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:24px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:21px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>SERUM ALBUMIN </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:135px; height:21px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; vertical-align:top; width:83px; height:21px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:21px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean serum albumin </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 4.0/3.7 g/dL (BCG/BCP) </SPAN
></TH>
<TD style="text-align:center; width:135px; height:21px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>19% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:21px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean serum albumin </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 3.5/3.2 g/dL (BCG/BCP) </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>63% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD Serum Albumin (g/dL) BCG </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>3.6 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.5 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD Serum Albumin (g/dL) BCP </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>3.3 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.6 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:24px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>CALCIUM </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:135px; height:24px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; vertical-align:top; width:83px; height:24px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with adjusted calcium 8.4 - 10.2 mg/dL </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>79% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with monthly calcium reported </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>84% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:22px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD calcium (mg/dL) </SPAN
></TH>
<TD style="text-align:center; width:135px; height:22px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>9.4 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 0.8 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:22px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; color:#000000"
>PHOSPHORUS </SPAN
></TH>
<TD style="text-align:center; vertical-align:top; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with mean phosphorus 3.5 - 5.5 mg/dL </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>56% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:middle; width:447px; height:23px; border-style: solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Percent of patients with monthly phosphorus reported </SPAN
></TH>
<TD style="text-align:center; width:135px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>83% </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:23px; border-style: border-style:solid none solid none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
<TR>
<TH style="vertical-align:bottom; width:447px; height:17px; border-style: solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>Mean </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> SD phosphorus (mg/dL) </SPAN
></TH>
<TD style="text-align:center; vertical-align:bottom; width:135px; height:17px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px">
<SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>5.2 </SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
>±</SPAN
><SPAN style="font-size:9pt; font-weight:normal; color:#000000"
> 1.4 </SPAN
></TD>
<TD style="text-align:center; vertical-align:top; width:83px; height:17px; border-style: border-style:solid none none none; border-color: #000000; border-width:1px 1px 1px 1px"/>
</TR>
</TABLE>
<P style="margin-bottom:-5px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^ Using the 2006 KDOQI guidelines and recommendations (29): For peritoneal dialysis patients with and without renal kidney function: weekly KtV</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>≥</SPAN
><SPAN style="font-size:7pt; font-weight:normal; color:#000000"
> 1.7. </SPAN
></P>
<DIV class="Sect">
<P style="text-align:; margin-bottom:0px; margin-right:27px; margin-left:617px">
<SPAN style="font-size:4.1pt; font-weight:normal; color:#000000"
>urea </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^ For the Oct 2006-Mar 2007 collection, CCPD and NIPD were not distinguishable. </SPAN
></P>
</DIV>
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>^^^ Excludes pts. with mean Hgb &gt; 12 g/dL (120 g/L) who are not prescribed ESA at anytime during the study period. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert hemoglobin conventional units of g/dL to SI units (g/L), multiply by 10. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert serum albumin conventional units of g/dL to SI units (g/L), multiply by 10. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert calcium conventional units of mg/dL to SI units (mg/L), multiply by 10. </SPAN
></P>
<P style="text-align:justify; margin-bottom:0px; line-height:12px">
<SPAN style="font-size:7pt; font-weight:normal; color:#000000"
>Note: To convert phosphorus conventional units of mg/dL to SI units (mg/L), multiply by 10. </SPAN
></P>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
